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The biology of cells of the mononuclear phagocyte system has been studied 
extensively in the mouse.   Studies of the pig as an experimental model have 
commonly been consigned to specialist animal science journals.   This thesis 
considered some of the many ways that pigs may address the shortcomings of mice 
as models for the study of macrophage differentiation and activation in vitro, and the 
biology of sepsis and other pathologies in the living animal.    
Flow cytometry was used initially to phenotype cells from the porcine lung, 
peritoneal cavity, blood and bone marrow using the LPS receptor CD14 and the FC 
receptor CD16, markers frequently employed to differentiate human monocytes into 
subsets.   The expression of SIRP-alpha (SWC3a, CD172a), which is present on all 
cells of myeloid origin, and the haemoglobin scavenger receptor, CD163 which has 
previously been used to study monocyte differentiation in the pig was also studied.   
The findings validated previous work where blood monocytes were divided into 
subsets on the expression of CD14 and CD163.   Furthermore, like human and 
mouse, pig monocytes also exhibited variation in CD16 expression, having a subset 
which was CD14hiCD16lo and another which was CD14loCD16hi.   A whole genome 
approach was then used to study the differences between the monocyte subsets in the 
pig, using monocytes sorted into two populations based on the expression of CD14 
and CD163.  The gene expression profiles obtained were then compared to publically 
available data from monocyte subsets in human and mouse.    
This thesis also investigated the expression of genes that are known to be 
differentially expressed between human and mouse.   To do this gene expression in 
porcine bone marrow derived macrophages was analyzed across an LPS time course.   
Like human macrophages, pig macrophages did not induce nitric oxide nor any 
arginine metabolizing genes in response to LPS.   Instead they responded with robust 
induction of indoleamine 2,3-dioxygenase (IDO) and other enzymes of the 
tryptophan metabolism pathway such as kynurenine hydroxylase, kynureninase and 
tryptophan-tRNA synthetase.   The tryptophan metabolism pathway has been 
implicated in sepsis in man and the absence of this pathway in the mouse may be one 
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of the reasons why an adequate rodent model of sepsis has not been developed.    The 
IDO inhibitor 1-methyl-tryptophan (1-MT) has been used to treat mouse 
macrophages where it had a protective effect after LPS administration.   Similar 
experiments on pig macrophages did not show the same protective effect and 
induction of key immune genes was increased after treatment with 1-MT suggesting 
IDO is involved in feedback control of the immune system. 
With the completion of the genome sequence and the characterisation of many key 
regulators and markers, the pig has emerged as a tractable model of human innate 
immunity and disease that should address the limited predictive value of rodents in 
preclinical studies.   This project aimed to address the gap in our knowledge of the 
control of innate immunity in the pig and provided further evidence that the pig can 
function as an ideal model to study innate immunity.  
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Chapter 1: Introduction 
 
1.1 Macrophage biology and transcription control 
In vertebrates, the first line of defence against pathogens is the resident tissue 
macrophage.   Macrophages represent the tissue compartment of the mononuclear 
phagocyte system (MPS), which also includes blood monocytes and their bone 
marrow progenitors, as well as the closely-related myeloid dendritic cells.  They 
comprise 10-15% of the total cells in most organs of the body, and are especially 
concentrated at locations of exposure to pathogen infiltration, lining all epithelia and 
the microvasculature (Hume, 2006; Hume, 2008a; Hume et al., 2002).   
 
Macrophage activation in response to microbial products has been studied 
extensively in mouse and human systems, most recently using genome-scale 
approaches generating complex interaction networks (Ghisletti et al., 2010; Nilsson 
et al., 2006; Ramsey et al., 2010).  In each species, the activation process involves 
induction and repression of thousands of genes across an extended time course.  
Amongst the most inducible genes in macrophages responding to a microbial 
stimulus are feedback control genes that act at every conceivable level of the 
activation cascade.   These inflammation suppressor genes are highly polymorphic 
within species and inactivating mutations in many of them are known to generate a 
hyper-inflammatory phenotype (Gilchrist et al., 2008; Gilchrist et al., 2006; Nathan, 
2002; Wells et al., 2005).  Although this complex effector network has many levels 
of post-transcriptional regulation, including inducible microRNAs (miRNAs) (El 
Gazzar and McCall, 2010; Li et al., 2010; Fontana et al., 2010; Fontana et al., 2007), 
the major control point occurs at the level of transcription initiation; the point at 
which the production of individual mRNAs is switched on and off.   Accordingly, a 
detailed knowledge of transcription control in macrophages is central to 
understanding all major human and animal infectious diseases and the molecular 
basis of genetic variations in disease resistance amongst species and individuals.   A 
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number of recent studies have approached the issues of macrophage differentiation 
and activation through genome-scale network analyses (Aderem, 2005; Ramsey et 
al., 2008; Ravasi et al., 2007).   This thesis investigates the transcriptional control of 
macrophage function in the pig and its relationship to infectious disease 
susceptibility. 
 
An effective response to pathogen challenge requires the host to distinguish self from 
non-self.   This involves the recognition of pathogen-associated molecular patterns 
(PAMPS).   PAMPS are classes of molecules that are generally intrinsic and essential 
to pathogen biology (and therefore not readily modified or eliminated in response to 
selection by the host) and are not found in the host.   There are many different pattern 
recognition receptor families, including toll-like receptors (TLRs), C-type lectins, 
DExH box family members and the NACHT-domain family (Takeuchi and Akira, 
2010).   The pattern recognition receptors, as well as many of the innate immune 
effector families (e.g.  chemokines, defensins, proteases) produced by activated 
macrophages, comprise large multigene families that vary greatly even between 
mammals in terms of the numbers of members, sequences of functional orthologs, 
and pattern of expression.    
 
Comparative analysis of RNA extracted from mouse and human macrophages 
cultured under the most similar conditions possible has revealed extensive 
differences.   The array data confirmed a known difference: human macrophages do 
not induce the effector enzyme, inducible nitric oxide synthase (iNOS, NOS2), 
which generates the toxic radical nitric oxide (NO), instead inducing indoleamine 
dioxygenase (IDO) in response to LPS (Roshick et al., 2006; Thoma-Uszynski et al., 
2001).  In a direct comparison of mouse and human macrophages responding to 
lipopolysaccharide, only around 30% of definitive orthologous genes that were 
induced in one species were also induced in the other (Schroder et al., 2012).   The 
differences in gene expression between species arise in part from functional promoter 
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evolution at some level, either in the promoters of the transcription factors 
themselves, or in the promoters of their target genes, or both.   Indeed, TLRs 2, 3 and 
4 each have operative promoter differences between mouse and human (Heinz et al., 
2003).  Human macrophages express the TLR9 receptor for bacterial DNA at lower 
levels than mouse and further induction of message is not observed in response to 
interferon-gamma priming because the human promoter lacks a key binding site for 
the macrophage transcription factor, IRF8 (Schroder et al., 2007).  The hypothesis of 
this thesis was that pig macrophages are phenotypically and genotypically closer to 
human macrophages than the more commonly used mouse model systems. 
 
Phylogenetic footprinting has been used in many genome-wide comparative studies 
of mammalian promoters to highlight conserved elements (Birney et al., 2007).  In 
genes where the regulation and function is shared amongst the species and there are 
clear orthology relationships, this approach is powerful.   Resources such as the ECR 
browser and CORG (Dieterich et al., 2007; Loots and Ovcharenko, 2007) provide 
important tools in promoter annotation, in identifying candidate enhancers in the 
vicinity of genes of interest, and in producing transcriptional networks.   A 
significant part of the pilot stage of the ENCODE project (Birney et al., 2007) which 
aims to understand the control of transcription at the molecular level, focused on 
comparative sequence analysis of functional elements across multiple mammalian 
species.   This thesis further aims to highlight the value of the pig as a model for 
human macrophage biology, and also as a third species to enable an understanding of 
evolution of innate immune responses.   
 
1.2 Macrophage biology in the pig 
Pigs are the most important meat-producing livestock species world-wide.   Because 
of the intensive mode of breeding and rearing, they are highly susceptible to 
pathogen epidemics, and consequently selection of animals for increased disease 
resistance is of major economic importance.   Amongst the major pathogens that 
cause economic losses in pigs, many viral (e.g.  vesicular stomatitis virus, porcine 
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circovirus 2, swine pox virus, African swine fever (ASF), classical swine fever, 
porcine adenovirus, swine vesicular disease virus, porcine respiratory and 
reproductive syndrome (PRRS), parainfluenza) and bacterial (e.g.  Salmonella spp, 
Yersinia enterocolitica, Mycoplasma hypopneumoniae, Actinobacillus 
pleuropneumoniae) pathogens replicate within macrophages and/or profoundly alter 
macrophage gene expression.   In addition to the economic and welfare issues these 
viral and bacterial species impart on the pig, many of these pathogens are candidate 
zoonoses. 
 
Like human and mouse macrophages, pig monocytes and monocyte-derived 
macrophages detect pathogens through receptors that recognise a range of pathogen-
associated molecular patterns, including cell wall components (lipopolysaccharide, 
peptidoglycan) and nucleic acids (Raymond and Wilkie, 2005).  They respond with 
rapid changes in expression of proinflammatory cytokines and other effectors.   
Macrophage gene products are clearly required for effective innate immunity, but 
they also initiate the symptoms of infection (sickness, behaviour, weight loss etc.) 
that cause morbidity or mortality.   Studies of viral (PRRS) and bacterial 
(actinobacillus) pathogens of pigs (Ait-ali et al., 2007; Moser et al., 2008) suggest 
that variation in disease susceptibility or pathology between breeds, or between 
individuals within a breed, is correlated with differences in macrophage activation.    
 
Despite the economic importance of the pig, and the clear relevance as a model for 
human biomedicine (Schook et al., 2005) there has not previously been an attempt to 
overview the similarities and differences between the pig, more commonly studied 
rodent models, and humans.   The publication of the pig genome and the advent of 
microarray technologies for this species mean that it is timely to examine this 
question.   This thesis examines in detail the knowledge of macrophage biology and 
the molecular basis of innate immunity and disease susceptibility in the pig, a species 
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that, unlike mice and rats, is of economic and welfare importance to humans, and 
shares many infectious challenges with us. 
 
1.3 Markers for the mononuclear phagocyte system 
The visualisation of mononuclear phagocytes in the circulation, and in tissues, 
depends upon the identification of cell surface proteins, many of them endocytic 
receptors, which are present only on these cells.   The advent of monoclonal antibody 
(mAb) technologies made it possible to identify cells bearing these proteins on their 
cell surface by immunohistochemical approaches.   Monoclonal-defined markers are 
now commonly used in rodent and human systems to identify mononuclear 
phagocytes and subsets of these cells with specialised functions or locations.   Only 
recently have such monoclonal antibodies been made explicitly for the study of pigs, 
in many cases advantage has been taken of the cross reaction of mouse monoclonal 
antibodies against human macrophage-expressed gene products (Ezquerra et al., 
2009).  Owing to the extensive functional differences between different macrophage 
populations, there are few gene products that are common to all members of the MPS 
of mouse or human.   In fact, many surface markers, such as the integrins CD11b and 
CD11c, lectin-like molecules such as sialoadhesin and macrosialin, EMR1 (F4/80), 
and certain chemokine receptors e.g.   CCR1, CCR2 and CX3CR1 are used rather 
arbitrarily to divide the MPS into putative functional subsets (Gordon and Taylor, 
2005).  However, many of the gene products that have been used to define 
macrophage identity in one species are not definitive markers of this cell type in 
other species.   For example, the F4/80 antigen, the product of the Emr1 gene which 
is a member of the EGF-TM7 family of G-protein coupled receptors, has been used 
extensively as a marker of macrophages in the mouse (Austyn and Gordon, 1981).  
There are only two members of the EMR family in mice, EMR1 and EMR4.   In 
humans four family members, EMR1-4, have been identified, although surprisingly 
EMR4 has acquired a truncation when compared to other primates (Kwakkenbos et 
al., 2004) and is now considered a pseudogene.   EMR1, 2 and 3 are all expressed in 
human monocytes (biogps.gnf.org), but have acquired specific functions in 
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granulocytes (Matmati et al., 2007).   This situation is not only true for markers; but 
for gene products that execute macrophage cell functions.   Although humans, mice 
and pigs diverged at approximately the same point in evolution (Springer et al., 2003; 
Jorgensen et al., 2005), the short generation time in rodents may have accelerated 
evolution in this species meaning that pigs and humans are closer in sequence than 
the mouse. Overall, compared to the mouse, the pig immune system has been found 
to more closely resemble human for more than 80% of parameters examined while 
mice were more similar to human than pigs for less than 10% (Schook et al., 2005).  
The extent of functional orthology between pigs, mice and humans in macrophage 
biology will be considered further throughout this chapter.    
 
One subset of mononuclear phagocytes that has been studied in detail is the so-called 
dendritic cell (DC), a cell population originally defined by its ability to present 
antigen to naive T lymphocytes.   It is not clear that this function is linked to any 
particular marker, and a growing body of opinion believes DCs are simply another 
cell of the MPS.   They can derive from the same precursor as macrophages, share 
many functions (including antigen presentation), respond to the same growth factors 
and share the same markers (Geissmann et al., 2010b; Geissmann et al., 2010a; 
Hume, 2008a; Hume, 2008b).  One factor that appears to be important for the 
production of the subset of DC found within the T cell areas of lymphoid organs is 
Flt3 ligand (Flt3L) (Li et al., 2010).   Guzylack-Piriou et al.  (Guzylack-Piriou et al., 
2010) recently characterised the pig Flt3L, and showed that, as in mice (Merad and 
Manz, 2009) expression of the receptor for this factor, Flt3, in lymphoid organs was 
restricted to interdigitating cells of T cell areas; the classical DC.   Amongst other 
candidate markers of DC from mouse or human, the C type lectin CD205 retains 
high level expression in epidermal DC (Langerhans cells) and lymphoid tissues of 
the pig (Flores-Mendoza et al., 2010).  Conversely, the integrin CD11c, which is 
often used as a marker for DC in mice despite its extensive expression in tissue and 
inflammatory macrophages (Hume, 2008a; Hume, 2008b), is expressed differently in 
pigs from humans or mice; being restricted to monocytes and absent from 
granulocytes (Ezquerra et al., 2009; Bailey, 2009). 
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1.4 Growth factors and myelopoiesis in the pig.    
Macrophages share committed progenitors with the other major mammalian 
phagocyte population, neutrophilic granulocytes (Metcalf, 2008).  Indeed, mature 
inflammatory neutrophilic granulocytes in mice and humans may retain the ability to 
convert into macrophages (Sasmono et al., 2007).  The differentiation of both cell 
types in mice is controlled by the haemopoietic growth factors, stem cell factor (SCF, 
Kit-ligand), interleukin 3 (IL3), macrophage colony-stimulating factor (CSF1), 
granulocyte macrophage colony-stimulating factor (GMCSF, CSF2) and granulocyte 
colony-stimulating factor (GCSF, CSF3) (Hume, 2006; Hume et al., 2002; Metcalf, 
2008; Sasmono et al., 2007).  Three of these factors in the pig, SCF, IL3 and GMCSF 
have been cloned and expressed, and like their human counterparts, were able to 
mobilise haemopoietic stem cells when injected into pigs and promote engraftment in 
bone marrow transplantation (Kozlowski et al., 1999).  One molecule that is 
expressed on the vast majority of mouse and human cells designated as mononuclear 
phagocytes is the receptor responsible for responding to CSF1.   The CSF1 receptor 
(CSF1R, CD115) is a type III integral member protein tyrosine kinase encoded by 
the c-fms protooncogene and displays restricted expression in mononuclear 
phagocytes and their precursors (Sasmono et al., 2003).  In the mouse, CSF1 alone is 
not sufficient for differentiation of early myeloid progenitor cells; however, it can 
function in synergy with the other haematopoietic stem cell factors to generate 
mononuclear phagocyte progenitor cells from multipotent progenitor cells.   CSF1 
synergises with GMCSF, GCSF and IL3 along with other growth factors such as 
SCF to regulate the maturation of hematopoietic progenitor cells into mature immune 
effector cells (Barton and Mayer, 1989).  CSF1 also acts with the receptor activator 
of NFκB ligand (RANKL) to regulate the generation of osteoclasts from 
mononuclear progenitors (Yao et al., 2002)  
 
CSF1 and GMCSF are both 4 helix bundle growth factors, but they have different 
tissue distribution and act through different receptor classes.   In the mouse, a Gmcsf 
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null mutant is not globally macrophage deficient (Hibbs et al., 2007), whereas both 
Csf1 and Csf1r mutants in mice or rats have severe macrophage deficiencies and 
multiple pleiotropic defects in growth and development (Gow et al., 2010; Dai et al., 
2002; Cecchini et al., 1994; Ryan et al., 2001) The major non-redundant function of 
GMCSF appears to be in the production or maintenance of macrophages and their 
function in the lung, and deficiency leads to pulmonary alveolar proteinosis (Carey 
and Trapnell, 2010; Hibbs et al., 2007).  Additionally, there are substantial 
deficiencies in resistance to a wide range of pathogens, suggesting that GMCSF is 
primarily involved in emergency production of macrophages and activation of 
several effector functions (Carey and Trapnell, 2010; Hibbs et al., 2007).  Cells 
grown in GMCSF, either from bone marrow or peripheral blood in mice or humans, 
have been widely studied as putative “immature DC” (Hume, 2008a; Hume, 2008b).  
However, the gene expression profiles of these cells does not distinguish them 
significantly from other macrophage populations (Mabbott et al., 2010).  Others have 
suggested that macrophages differentiated in the presence of GMCSF display a 
“classically activated” phenotype while those differentiated in the presence of CSF1 
have a phenotype closer to “alternatively activated” macrophages (Fleetwood et al., 
2009).  GMCSF has been used to generate monocyte derived DCs in the pig 
(Carrasco et al., 2001; Summerfield et al., 2003); the cells elicit T cell activation in 
vitro, although unlike human monocyte-derived DC, the pig “DC” retained the 
macrophage markers CD14 and CD16.    Pig GMCSF encoded within plasmid DNA 
has been used to boost antigen presenting cell activity in vaccines (Melkebeek et al., 
2008).  In mouse and human, some protocols for the generation of culture-derived 
DC also employ IL4 as an additional stimulus.   IL4 is not a prominent cytokine in 
the blood in pigs; the function apparently being replaced by the related IL13.   
GMCSF in combination with IL13 was found to generate active antigen-presenting 
cells from pig peripheral blood monocytes (Bautista et al., 2007).   
 
CSF1, and its receptor, have evolved rather rapidly across vertebrates suggesting that 
it is under immune selection (Garceau et al., 2010).  CSF1 is commonly used to 
generate bone marrow-derived macrophages (BMDMs) from the mouse, and to 
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mature peripheral blood monocytes from humans to give rise to monocyte derived 
macrophages (MDM).   Interestingly, a recently-discovered second ligand for the 
CSF1R, named Interleukin-34 (IL34) was identified in a high through-put functional 
ligand-receptor expression screen (Lin et al., 2008).  IL34 is much more conserved 
across species than CSF1.  It probably binds a different part of the CSF1 receptor 
(Garceau et al., 2010) and has quite distinct expression pattern in the mouse (Wei et 
al., 2010).      
 
The major non-redundant function of CSF1 in mice is to promote the maturation of 
peripheral blood monocytes to become the immediate precursors of resident tissue 
macrophages (Macdonald et al., 2010).  Surprisingly, there has been relatively little 
study of actions of CSF1 in the pig and until recently, CSF1 had not been widely-
studied in other species. Human CSF1 can act on all mammals tested, but human 
macrophages do not respond to the mouse ligand (Lin et al., 2008; Wei et al., 2010).  
Pig peripheral blood or bone marrow cells have been differentiated into macrophages 
in vitro using L929 conditioned media, a source of CSF1, or CSF1 purified from 
L929 conditioned media (Denham et al., 1996; Genovesi et al., 1990; Mayer, 1983).  
SIM mouse embryo fibroblasts resistant to thioguanine and oubain (STO cells), 
which express CSF1, GMCSF, IL3, SCF and leukaemia inhibitory factor, have also 
been used as a feeder layer upon which to grow porcine macrophages (Talbot et al., 
1998).  It would appear that unlike human macrophages, porcine macrophages 
respond to murine CSF1.   Our laboratory has isolated and characterised pig CSF1 
and IL34(D Gow, unpublished), and developed techniques to generate macrophages 
from bone marrow material and peripheral blood monocytes.  Factor-dependent cell 
lines expressing the pig CSF1R have also been produced, which respond to 
recombinant pig and human CSF1 and are currently producing monoclonal 
antibodies against the pig CSF1R, which is commonly used as a marker in studies of 
human monocytes (Ingersoll et al., 2010).   The receptor diverges quite rapidly 
across species, and anti-human CD115 antibodies tested thus far have not cross-
reacted with the pig.   These reagents will allow well-defined comparative studies of 
macrophage transcriptional responses and function in the pig, mouse and human 
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under comparable conditions.   Such comparisons are of particular interest because it 
is known that mice and human monocyte-macrophages respond in different ways to 
human CSF1 (Irvine et al., 2009).  The use of a third species such as the pig will help 
to identify whether such differences are due to changes in the rodent and primate 
lineages since their divergence or intrinsic differences between the rodent and 
primate immune system. 
 
1.5 Cell surface markers on porcine monocytes and 
macrophages 
The swine leukocyte consortium has tested a wide range of anti-human monoclonal 
antibodies, and antibodies generated against pig macrophages, for reactivity with pig 
macrophages.   Many human antibodies cross-react and a number of antibodies are 
commercially available (Ezquerra et al., 2009).   Of these, a useful pan-monocyte 
marker for the pig (in the absence of anti-CD115) is SWC3, which recognises the 
regulatory molecule SIRP alpha, also known as SHPS-1, the macrophage fusion 
receptor or CD172a (Alvarez et al., 2007).  Antibodies against the endosomal 
protein, CD68, have also been useful for visualising pig macrophages in tissue 
sections (Frich et al., 2006; Ackermann et al., 1994).    
 
In both humans and mice, it has become clear that peripheral blood monocytes can 
be divided into at least two functionally distinct classes (Ingersoll et al., 2010; Cros 
et al., 2010; Geissmann et al., 2010a; Geissmann et al., 2010b) and the most recent 
classifications have introduced  a third, intermediate subset of monocytes (Wong et 
al., 2011; Ziegler-Heitbrock et al., 2010).  From mouse studies, it has been inferred 
that one population, defined by expression of a surface marker shared with 
granulocytes (Ly6C) is the immediate precursor of inflammatory macrophages, 
where the other population, defined by a lack of Ly6C and expression of the 
chemokine receptor, CCR2, and high expression of another chemokine receptor, 
CX3CR1, is the precursor of most resident tissue macrophages (Geissmann et al., 
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2003).    In mice, each population makes up around 50% of the total.    Several lines 
of evidence indicate that the “resident” monocytes mature from the “inflammatory” 
Ly6C-positive monocytes (Sunderkotter et al., 2004) and, as noted above, this 
process is CSF1 dependent in vivo (Macdonald et al., 2010).  In both mouse and 
human the cDNA microarray profiles of the ”resident” monocytes support the view 
that monocyte heterogeneity reflects a maturation profile (Ancuta et al., 2009; 
Ingersoll et al., 2010; Wong et al., 2011).    
 
In humans, the key markers of monocyte maturation are the lipopolysaccharide 
receptor CD14 and the low affinity immunoglobulin Fc receptor, FCGR3, detected 
with antibodies against CD16.   The functional equivalent of mouse “resident” 
monocytes in humans appears to be those that express high CD16 and low CD14.    
By contrast to the mouse, these cells make up only around 10% of monocytic cells in 
humans (Ancuta et al., 2009; Ingersoll et al., 2010).  In mice, CD16 is present on all 
peripheral blood monocytes, albeit at different levels in the two subpopulations 
(Ingersoll et al., 2010).  The data on humans cannot be translated to other species, 
because humans have at least a duplication of the FCGR33 gene (some individuals 
have further copies), and the second gene (FCGR3B) encodes a GPI-anchored 
isoform.   In common with the mouse, most monocytes in the pig are CD16+ 
(Chamorro et al., 2005; Sanchez et al., 1999) although the levels vary significantly 
(Chapter 3).   
 
Similar to mouse and human, pig monocytes have been divided into two major 
subpopulations on the basis of marker expression, in this case CD163 (also known as 
haptoglobin scavenger receptor and p155) which is a transmembrane glycoprotein 
and member of the scavenger receptor cysteine-rich family of proteins (Sanchez et 
al., 1999).  As in mice the numbers of each monocyte subset are close to 50% of the 
total therefore it is unclear at present whether monocyte subsets in the pig can be 
directly compared to similar populations of cells in other species.  This thesis aimed 
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to address this concern by examining surface marker expression on porcine 
monocytes and differential gene expression between previously identified sub 
populations.  Previous findings on monocyte subsets in the pig are covered in more 
detail in Chapters 3 and 4. 
 
1.6 The mononuclear phagocyte system in host 
defence, the pattern recognition receptors 
Analysis of the transcriptomic response of macrophages to PAMPS in mouse and 
human has been greatly expedited in the post-genomic era (Aderem, 2005; Ramsey 
et al., 2008; Ravasi et al., 2007).  The completion of genome sequences in the pig has 
recently enabled similar approaches (Uthe et al., 2007; Wang et al., 2007) such as 
described in this thesis (Chapter 4, 5 and (Kapetanovic et al., 2012)).    
 
The best-characterised PRRs are the Toll-like receptors (TLRs), of which the 
archetype is TLR4 that functions as a receptor for LPS (Figure 1).   TLRs are type I 
trans-membrane proteins with a large extra-cellular domain containing multiple 
leucine rich repeats (LRRs), a trans-membrane domain and a cytoplasmic Toll/IL1R 
(TIR) domain.   Generally TLR1, 2, 4, 5, 6 and 10 are expressed on the cell surface 
and recognise microbial compounds although TLR4 can also be found intracellularly 
(Guillot et al., 2004; Ueta et al., 2004).  TLR3, 7, 8 and 9 are found on the 
membranes of intracellular organelles e.g.  endosomes.  These patterns are conserved 
in pigs as in other mammals (Chaung et al., 2008).  TLR4, previously named hToll, 
was the first mammalian TLR discovered and implicated in pro-inflammatory 
signalling in macrophages (Medzhitov et al., 1997).  Its role in LPS detection was 
demonstrated when C3H/HeJ mice, which are resistant to LPS, were found to have 
naturally occurring mutations in their copy of TLR4 (Poltorak et al., 1998; Qureshi et 
al., 1999).  LPS binding protein (LBP), synthesised in the liver, binds LPS then the 
LPS/LBP complex binds to CD14 which forms a complex with TLR4  (Jiang et al., 
2000).  MD2, a 160 amino acid (aa) protein, associates with the extracellular portion 
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of TLR4 and is required for LPS responsiveness (Dziarski and Gupta, 2000).  Ligand 
binding to TLRs promotes the recruitment of adaptor protein(s), MyD88 and/or TRIF 
to the highly conserved intracellular TIR domain which leads to a well-studied 
signalling cascade (Doyle and O'Neill, 2006) (Akira, 2006; Kawai and Akira, 2007; 
Takeuchi and Akira, 2010)  that ultimately leads to generation of numerous 
proinflammatory and anti-pathogen effector molecules.  Different TLRs differ in the 
ability to recruit the adaptors.  TLR signalling is MyD88 dependant with the 
exception of TLR3 which signals independently of MyD88 through TRIF, whilst 
TLR4 can signal through MyD88 or TRIF.   Most of the components of TLR 
signalling have been studied in the pig.   For example, Porcine MyD88 has a high 
degree of identity with the human protein, and its involvement in the TLR2-
dependent and TLR4/MD2 signalling pathway has been demonstrated (Tohno et al., 








Figure 3-1 LPS signals through TLR4. 
Adapted from Kawai et al. (2010) 
 
Chapter 1 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 15 
TLRs form part of the pathogen recognition system in organisms as simple as 
drosophila, and they have expanded and diversified in different vertebrate species 
(Jann et al., 2009).  In humans, 10 functional TLRs have been identified, as well as 
RP105, a protein similar to TLR4 but which is preferentially expressed on mature B-
cells and does not have a TIR domain (Yazawa et al., 2003).  The orthologs of the 
human genes have been cloned and characterised in the pig and shown to be more 
closely related to human than the orthologous murine genes (Morozumi and Uenishi, 
2009; Roach et al., 2005; Tohno et al., 2007).  The similarity may be especially 
important for studies of TLR8, which was initially thought to be non-functional in 
mice, but was recently found to contribute to viral DNA recognition (Martinez et al., 
2010).  Another gene with quite distinct functions in mice and humans is the receptor 
for CpG DNA, TLR9 (Bauer et al., 2001).  The TLR9 gene is discordantly-regulated 
between mice and humans (Schroder et al., 2007) and there is distinct DNA sequence 
specificity in binding specific CpG-containing oligonucleotides (Roberts et al., 
2005).  Pigs are mainly human-like in both the cellular expression and DNA 
sequence specificity of responses to CpG containing oligonucleotides (Dar et al., 
2010).  Nevertheless, pig-selective CpG oligonucleotides have been selected and 
tested for optimal ability to stimulate cytokine production by peripheral blood cells 
(Kamstrup et al., 2001).  As in humans, these oligonucleotides varied in their activity 
across individuals, suggesting that there might be functional polymorphism in TLR9 
sequence specificity.  Studies examining LPS regulated orthologous genes in mice 
and humans have shown that divergently regulated orthologues were enriched for 
genes encoding “cellular inputs" such as cell surface receptors (eg. TLR6, IL7R) and 
their “functional outputs" such as inflammatory cytokines/chemokines (eg. CCL20, 
CXCL13). Conversely, the intracellular signaling components activated by the 
“cellular inputs” were mainly convergently regulated (Schroder et al., 2012).  Several 
of these “cellular inputs” have been shown to be similarly LPS regulated in the pig 
and humans (Schroder et al., 2012; Kapetanovic et al., 2012).  Such divergence in 
cell surface receptors between species suggests that LPS may have differing effects 
on sensitivity to further immune challenge in mice versus humans and pigs.  TLR6 
was upregulated in mice macrophages but not human after LPS stimulation.  LPS 
priming boosted IL6 production in response to a TLR6 agonist in mouse but not 
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human macrophages (Schroder et al., 2012).  Such species differences are likely to 
play a part in infections or inflammation where multiple immune receptors are 
required. 
 
Structural alterations to TLRs affect their ability to recognise PAMPs and single 
nucleotide polymorphisms (SNPs) in human TLR genes can increase or decrease the 
risk of disease e.g.   tuberculosis (TLR1) or legionnaires disease (TLR5) (Misch and 
Hawn, 2008).  Similar polymorphisms in TLR genes in pigs may explain the 
differences in susceptibility to disease observed in some animals (Jann et al., 2009; 
Uenishi and Shinkai, 2009).  Distribution of SNPs in TLR1, TLR2, TLR4, TLR5, 
and TLR6 across 11 different breeds of pig were found to be mainly in the LRRs 
which are important in detection of PAMPs.   This maintenance of diversity in TLRs 
must have some advantage for the immune system that ensures its preservation 
across breeds despite the pressures of intensive breeding.   Studies looking at SNPs 
in TLR3, TLR7 and TLR8 revealed they have fewer polymorphisms leading to 
amino acid substitutions than TLRs found on the cell surface (Morozumi and 
Uenishi, 2009; Shinkai et al., 2006).  The authors suggest these could have been 
eliminated by intensive breeding although the extent of heterogeneity found in LRRs 
of cell surface TLRs would suggest otherwise.     
 
Functional polymorphisms in TLR4, the receptor for lipopolysaccharide, have been 
associated with increased susceptibility to a wide range of human diseases (Ferwerda 
et al., 2008a).  Porcine and human TLR4 proteins share around 52% identity in the 
ligand-binding sites which rises to over 90% in the TIR domain, reflecting possible 
diversity in the ligands but a very highly conserved signalling pathway.   The gene 
structure, 3 exons and 2 introns alternatively, is highly conserved in human, mouse 
and pig.   The porcine and human promoters are more related to each other than to 
the mouse, but all three species contain TATA-less, purine-rich promoter typical of 
myeloid-expressed genes (Thomas et al., 2006).  Consistent with this view, TLR4 in 
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the pig can be detected in the liver, spleen, bone marrow and lymph nodes, as well as 
on monocytes and macrophages (Thomas et al., 2006).   Diverse function of TLR4 
amongst pig breeds could provide models for humans, as well as identifying possible 
disease susceptibility alleles in the pig.   Palermo et al.  (Palermo et al., 2009) 
identified 34 SNPs including 17 in the non-coding sequence and 17 in the coding 
sequence, in particular 5 non-synonymous substitutions within exon 3, which codes 
for the LRR ligand-binding domain.  Shinkai et al.   investigated TLR SNPs in 96 
individual pigs and found 7 non-synonymous SNPs within TLR4, also predominantly  
in the LRR region (Shinkai et al., 2006).   There were actually fewer SNPs within 
TLR4 than within other TLRs sequences; the presence of ligand-binding and 
important co-receptor-binding domains (CD14, MD2) imposes constraints on 
divergence.  However, the ligand-binding domain of TLR4 diverged most rapidly 
between all species.  Such variation can generate species-specific responses; for 
example forms of lipopolysaccharide that are antagonists of TLR4 in humans, are 
agonists in horse (Bryant et al., 2007).  Hence, it will be of interest to explore the 
structural constraints on LPS recognition in the pig model to determine how 
accurately it can model human biology.   Recently, a cyanobacterial LPS-like TLR4 
antagonist that blocks LPS-induced shock in mice was found also to block actions of 
pure E.coli LPS in pig blood (Thorgersen et al., 2009). 
 
1.7 Other pattern recognition receptors 
Aside from the TLRs, there are many other pattern recognition receptors on the cell 
surface and within innate immune cells.   There has recently been considerable 
interest in C type lectin receptors, such as Dectin and Mincle (Kerrigan and Brown, 
2010; Kerrigan and Brown, 2009; Wells et al., 2008; Yamasaki et al., 2008) that 
recognise complex polysaccharides and beta-glucans found in cell walls of bacterial 
and fungal pathogens.   Sonck et al.  (Sonck et al., 2010) have reported that a range 
of β-glucans can activate cytokine secretion and reactive oxygen production by pig 
monocytes and neutrophils.   The spectrum of intracellular pattern recognition 
receptors that bind to microbial products (nucleic acids, microbial peptidoglyans) 
Chapter 1 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 18 
(RIG-I, MDA5, the NOD/Nacht family) has also been delineated in the pig and to an 
even greater extent than the TLRs, these gene appear to contain many non-
synonymous amino acid substitutions amongst pig breeds (Kojima-Shibata et al., 
2009).  One of these genes, NOD2, has been implicated in human Crohn’s disease 
(Hugot et al., 2001).  Genetic manipulation of NOD2 in the mouse has failed to 
provide either a useful model of small intestinal pathology in the mouse (Maeda et 
al., 2005) nor resolution of whether NOD2 mutations associated with Crohn’s 
disease result in gain of function or loss of function (Eckmann and Karin, 2005).    
Tohno et al.   have cloned and characterised pig NOD2 (Tohno et al., 2008) which is 
more closely related to human (81.6%) than to mouse.   Furthermore, they confirmed 
that pig NOD2 was, like human NOD2, localized intracellularly and induced NF-κB 
activation after stimulation with the ligand muramyl dipeptide (MDP).   NOD2 
detects peptidoglycan motifs (Girardin et al., 2003) and in both mouse and human 
recognizes multiple pathogens like Mycobacterium tuberculosis or Staphylococcus 
aureus (Deshmukh et al., 2009; Divangahi et al., 2008; Kapetanovic et al., 2010).  
Recently, using a porcine model of Salmonella typhimurium infection, Meurens et al.  
(Meurens et al., 2009) demonstrated induction of NOD2 in the Peyer’s patch and the 
gut wall.   Studies on the distribution of SNPs have revealed that NOD2 has seven 
nonsynonymous SNPs in the LRR domain (Kojima-Shibata et al., 2009).  Indeed, a 
substitution in NOD2 appears to alter sensitivity to MDP (Jozaki et al., 2009).  There 
is clearly potential within the pig model to understand the biology of NOD2-related 
disease susceptibility in humans, and potentially vice versa.    
 
Another class of proteins involved in the pattern recognition process includes 
members of the HIN200 family of interferon-inducible genes, which form a genomic 
cluster that is clearly syntenic between mouse and humans.   Of these HIN200 
domain-containing genes present in the mouse, absent in melanoma 2 (AIM2) acts as 
a detector of cytoplasmic dsDNA (Burckstummer et al., 2009; Hornung et al., 2009; 
Roberts et al., 2009) linking recognition to activation of the inflammasome with IL1b 
processing and macrophage cell death, whilst a second family member, p202, acts as 
a repressor of activation (Roberts et al., 2009).  The number of members of this 
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family varies substantially amongst species and even within species.   All of the 
mammals appear to have a copy of the myeloid nuclear differentiation antigen 
(MNDA), a gene implicated in cell cycle control in myeloid cells.   Some mouse 
strains have an additional copy, called MNDAL (Zhang et al., 2009).  Variation in 
the number of, sequence and gene complement have been linked to autoimmunity in 
mice and humans (Choubey and Panchanathan, 2008).  In the pig, no evidence can be 
found for the existence of clear functional orthologs of either AIM2, or the putative 
repressors, despite conservation of the syntenic genomic region where these genes 
reside in mice and humans (www.ensembl.org).   However, pig macrophages do 
undergo cell death in response to transfected dsDNA (D Sester, unpublished).   
 
1.8 Macrophage activation in the pig 
Mononuclear phagocytes recruited into tissues are plastic in their function.   
Macrophages are the major infiltrating population during development, in sterile 
wounds, tissue injury and foreign body reactions.   Their activities are biased towards 
phagocytosis, extracellular proteolysis and production of growth factors that promote 
growth and repair.   Infectious agents and/or immunological stimuli attract 
macrophages that differ greatly depending on the precise nature of the challenge.   
These phenotypes have come to be broadly classified into two classes of 
"activation"; Classical activation, which is often dependent on a priming signal, is 
associated with production of pro-inflammatory cytokines, antimicrobial and 
tumoricidal effectors along with a polarization of the T-cell compartment to that of a 
Th1 phenotype (Gordon and Martinez, 2010; Gordon and Taylor, 2005; Martinez et 
al., 2008; Taylor and Gordon, 2003; Taylor et al., 2005).  The archetypal 
macrophage-activating cytokine in both mouse and human is interferon-gamma, 
which acts in part to prime responses through the various TLRs (Schroder et al., 
2004; Schroder et al., 2006).  There is only a limited literature on classical and 
alternative activation in pig systems, although there is no reason to suspect any 
distinct pattern of responsiveness to cytokines.   In fact, most published work on the 
pig focuses on antiviral functions of interferon-gamma.  Interferon-gamma 
Chapter 1 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 20 
production is controlled by a number of quantitative trait loci in the pig (Lu et al., 
2010) and correlated with effective resistance to the macrophage-trophic viral 
pathogen PRRSV (Lunney et al., 2010).   Early studies of interferon gamma in pigs 
focussed on its ability to induce an antiviral state in macrophages (Esparza et al., 
1988) and subsequently the classical priming activity was demonstrated, wherein 
interferon-gamma pretreatment of monocytes enhanced subsequent activation of 
interleukin 1 production (Charley et al., 1990).  More recently, interferon gamma has 
been shown to protect against foot and mouth disease virus in pigs (Diaz-San 
Segundo et al., 2010).    
 
Alternative activation of macrophages leads to the induction of sets of genes that 
promote direct toxicity against macropathogens, antibody-mediated host defence, 
suppression of classical T cell response, resolution of inflammation and promotion of 
wound repair (Martinez et al., 2008; Sica et al., 2008).  It is associated with 
production of cytokines such as IL10 and TGFβ, and in pathological situations, with 
fibrosis.   In general, alternative activation is associated with increased secretion of 
IL4 by Th2 cells and mast cells, and the induction of IL4 target genes in 
macrophages.   As noted above, one confusing feature of the literature is that IL4 is 
commonly used in culture with GM-CSF to increase the production of monocyte-
derived dendritic cells.   Bautista et al.  (Bautista et al., 2007) have suggested that in 
pigs, the IL4-related cytokine IL13 is more abundant and more physiologically 
relevant than IL4.   
 
1.9 Inflammatory cytokine production in pigs 
Macrophages respond to the ligation of pattern recognition receptors with induction 
of numerous inflammatory mediators, including chemokines and cytokines that 
recruit and activate other immune cells.    The cytokines produced will differ 
depending on the pathogen present and the manner in which it activates the 
macrophage.   There have been numerous studies of pig macrophage responses to 
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activation that largely recapitulate findings from mouse or human systems.   Porcine 
macrophages from various locations treated with LPS increase production of the 
major pro-inflammatory cytokine, TNFα (Izeboud et al., 2000; Taylor et al., 1993; 
Vezina et al., 1995) and expression of IL1β (Charley et al., 1990; Foss et al., 1999; 
Sacco et al., 1996) IL6 (Choi et al., 2002; Lee et al., 2004), IL8 (Cagiola et al., 2006; 
Lin et al., 1994a) and IL12 (Foss et al., 1999; Pappaterra Mendoza et al., 2000).   
Useful microarray platforms are in their comparative infancy in pigs (see below), but 
have already been used in a study of transcriptional responses within the lymph 
nodes of pigs infected with salmonella (Wang et al., 2007) and with monocytes 
infected with African swine fever virus (Afonso et al., 2004).  A recent microarray 
study of the activation of pig peripheral blood mononuclear cells by LPS identified 
the inflammatory chemokines, CCL2, CCL8, CXCL2, CXCL3, CXCL5 and IL8 (for 
which there is not a clear mouse ortholog) as the most inducible genes (Gao et al., 
2010).   Interestingly, LPS also induced the calgranulins, S100A8, S100A9 and 
S100A12.   There has been considerable interest in the role of these proteins in 
inflammation (Goyette and Geczy, 2010; Perera et al., 2009) and S100A12 does not 
have a clear ortholog in mice (Ravasi et al., 2004).   
 
1.10 Of mice and men...   and pigs.    
Mice are commonly used as models to study fundamental features of innate and 
acquired immunity.   But the innate and acquired immune systems of mouse and 
human have clearly diverged substantially (Mestas and Hughes, 2004).  An obvious 
example that highlights the difference between the two animals is the cellular 
constituents of the circulation.   The neutrophil population represents 50 to 70% of 
peripheral blood cells in humans but only 10 to 25% in the mouse.   In contrast to 
rodents, human neutrophils produce defensins (Eisenhauer and Lehrer, 1992) and no 
direct homologue of IL8, a neutrophil chemoattractant, has been identified in the 
mouse (KC, MIP-2 or LIX can be considered functionally similar although they are 
still quite different in their sequences) (Lehrer et al., 1993).  As noted above, there is 
a clear difference in relative abundance of the two populations of monocytes 
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(Ingersoll et al., 2010) less than half of the genes that distinguish subsets are 
conserved between mouse and human, and some markers (CD36, CD9, TREM-1) are 
completely divergent.  This thesis is the first description of differential gene 
expression between monocyte subsets in the pig, such studies provide useful 
evidence on whether subpopulations of monocytes in different species may be 
comparable in their functions. 
 
One striking and well characterised example of an innate immune effector pathway, 
downstream of TLR activity that is differentially regulated in mouse and human is 
the nitric oxide (NO) pathway.   In the mouse NO is an important antimicrobial 
molecule produced via the action of the calcium-independent/inducible NO synthase 
(NOS2, iNOS) following activation of macrophages by pathogens.   A protective role 
for this effector has been described in numerous infection models in mouse.  Optimal 
induction of NOS2 in mice requires the combined actions of interferon-gamma and 
TLR signalling a reflection of a more general intersection between the two signalling 
pathways in which interferon sensitises to TLR signals (Schroder et al., 2006; 
Schroder et al., 2004).   Mouse macrophages activated with LPS, with or without 
interferon, also induce an arginine transporter to bring the substrate into the cells, and 
arginase, which converts L-arginine, a by-product of NO synthesis, into L-ornithine.   
They also induce enzymes such as GTP cyclohydrolase1 (GCH1) required to 
produce the cofactor for NOS, tetrahydrobiopterin (BH4).   None of these pathways is 
active in human macrophages activated in vitro (Liu et al., 2006).  There has been a 
considerable inconsistency in the literature as to whether human macrophages 
actually express NOS2, and produce nitric oxide via a NOS2-catalysed mechanism, 
under any circumstances (Fang and Nathan, 2007; Liu et al., 2006; Schneemann and 
Schoeden, 2007).  What is clear is that the control of NOS2 gene expression is 
different between the species.   Like most groups, our laboratory has failed to find 
NOS2 induction by human macrophages in response to LPS, and like previous 
authors (Jungi et al., 1996; Zelnickova et al., 2008), this thesis reports similar results 
with pig macrophages from multiple tissue sources.  So in this respect, the pig 
resembles a human.    
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Whether or not NO is a functional antimicrobial effector in some contexts, NOS2 is 
not a pseudogene in humans or pigs.  But there are substantial insertions 
rearrangements in the genomic interval comparing the mouse and human syntenic 
regions surrounding NOS2 and the promoter is poorly conserved 
(www.ensembl.org).  A change in the regulation of the NO pathway in humans 
could be compensated by alternative antimicrobial pathways.   One example is the 
TLR-mediated up-regulation of the vitamin D receptor which facilitates induction of 
the antimicrobial peptide cathelicidin (LL37) in humans but not mice (Liu et al., 
2006).  As vitamin D3 is produced after exposure to ultraviolet B light, this pathway 
is presumed to have either evolved in diurnal humans who are active during the day, 
or was not maintained in nocturnal mice since splitting from our common ancestor. 
This thesis provided some evidence that this pathway may also be active in pigs 
(Chapter 5) . 
 
Another alternatively regulated immune pathway of mouse and human macrophages 
is the regulation and production of indoleamine 2,3-dioxygenase (IDO).   IDO is 
produced after stimulation with different pathogens in IFN-γ-treated human 
macrophages but not mouse macrophages, supposedly due to the inhibitory effects of 
NO (Murray et al., 1989; Thomas et al., 1994).   As with iNOS and arginine 
metabolism, induction of IDO is part of the induction of an entire pathway of 
tryptophan metabolism, including a tryptophan transporter, and the enzymes 
kynureninase and kynurenine hydroxylase, which leads to production of potentially 
toxic metabolite, quinolinic acid.   IDO and tryptophan metabolism have been 
implicated in numerous aspects of immune regulation, and indeed the serum 
tryptophan/kynurenine ratio is an index of immune activation (Mellor and Munn, 
2004; Schrocksnadel et al., 2006).  In this respect, pig macrophages again resemble 
human, in that IDO is one of the most LPS-inducible genes in multiple different 
macrophage populations ((Gao et al., 2010; Kapetanovic et al., 2012), our 
unpublished observations).    
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One final striking example of divergent immune regulation includes the use of family 
members of the p47 immunity-related GTPases (IRG) family; there are 23 members 
in mice and they are immune-regulated and clearly required in host defence (Bekpen 
et al., 2005).  Surprisingly, only a full length gene for one family member is present 
in humans, IRG1, with an additional truncated pseudogene being present.   IRG1 is 
profoundly inducible in human macrophages after IFN-g and LPS treatment 
(Martinez et al., 2006).   The human and pig IRG1 loci are very similar, flanked in 
close proximity by ceroid-lipofuscinosis neuronal protein 5 (CLN5) and potassium 
channel tetramerisation domain containing 12 (KCTD12) (www.ensembl.org).    
Type I IFNs are the primary immune defense against viruses (Stark et al., 1998) and 
have additional roles in modulating the adaptive immune system and controlling 
cellular proliferation and death among other functions (Goodbourn et al., 2000).  
Perhaps due to their many roles in the immune system, Type I IFNs have diverged 
into at least eight distinct subfamilies: IFNκ (IFNK), IFNβ (IFNB), IFNε (IFNE), 
IFNδ (IFND), IFNζ (IFNZ), IFNα (IFNA), IFNω (IFNW), and IFNτ (IFNT) (Krause 
and Pestka, 2005).  All  Type I IFN genes in human and mouse, except IFNK are 
clustered in an approximately 400 kb length of DNA between IFNB and IFNE. There 
is some evidence that species-specific evolution of IFN families has 
occurred, IFND has only been identified in the pig and is absent in the mouse and 
human (Lefevre et al., 1998), while IFNZ is represented in the mouse, but is 
completely absent in humans (Oritani et al., 2001; Takahashi et al., 2001) and IFNW, 
which is present as a single functional gene and at least two pseudogenes in humans, 
has only been described as a single pseudogene in mice (Hardy et al., 2004).  IFND 
and IFNT appear to have evolved different functions in swine and ruminants.  They 
are not induced by viruses but instead are instead involved in pregnancy (Roberts et 
al., 2008; Lefevre et al., 1998).  Differences between type I IFN responses have been 
described between man and mice (Rogge et al., 1998).  Furthermore the type I IFN, 
IFNα which is secreted by several cell types including macrophages, provide an 
important link between the innate and adaptive immune system by inducing Th1 
differentiation.  This process requires STAT4 activation through recruitment to the 
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IFNα receptor by STAT2.  In mice, however, IFNα does not activate STAT4 or 
cause Th1 differentiation due to an insertion in the STAT2 gene (Farrar et al., 2000) 
suggesting the control of the adaptive immune system may differ between mice and 
humans.   
 
A recent study carried out systematic comparisons of transcriptional regulation in 
mouse versus human macrophages responding to LPS.   Broadly-speaking more than 
10% of genes (including the examples above) showed absolutely divergent 
regulation, and around 25% were quantitatively very divergent (Schroder et al., 
2012).   Similar analysis in pigs using arrays and RNAseq is underway in our 
laboratory, but it is already clear that for a set of genes that show the greatest 
divergence (iNOS, CCL20, STAT4, IDO), pigs resemble humans (D Beraldi, 
unpublished).    
 
Aside from the differences in gene regulation, mice and human are also divergent at 
the protein sequence level, especially amongst genes expressed by innate immune 
cells.   Murphy et al (Murphy, 1993) assembled a large database of human and rodent 
orthologous proteins.   The majority of proteins (79%) varied little between the 
species, this included structural and cytoskeletal proteins, cell cycle regulators, 
neurotransmitters, growth factors and associated receptors.   In contrast proteins 
involved in host defence were approximately 3-fold more divergent than the average.   
The highly divergent proteins were mainly the extracellular or transmembrane 
components of the intracellular signalling pathways which mediate the host response 
to infection, such as the interleukins, interferons, colony-stimulating factors, 
chemokines, chemoattractants and Fc receptors, and plasma or exocrine proteins 
such as opsonins, thrombogens and proteins which bind to hormones, lipids, 
metabolites, drugs and heme.  Such evolutionary divergence in cell surface receptors 
and secreted effectors activated via the pathogen recognition systems has been 
reported by others (Schroder et al., 2012).   The divergence among these immune 
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mediators demonstrates the strong evolutionary selection that genes involved in 
innate immunity are under.   Generally the average non synonymous v synonymous 
(Ka/Ks) base change was 3-4 fold higher in immune related genes in primates versus 
rodents demonstrating enhanced fixing of mutations due to the advantage provided 
by altered protein function (Ellegren, 2008).  A comparison of such genes across 
species is provided at ImmTree (http://bioinf.uta.fi/ImmTree)(Ortutay et al., 2007).   
 
Systematic large scale genomic analysis of the pig was initiated in the 1990s with the 
formation of the European Pig Gene Mapping Project (PiGMaP) (Archibald et al., 
1995) and generation of a large databank that continues to be maintained at the 
Roslin Institute (http://www.thearkdb.org).   Even the earliest comparisons 
indicated that the pig genome is more closely related to the human genome than the 
mouse (Federico et al., 2004).  A more detailed comparison of shotgun reads 
established that the pig bisects the evolutionary branch between mouse and human, 
with the mouse at a three-fold greater evolutionary distance, regardless of whether 
one considers coding, UTR or intergenic regions (Wernersson et al., 2005).  This 
analysis identified a set of 50 conserved miRNAs, of which 23 were more closely-
related to human than mouse, and 25 equidistant.  The small effective population size 
of humans and pigs is associated with accumulation of slightly deleterious mutations 
which have no adaptive benefit but are fixed essentially by chance.   Accordingly, 
humans have an overall greater functional genetic diversity than mice, manifested by 
a greater Ka/Ks ratio within the species.   Similarly, the Ka/Ks ratio is higher for 
comparisons between primate species than between rodent species.   In simple terms, 
rodents are more highly evolved than humans or pigs, perhaps due to their shorter 
generation time, and pigs are more like humans than mice. 
 
1.11 The pig as an inflammatory model   
The use of pigs to model the human immune system is becoming increasingly 
common.   Pigs are already widely used  to study gastroenterology, cardiology, 
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xenotransplantation and nutrition (Lunney, 2007; Spurlock and Gabler, 2008; Truty 
and Smoot, 2008) and there is some evidence that the porcine response to infectious 
challenge is more similar to mans than the more commonly used mouse 
(Kapetanovic et al., 2012).  There are many valid reasons for using pigs; they are 
economically important in their own right, are physiologically similar to humans and 
share many infectious challenges with us.    Streptococcus suis, a common porcine 
pathogen, can cause meningitis or sepsis in humans (Wertheim et al., 2009) and the 
2009 H1N1 influenza pandemic demonstrated the thin barrier between the species 
(Mehle and Doudna, 2009).  The larger size of pigs compared to rodents provides an 
additional benefit for drug trials that require invasive monitoring, as the animals can 
be treated in a similar manner to patients in an intensive care unit, healthy pigs 
subjected to prolonged mechanical ventilation have developed ventilator-acquired 
pneumonia (Marquette et al., 1999). 
 
Although the limitations of the commonly-used rodent models for understanding the 
nuances of innate and acquired immunity are becoming widely appreciated, mice and 
rats are still the animal models of choice for the vast majority of biomedical research.   
Rodents have many advantages, they are relatively inexpensive to buy and maintain, 
they do not take up a large amount of space and so can be easily housed.   The vast 
array of transgenic animals and bio-molecular tools available for rodents ensures that 
they remain a useful tool but this thesis aims to show they may not always be the best 
choice for studying the human immune system.   Like humans, pigs are largely out-
bred, but domestication and selection has generated major breeds in which 
individuals are genetically similar to each other.   In the process, different breeds 
have acquired breed-specific phenotypic traits, including specific disease resistance 
traits, which may offer insights into similar genetic variation in humans (Hoeltig et 
al., 2009; Doeschl-Wilson et al., 2009; Vincent et al., 2005).    
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One area in which rodents have severe limitations as an experimental model is 
sepsis.   Sepsis is defined as a systemic inflammatory response syndrome (SIRS) 
with either suspected or proven (e.g.  positive blood culture) infection (Annane et al., 
2005).  A diagnosis of SIRS is given when there is a combination of two or more of 
the following symptoms: fever or hypothermia, tachycardia, tachypnea and 
leukocytosis or neutropenia.   Sepsis is one of the principal causes of mortality in 
U.S, where it is responsible for 9.3% of all deaths, similar to the mortality rate from 
myocardial infarction (Angus et al., 2001).   In terms of morbidity, sepsis is 
responsible for 50-95 cases per 100,000 patients and its incidence has increased by 
9% each year (Martin et al., 2003).   
 
The pathology of sepsis is attributable to sustained activation of macrophages and the 
production of numerous secreted products that cause disseminated intravascular 
coagulation and multiple organ failure.  Despite numerous trials, there are still no 
effective therapies (Stearns-Kurosawa et al., 2011) which can at least partly be 
attributed to the lack of predictive animal models.  Mice have been used extensively 
to simulate sepsis and endotoxin shock however they have many faults as a model 
for these human conditions (Dyson and Singer, 2009).  The murine response to 
endotoxin challenge generally results in hypothermia; a consequence of peripheral 
vasodilatation, while fever is the more common outcome in humans (Habicht, 1981).  
Mice are also approximately 105 more resistant than humans to endotoxin shock 
(Munford, 2010) and the lethal dose (LD) for mice is 5-12 times more (mg/kg) than 
for men, or pigs (Berczi et al., 1966).  The underlying cause of this resistance is 
currently unknown; however the involvement of circulating protein(s) present in sera 
has been proposed (Warren et al., 2010).  The inherent resistance of mice can be 
overcome with the administration of priming agents such as D-galactosamine but the 
resulting pathology in this model is more representative of acute hepatotoxicity than 
a true model of sepsis (Mignon et al., 1999).  It is hoped that comparative genetic 
studies in a third species such as the pig, as outlined in this thesis, may provide some 
clues towards why humans are so much more sensitive to bacterial products than 
mice and hence provide targets for the therapeutic use. 
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The failure of the mouse to adequately mimic the pathologies observed in sepsis in 
man has led researchers to turn to the pig as a possible model.  Multiple different 
experimental approaches have been used to mimic the human pathophysiology of 
sepsis: intravenous (iv) or intraperitoneal (ip) injection of  LPS or bacteria or ip 
injection or “release” of faeces are the most commonly used (Rittirsch et al., 2007).  
Perhaps the simplest sepsis models results from the iv infusion of LPS (Carlsson et 
al., 2009).  In this model, reducing the endotoxin concentration had little effect on 
TNF production but an improvement in respiratory function was noted.   Lipcsey et 
al.  (Lipcsey et al., 2008) used the same model to demonstrate the correlation 
between the speed of LPS infusion and the physiological responses.   The infusion 
model in pigs has been used in several studies to investigate the effect of different 
drugs on long-term, hyperdynamic porcine endotoxemia (Hauser et al., 2006; Konrad 
et al., 2004; Murphey and Traber, 2000).  Various studies have validated bacterial 
injection as a sepsis model using a variety of bacteria.   Injection of Pseudomonas 
aeruginosa (Rimmele et al., 2006) produced pigs with inflammatory cytokine 
profiles and a cardiovascular profile similar to human pathology while continuous 
infusion of serogroup A streptococci led to acute septic shock with pulmonary 
hypertension, artery hypotension and reduced cardiac output (Saetre et al., 2000).  
More recently, Nielsen et al (Nielsen et al., 2009) described a model for human 
meningococcal sepsis by injection of Neisseria meningitidis in pigs.   Similar to 
human sepsis, this porcine model resulted in hemodynamic and cardiovascular output 
failures as well as increased inflammatory cytokine production (TNF, IL1b and IL6). 
 
Blood poisoning or sepsis is perhaps the most serious complication arising from an 
inflammation of the peritoneum (peritonitis) in human patients.    A surgical model 
of caecal ligation and perforation of the bowel, or inoculation of faecal material or 
bacteria into the peritoneal cavity can be used to simulate peritonitis.   Several 
laboratories have validated a porcine model by injecting either E.coli or autologous 
faecal content into the peritoneal cavity (de Azevedo et al., 2007; Goldfarb et al., 
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1996).  Although the resulting peritonitis appeared to have no impact on circulating 
creatinine levels, it induced coagulation disturbance, leukopenia, decrease in arterial 
pressure, acute lung injury and increased levels of IL6 resembling many of the 
physiological outcomes observed in human patients.   Kazarian et al.   (Kazarian et 
al., 1994) compared ip inoculation with E.  coli or autologous faecal material.   There 
were distinct responses, with the latter proving a better model for human peritonitis.  
Injection of faecal material resulted in formation of abdominal abscesses and 
pyogenic granuloma and the slow onset of sepsis.   
 
1.12  Inflammatory models 
The close physiological and immunological resemblance of pigs to humans has 
allowed the modelling of many inflammatory lung disorders.   Cystic Fibrosis (CF) is 
a genetic disease caused by mutations in the gene encoding a chloride channel; the 
protein product of this gene is called the cystic fibrosis transmembrane conductance 
regulator (CFTR) protein (Lyczak et al., 2002).  Mutations in CFTR result in chronic 
pulmonary inflammation.   Models using the CFTR-deficient mouse have proven 
useful in providing a basic understanding of CF however mice do not develop the 
same pancreatic, liver, intestinal or lung abnormalities as human CF patients.   
Rogers et al.  developed  CFTR-/- pigs which have defective chloride transport and 
develop intestinal obstruction (meconium ileus), exocrine pancreatic destruction and 
focal biliary cirrhosis.  This model more closely mimics the pathology commonly 
shown by CF patients.   The development of a genetically modified pig model for CF 
will aid understanding of the pathology associated with this condition (Rogers et al., 
2008).    
 
Pigs can be useful for modelling many human inflammatory disorders.  Infection 
with Erysipelothrix rhusiopathiae has been used as to study human chronic 
polyarthritis.  The resulting pathology (IL1 beta production, infiltration of cells and 
increased expression of ICAM1 and MHC II) was found to be similar to the human 
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disease and the use of larger animals allowed a clearer view of the inflamed joint 
(Davies et al., 1994; Davies et al., 1992).   Pigs infected with Mycobacterium bovis 
have proven useful to study tuberculosis (Bolin et al., 1997) and a model using 
Bordetella pertussis has been established to study whooping cough  in newborn 
infants (Elahi et al., 2005).  B.  pertussis infected pigs displayed similar symptoms to 
infected humans such as nasal discharge, nonparoxysmal cough, breathing 
difficulties, and growth retardation.   A pig model for the gram-negative bacterium 
Helicobacter pylori has also been developed.   H.  pylori colonises the human 
stomach and can be detected in more than 50% of people.   Infection leads to gastric 
or duodenal ulcers and atrophic gastritis in a small percentage of patients.  Poutahidis 
et al.  (Poutahidis et al., 2001) developed a promising model of crossbred (Large 
White and Pietrain) pigs which were infected with H.   Pylori leading to stomach 
lesions and adhesion to the gastric epithelium resembling the pathology in human 
patients.  
   
1.13 Conclusions 
We now know so much about mouse biology that there are few mouse diseases that 
could not be cured.    But in terms of translation into the clinic, mice lie!  Perhaps it 
is time to utilise an animal that may be more beneficial to us.  This thesis aims to 
determine whether transcriptional control of the mononuclear phagocyte system in 
the pig is closer to humans than the more commonly used mouse.  Macrophage 
biology underlies most of the pathology of the disease that afflict us.  Table 1 
summarises some of the advantages of the pig as a model system for the study of 
human disease.   The study of pig macrophages is practical (one can obtain very 
large numbers of cells from multiple sites of the same animal, and they can be stored 
frozen), and with completed genomes, genetics of breeds, transcriptomic resources, 
increasing availability of cytokines and antibodies, and even transgenics, the 
technical advantages of the mouse as a model are evaporating.  As in the words of 
the popular French addage, “tout est bon dans le cochon” (everything is good in the 
pig).   Most importantly, studies in the pig are actually much more likely to be 
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predictive of therapeutic efficacy in humans, and there are economic reasons to study 










Pig Model Mouse Model References 
Biological + large litter + small facility, cheaper   
  
  
 (Zelnickova et al., 2008; 







+ physiology closer to human (blood volume, blood pressure, etc.) + large literature 
+ bigger organs, lymphoid organs similar to human + large litter size 
+ repeat blood sample and invasive observation possible  + easy to handle 
+ pig macrophages do not produce NO + large knowledge of physiology 
+ many cells and large volume of tissue per animal, many 
experiments can be performed per animal 
+ large number of immunological tools 
 
- large animal, difficult to handle - Mouse macrophages produce NO 
 
- expensive - low no. of cells and small volume of tissue per 
animal,  many animals needed for one experiment 
 




limited availability of immunological tools 
 
  
Genetics + outbred, closer to the genetic variation seen in humans + inbred, good to understand basic molecular 
biology 
  
(Archibald et al., 1995; 




+ genetically closer to human + large number of transgenic or knock out animals 
available 
+ genome sequencing almost finished + genome sequenced 
- outbred can be problematic for some experiments - evolving at a higher rate than human 










          
Sepsis + Strong reaction to endotoxin - endotoxin resistant (Habicht, 1981; 
Rittirsch et al., 
2007; Rimmele 
et al., 2006; de 
Azevedo et al., 
2007; Jiang et 
al., 2000) 
+ haemodynamic and cardiovascular values close to human - no fever, mostly hypothermia 
  - Young mice mainly used, sepsis patient are often 
elderly 
      
Lungs inflammation + lung size and functional capacity are similar to man + molecular and immunological tools available (Kirschvink and 
Reinhold, 2008; 
Reinhold et al., 
2008; Salez et 
al., 2000) 
 
+ similar respiratory mechanics, gas exchange, glycoprotein 
composition of submucosal gland 
- 4 right lobes, 1 left lobe 
+ can use similar diagnostic and experimental techniques as used in 
humans (endoscopies, alveolar lavages) 
- macrophages do not respond to TLR9 stimuli  nor 
produce IL-10 
- 4 right lobes, 2 left lobes (humans have 3 right lobes and 2 left 
lobes)  
- breathing patterns different, no respiratory 
bronchioles (Dixon al, 1999) 
- have interstitial macrophages which are not present in human lungs  
    
Cystic Fibrosis (CFTR -
/- animals) 
+ develop human-like symptoms (lung or pancreatic disease ) + small, good for studying molecular proprieties (Rogers et al., 
2008) 
    - no human-like symptoms 
Rheumatoid arthritis + easy to view the cartilage - small joints are hard to study  (Davies et al., 
1992; Davies et 
al., 1994) + human-like symptoms   
+ natural host for Ery. Rhusiopathice   




+ good model for tuberculosis (similar resistance, lesions, histology, 
natural host)  
+ helpful to understand mechanisms (Bolin et al., 
1997; Elahi et 
al., 2005) 
+ major histocompatibility complex quite similar to human - mice are often not natural host and are more 
resistant 
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Influenza, Hepatitis E) + similar clotting mechanism to humans - inbreed (no genetic variation) 
  - different physiology 
    
Other Human 
Pathology 
          
           
Nutrition Studies + omnivorous - different food intake, coprophagy (Spurlock and 
Gabler, 2008; 





+ physiology and metabolic processes similar to human - different lifespan and body proportion 
- require more space and more food - different intestinal microbiota and intestinal morphology 
- pig intestines differ in length - body fat depending on age    
- coprophagy rare but possible    
Neurodegenerative 
Diseases 
+ relatively large brain, human-like blood supply and immunologic 
response characteristics 
- small  brain  (Hu et al., 
1996; Imai et 
al., 2006; 
Bjarkam et al., + good model for stroke and MPTP model of Parkinsons disease - complexity and the development of cognitive circuitry are 
different 
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        2008) 
Atherosclerosis + growth and aging of aorta similar + apolipoprotein E (apoE) and LDL receptor knockout mice (Ratcliffe and 
Luginbuhl, 
1971; Cullen et 
al., 2003)  
+ coronary artery distribution is similar to humans  - mice do not develop atherosclerosis without genetic 
manipulation 
+ morphology and biochemistry of plaque is similar to humans - lipid physiology that is radically different 
    - lesions in the mouse coronary artery often extend beyond 
the elastic lamina 
    - do not exhibit plaque rupture leading to vessel occlusion 
Wound healing + same epidermal and dermal thickness ratios and turnover as human + accelerated modes of healing (experiment are quicker) (Sullivan et al., 
2001) 
+ porcine dermal collagen similar to human  - bandages or treatments may be problematic due to dense 
fur 
+ similar healing processes, similar physiology - very thin epidermis and dermis 
+ porcine model generally in agrement with human data 78% (53% for 
small mammals) 
- rodents mainly heal through wound contraction rather than 
migration of epidermal cells as in human 
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- pig dermis relatively elastic but still less than human   
- no eccrine glands on pigs     
 
Ophtalmology + similar time course for retinal degeneration - small size of the eye (Chandler et al., 
1999; Ruiz-
Ederra et al., 
2005; Lei and 
Yao, 2006)  
+ size well suited to sub-retinal injections and somatic gene 
therapy 
- differences in dimensions of the the lenses (thickness 
and diameter) 
+ good model for glaucoma - transmission of the mouse lens different  
+ similar size/thickness of the eye/retina and distribution of the 
cells 
    
- pigs do not possess a cone-exclusive true macula or fovea as in 
human 
    
Bone metabolism, 
skeleton 
+ anatomy, morphology, composition close to human +  investigation of molecular processes simple (Cardis et al., 
2007; Pearce et 
al., 2007) + reliable and duplicable model for scoliosis - small bone size 
- large animal when older - bone density measurement more complicated 
- denser trabecular network     
Xenotransplantation + easy supply   Not Possible in mice (Ekser and 
Cooper, 2010; 
Truty and Smoot, 
2008)  
+  genetic manipulation possible     
- viral recombination not ruled out     
- transmission of swine-pathogens to human host need to be 
evaluated 
    
Table 6.1 Description of Animal Models: Advantages and Disadvantages of the Mouse and Pig Models in General, Inflammatory Pathologies, and Other 
Human Pathologies 
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2.1.1 General reagents 
Lipopolysaccharide (LPS) (from Salmonella minnesota rough strain RE595) was 
used at a final concentration of 100ng/mL.  Recombinant human colony stimulating 
factor-1 (rhCSF1) (a gift from Chiron, Emeryville, CA, USA) was used at a final 
concentration of 1x104 U/mL (100ng/mL). 1-methyl-DL-trptophan (Sigma) was 
dissolved in DMSO (Sigma) and used at a final concentration of 1:1000 (100µM).  
L-tryptophan (Sigma) was diluted in RPMI 1640 (Invitrogen) and used at a final 
concentration of 250µM. 
 
2.1.2 Antibodies 
All antibodies and working antibody concentrations used in these studies are 
described in Appendix 1. 
 
2.2 Mammalian cell culture 
 
2.2.1 Primary macrophages 
Porcine monocyte derived macrophages (MDM) and bone marrow derived 
macrophages (BMDM) were obtained by ex vivo differentiation from peripheral 
blood mononuclear cells (PBMCs) and bone marrow cells (BMC) in the presence of 
rhCSF1 as described previously (Kapetanovic).  Animals used are detailed in 
Appendix 1.  The pigs were sedated with ketamine and euthanized using a captive 
bolt.  Two different freezing Media were assessed, FM1 (10% DMSO, 90% FCs) and 
FM2 (20%DMSO, 80% FCS).  FM1 was used for all experiments. 
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2.2.1.1 Monocyte derived macrophages 
 Blood was collected by intra-cardiac puncture into a vacuum sealed glass bottle 
containing 100mLs Acid Citrate Dextrose (ACD) buffer.  Whole blood was 
separated into 10, 50mL falcon tubes (Greiner Bio one) which were centrifuged at 
1200g for 15 minutes with no brake.  The buffy coat was removed and 25mLs mixed 
with 25mLs RPMI (Sigma).  30 mLs of the buffy coat/RPMI mix was layered on top 
of 15mLs of Lymphoprep (Axis-Shield, Norway) and centrifuged at 1200g for 25 
minutes with no brake.  PBMCs separate out into a distinct layer which can be easily 
removed.  This was washed twice with RPMI 1640 and centrifuged at 600g for 10 
minutes then 400g for 10 minutes. Red cells were lysed using 5mL of erythrocyte 
lysis buffer (10mM KHCO3, 155mM NH4Cl, 0.1M EDTA, sterile 0.2uM filtered) 
for 5 minutes then the cells washed and centrifuged at 400g for 10 minutes.   The 
pellet was collected, re-suspended in PBS (Mg2+ Ca2+ free) and counted before 
being slow frozen at   -80°C in an isopropanol bath then moved to -155°C for long 
term storage. 
 
2.2.1.2 Bone marrow derived macrophages 
 Five posterior ribs were removed from each side of the rib cage The outer surface of 
the bone was cleaned with alcohol, both extremities were cut and, using a 20ml 
syringe with an 18g needle, bone was flushed in both sides with RPMI-1640 (Sigma, 
UK) containing 5 mM EDTA to prevent clotting.  Cells were spun, suspended in red 
cell lysis buffer (10mM KHCO3, 150mM NH4Cl, 0.1mM EDTA pH 8.0) for 2min, 
spun again and washed with phosphate buffered saline followed by RPMI-1640.  
Bone-Marrow cell (BMC) were finally suspended in a freezing medium (90% heat-
inactivated Fetal Calf Serum (hiFCS) – 10% DMSO) and frozen as per MDMs. 
 
2.2.1.3 Peritoneal macrophages 
A small incision was made in the peritoneal cavity and a catheter with a 30cc 
concentric balloon that allows internal sealing of the entry site by inflation with a 
50mL syringe was inserted.  A sterile i.v. bag containing 1.5L PBS was attached and 
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held above the pig to allow PBS (Mg2+ Ca2+ free) to drain into the peritoneal 
cavity.  The pig’s peritoneal cavity region was massaged then the i.v bag lowered to 
below the pig and the PBS drains out into the sterile i.v. bag.  The peritoneal lavage 
was poured into 500mL centrifuge tubes (Corning Incorporated, USA) and 
centrifuged at 400G for 10 minutes.  Cells were counted and frozen as MDMs 
 
2.2.1.4 Alveolar macrophages 
Once the peritoneal lavage has been collected the pig was cut down the middle and 
the lungs removed.  The trachea was clamped with locking forceps to stop blood 
entering the lungs.  The lungs were filled with 750mL PBS, massaged for 20 seconds 
and emptied and this process repeated.  The lavage was collected in 500mL 
centrifuge tubes and centrifuged at 400xg for 10 minutes.  The pellet was collected, 
re-suspended in PBS and the cells processed for freezing as MDMs, if necessary red 
blood cells are lysed as MDMs 
 
2.2.1.5 Macrophages from septic pigs 
Four Goettingen minipigs (Ellegaard, Denmark) were anaesthetised, intubated and 
10^5 cfu Actinobacillus pleuropneumoniae (provided by Moredun Scientific) 
delivered by direct bronchoscopic inoculation into the right lower lobe of the lung.  
Following extubation and recovery pigs were returned to their enclosure and 
temperature and heart rate monitored remotely by radiotelemetry (Data Sciences 
International). On advice of the veterinarian the animals were euthanased four to six 
hours after initial infection due to the severity of clinical symptoms and the death of 
one animal. Blood was collected and PBMCs isolated as described above 
 
2.2.2 Culture conditions 
Cells were retrieved from cryopreservation and seeded at 5x106 cells/10cm2 in a 
complete media consisting of RPMI 1640 (Invitrogen) supplemented with 10% heat 
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inactivated FCS (Sigma), penicillin/streptomycin (25U/25µg/mL, Gibco), 2mM 
Glutamax (Invitrogen).   
 
Primary macrophages were seeded on bacteriological plates (Sterilin, UK).  AMs and 
PMs were left at 37˚C for 2 hours in complete media, non-adherent cells removed by 
washing then cells used within 24 hours.  MDM and BMDMs were incubated for in 
complete media supplemented with rhCSF1, Cells were maintained for a maximum 
of 10 days in culture. 
 
Prior to experiments, cells were split, using an 18-gauge hypodermic needle and 
syringe, and seeded onto tissue culture plastic (Nunc) at    1million cells/mL and 
allowed to adhere for 24 hours.  Cells were grown in 37˚C humidified air venting 5% 
CO2. 
 
2.3 Flow cytometric analysis 
Cells for FACS analysis were prepared using pre-chilled solutions and all 
centrifugation steps were carried out at 4˚C.  Cells were recovered from 
cryopreservation as previously described or harvested from culture using an 18G 
needle, washed, pelleted and incubated 5M cells/mL in hi block (1x PBS, 0.1% 
NaN3, 2% heat inactivated FCS, 0.1% BSA) with 2% heat inactivated normal mouse 
serum on ice for 15 minutes.  Cells are pelleted, the hi block removed then 
resuspended in 100µL lo block (1x PBS, 0.1% NaN3, 0.2% heat inactivated FCS, 
0.1% BSA) containing the appropriate antibody or isotype control (appendix 1).  
Samples were incubated at 4˚C in the dark for 30 minutes before washing 3 times 
with lo block.  Cells were resuspended in 200ul lo block with 0.1% Sytox Blue 
(Invitrogen) for FACS analysis using the CyAn (Dako). Data collection and analysis 
was performed using Summit 4.1 software (Dako). 
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2.4 RNA analysis 
 
2.4.1 RNA extraction 
RNA extraction was carried out using the Qiagen RNeasy mini kit using on column 
DNase treatment  (Qiagen, UK) and RNA quantified using a Nanodrop (Nanodrop, 
USA).  RNA quality was assessed using Agilent nanochip (Agilent) 
 
2.4.2 RT qPCR 
 
2.4.2.1 cDNA synthesis 
cDNA was synthesized from 1µg RNA using Superscript III (Invitrogen).  11µL 
reactions containing 500ng random primers (Invitrogen) and RNA were prepared and 
heated to 70˚C for 10 minutes then chilled on ice.  Reverse transcription occurred in 
a reaction containing 1x first strand buffer, 2µL 1M DTT, 1µL 10mM dNTP and 1µL 
Superscript III (Invitrogen).  This was incubated at 50˚C for 50 minutes then 70˚C 
for 10 minutes.  Negative controls were performed with the omission of Superscript 
III to check for genomic contamination.  The cDNA was diluted 1:20 for use in RT 
qPCR reactions. 
 
2.4.2.2 Primer design and optimisation 
Primer pairs used for RT qPCR are detailed in appendix 2.  All oligonucleotides were 
designed using Primer3 (Steve Rozen, Helen J. Skaletsky (1998) Primer3. Code 
available at http://www-genome.wi.mit.edu/genome_software/other/primer3.html.) 
and synthesised by Invitrogen (Paisley, UK).  Primers were designed with an optimal 
amplicon size between 80-150 bp.  Primer pairs were designed so that one of the 
primers overlapped an exon junction to prevent possible amplification of any 
remaining genomic DNA. Primers are designed with an annealing temperature of 
60˚C and optimised using a pool of cDNA consisting of the samples to be tested. The 
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Dissociation curve analysis for each primer pair ensured that only a single 
amplification product was produced and efficiency was between 95-105%.  Primers 
were used at 500nM 
 
2.4.2.3 Quantification of mRNA expression for specific genes  
mRNA expression was quantitated using the SybrGreen quantitative PCR system 
(Invitrogen, Carlsbad, CA, USA) in 25 µL reactions of a 96 well plate. Each reaction 
contained 9.5 µL diluted cDNA and 0.5µM forward and reverse primers in 1 x 
SyberGreen reagent. Samples were measured by real-time quantitative PCR using a 
Stratagene MX300P real-time PCR system (LaJolla, CA) at 1 cycle of 50 °C for 2 
minutes then 95 °C for 2 minutes, followed by 40 cycles of 15 seconds at  95 °C then 
30 seconds at 60 °C.  One cycle of 95°C for 1 minute, 60°C for 30 seconds, 95°C for 
15 seconds then 25°C for 30 seconds was used for melting curve analysis. Transcript 
abundance relative to HPRT and standard deviation (SD) was determined using the 
following equations (as recommended by Applied Biosystems).  Standard error of 
the mean was used where appropriate 
 
gene/HPRT = 2-∆Ct ; where ∆Ct = geneCt – HPRTCt (the difference in cycle 
threshold) 
SD = 2-∆Ct – 2-x ; where x = ∆Ct + SQRT (SDgene2 + SDHPRT2) 
 
2.4.3 BMDM microarray 
Gene expression levels in BMDM were anlaysed by 3’ Affymetrix array performed 
by ARK genomics (Roslin, Edinburgh).  RNA was first reverse transcribed using an 
Oligo-dT Promoter Primer in a first strand cDNA reaction.  Following RNaseH 
mediated second strand cDNA synthesis the double stranded cDNA was purified and 
served as a template in the subsequent in vitro transcription (IVT) reaction.  The IVT 
reaction was carried out in the presence of T7 RNA Polymerase and a biotinylated 
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nucleotide analog/ribonucleotide mix for cRNA amplification and biotin labelling.  
The biotinylated cRNA targets were then cleaned up, fragmented and hybridised to 
the Affymetrix GeneChips as described in user manual of Ambion® WT expression 
Kit (Affymetrix).  Probe set expressions were normalized using the robust multi-
array average (RMA) algorithm as implemented in the Bioconductor package 
(Affymetrix). The annotation of the genes was obtained thanks to Prof. Chris K. 
Tuggle, using the Affymetrix porcine annotation in addition to the Affymetrix human 
annotation.  Differentially expressed probes were detected by comparing un-
stimulated macrophages with each of the other time points then fitting a linear model 
through each probe using the Bioconductor package LIMMA. The design matrix for 
the linear models included a coefficient for each of the three pigs and a coefficient 
for the comparisons of interest: 0 vs 2 h, 0 vs 7 h and 0 vs 24 h (statistical analysis by 
Dario Beraldi).  Normalized array data were uploaded to the software Biolayout 
Express(3D) (http://www.biolayout.org/) and a graph was created using parameters 
of R mean 0.95, Markov clustering algorithm of 2.2, and a minimum number of 6 
nodes per cluster.  The 500 most inducible probesets were identified using fold 
change (p<0.01) then compared to available array data from mouse and human 
macrophages treated in exactly the same manner (Schroder et al., 2012) 
 
2.4.4 Monocyte microarray 
Monocytes gene expression data levels were analysed by use of a whole genome 
array performed by ARK Genomics (Roslin, Edinburgh).  The array was 
commissioned by the Roslin Institute (Freeman et al. Manuscript in preparation) and 
prepared by Fios Genomics and Affymetrix.  Data was sorted to extract all genes 
differentially expressed between subsets (> 1.5 fold change or <0,67 fold change) 
Normalized, sorted array data was then uploaded to the software Biolayout 
Express(3D) (http://www.biolayout.org/) and a graph was created using parameters 
of R mean 0.95, Markov clustering algorithm of 2.2, and a minimum number of 6 
nodes per cluster.  Genes which were differentially expressed in mouse and human 
monocyte subsets was identified from the literature (Ingersoll et al., 2010) and 
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expression levels of these genes analysed in pig monocyte subsets.  Probes were 
selected as detailed below.  
 
2.4.4.1 Design of the 'Snowball' array and annotation of the probesets 
Porcine expressed sequences (cDNA) were collated from public data repositories 
(ENSEMBL, RefSeq, Unigene and the University of Iowa ANEXdb database) to 
create a non-overlapping set of reference sequences.  A series of sequential BLASTN 
analyses, using the NCBI blastall executable, were performed with the -m8 option.  
The initial subject database comprised 2,012 sequences manually annotated S. 
scrofa gene models from Havana provided by Jane Loveland on 29 July 2010, plus 
21,021 sequences acquired using Ensembl BioMart Sscrofa (build 9, version 59 on 
22 July 2010).  For each iteration query sequences that did not have an alignment 
with a bitscore in excess of 50 were added to the subject database prior to the next 
iteration.   
 
The iterations involved the following query datasets: 
1. 35,171 mRNA sequences from NCBI, downloaded on 15 July 2010; 6,286 
added to subject database 
2. 7,882 RefSeq sequences from NCBI, downloaded on 15 July 2010: 0 added 
to subject database 
3. 43,179 Unigene sequences from NCBI, downloaded on 15 July 2010 (filtered 
to include only those longer than 500 bases): 10,125 added to subject 
database 
4. 121,991 contig sequences, downloaded from Iowa Porcine Assembly v1 
(annexdb.org) on 30 July 2010 (filtered to include only those longer than 500 
bases): 10,536 added to subject database 
5. 2,370 miRNA sequences (pig, cow, human, mouse), downloaded from 
miRbase, 30 July 2010 (Release 15, April 2010, 14197 entries): all added 
without blastn analysis. 
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The final subject database comprised 52,355 expressed sequences. 
  
To facilitate the design of array probes that were uniformly distributed along the 
entire length of transcripts, each transcript was split into several probe selection 
regions (PSRs), each of which was then the target for probe selection.  The size of 
each PSR, typically ~150 nucleotides, was determined by the length of the input 
sequence, with the ultimate aim being to obtain 20-25 probes per transcript.  Oligo 
design against the ~343,000 PSRs was performed by Affymetrix.  In addition, 
standard Affymetrix controls for hybridisation, labelling efficiency and non-specific 
binding were included on the array (a total of 123 probesets), together with complete 
tiling probesets for 35 porcine-related virus genome sequences (both strands, centre-
to-centre gap of 17 nucleotides) for possible future infection-based studies. The final 
array is comprised of 47,845 probesets, with a mean probe coverage of 22. 
  
Initial annotation of the gene models was obtained from the sequence sources and 
converted into an annotation set using the AnnotateDbi Bioconductor package.  
However, following this exercise many probesets were without useful annotation. 
Therefore the original sequences from which the probes had been designed were 
blasted against NCBI Refseq in order to try and impute the most likely orthologous 
gene of the 'unannotated' pig transcripts. In order to have one gene per query 
sequence the following annotation pipeline was followed: 
 
1. For each query the hit with lowest e-value within each species was chosen 
2. Genes with e-value hits <1e-9 against H. sapiens were annotated with HGNC 
names/descriptions, however genes with matches starting with 'LOC' were 
not used.  
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3. Step 2 was repeated using in order: Sus scrofa, Bos taurus, Pan troglodytes, 
Mus musculus, Canis lupus familiaris, Pongo abelii, Equus caballus, Rattus 
norvegicus, Macaca mulatta. 
4. Step 3 was repeated using any other species (in no particular order) to which 
a hit could be obtained. 
5. For the remaining probes use LOC genes from (in order of priority): Homo 
sapiens, Sus scrofa, Bos taurus, Pan troglodytes, Mus musculus 
6. Use everything else, in no particular order. 
 
Out of 47,845 sequences represented on the array, 27,322 probesets now have 
annotations that correspond to a current (15th Dec. 2011) HGNC symbol for human 
protein coding gene, 14,426 of which are unique (out of a total 19,219 listed by 
HGNC).  The remaining probesets were annotated with the information available for 
those sequences. 
 
2.5 Investigation of the nitric oxide pathway 
 
2.5.1 Nitrite assay 
Activity of the inducible nitric oxide synthetase (iNOS/NOS2) enzyme generates the 
unstable effector molecule, nitric oxide.  iNOS activity was determined by the 
detection of nitrite, the stable metabolite of nitric oxide using the Greiss reagent 
(0.1% α-napthyl-amine, 1% sulfanilimide, 2.1% phosphoric acid).  Differentiated 
macrophages were seeded at 1M/mL in a 6 well plate and allowed to adhere for 24 
hours before treatment with 100ng/ml LPS.  Supernatants were removed and stored 
at -20˚C.  Nitrite concentration was assayed against standards by incubating 50µL of 
supernatant/standard with 50µL Greiss reagent for 10 minutes.  Absorbance was 
measured at 540nm. 
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2.6 Cloning and sequencing of RT qPCR  gene 
products 
cDNA was synthesised as previously using primers for the IDO, STAT4, CCL20 and 
HPRT.  The pGEM-T easy kit (Promega) was used as per instructions to clone the 
pcr products in XL-1 blue competent cells.   Plasmid DNA was purified using the 
Miniprep kit (Quiagen).  DNA sequencing was performed by DNA Sequencing & 
Services (MRCPPU, College of Life Sciences, University of Dundee, Scotland, 
www.dnaseq.co.uk) using Applied Biosystems Big-Dye Ver 3.1 chemistry on an 
Applied Biosystems model 3730 automated capillary DNA sequencer. Sequencing 
results were blasted against the pig genome to ensure the correct gene product was 
amplified by the prime
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As discussed previously the LPS receptor CD14 and Fc gamma receptor CD16 are commonly 
used as markers to distinguish  human monocytes subsets (Ziegler-Heitbrock, 2007) while the 
glycophosphatidyl-inositol (GPI)-anchored glycoprotein Ly6C and the chemokine receptors 
CCR2 and CXCL3 have been used for the same purpose in mice (Auffray et al., 2009).  
Monocyte heterogeneity has also been shown in rats where CD43 is used to distinguish 
monocytes (Ahuja et al., 1995).  In both mouse and human, “intermediate” monocytes 
populations between the two extremes have also been distinguished (Sunderkotter et al., 
2004; Cros et al., 2010; Grage-Griebenow et al., 2001a; Grage-Griebenow et al., 1993; 
Grage-Griebenow et al., 2000; Wong et al., 2011).  A consortium of investigators has 
proposed that the CD14 high population, which is more numerous in humans, be referred to 
as “classical” monocytes; the minor CD16 positive expression being “non-classical” and 
monocytes which express both CD14 and CD16 be termed intermediate (Ziegler-Heitbrock et 
al., 2010; Wong et al., 2011).  This nomenclature has not yet been widely accepted and it is 
not clear how well it translates across species other than humans, where the monocyte 
populations are more similar in relative abundance. The presumption in all such efforts is that 
the marker-defined subpopulations also have distinct functions, differing in inflammatory and 
differential potential, cytokine production and recognition of pathogens.  This chapter will 
review the markers used to distinguish monocyte populations in other species, discuss the 
functions of monocyte subsets and examine markers in the pig and their regulation during 
monocyte differentiation.  
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Figure 3-1 Comparison of CD14 promoters in human, mice and pigs.  
Promoters for the CD14 gene in human, mice and pigs were extracted and analysed by Pustell and ClustalW Alignments.  The human and pig 
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3.1.1 Monocyte markers 
 
3.1.1.1 CD14 
CD14 is a GPI-linked protein and acts as a receptor for LPS and LPS/LPS binding protein 
(LBP) complexes. It is required to detect low concentration of endotoxin and for signalling 
through TLR4 and MD2 (Pugin et al., 1993).  Like humans, pigs require CD14 for detection 
of LPS (Thorgersen et al., 2009).  However, as in mice and men, higher concentrations of 
LPS (100µg/mL) can facilitate binding in a CD14 independent manner (Kielian et al., 1995).  
Porcine CD14 cDNA has been cloned and the sequence encodes a 373 aa peptide, which 
shows 70% homology with the human protein. Porcine CD14 was first identified using 
human anti-CD14 monoclonal antibodies which show cross-reactivity with primates and pig 
but not mouse.  Different anti-CD14 antibodies display different staining patterns, although it 
is not known whether this is due to differences in the affinities of the antibodies or because 
different antibodies recognise different forms of CD14 (Ziegler-Heitbrock et al., 1994).  
 
CD14 is commonly used in humans as a marker for monocytes/macrophages but is also 
detected on granulocytes, albeit at much lower levels (Antal-Szalmas et al., 1997).  Similarly 
porcine CD14 is highly expressed on monocytes, tissue macrophages and at lower levels on 
granulocytes (Sanz et al., 2007; Qiu et al., 2007; Petersen et al., 2007b).  As in human and 
mice, porcine CD14 expression is induced relatively late during macrophage differentiation, 
it is not present on early myeloid progenitors but is expressed after cells have differentiated 
into blood monocytes (Summerfield and McCullough, 1997; Chamorro et al., 2004).  CD14 
is highly expressed in human liver, by hepatocytes as well as Kupffer cells, but no mRNA is 
produced in murine liver (Hetherington et al., 1999; Pan et al., 2000) (see also cDNA array 
data on biogps.gnf.org).  CD14 also has tissue specific expression in the pig, most notably it 
is expressed at high levels in the liver as it is in man (Sanz et al., 2007; Qiu et al., 2007; 
Petersen et al., 2007b).  The lack of Cd14 expression in mouse liver is a fundamental 
difference between mice and humans (and pigs) which may have some importance to 
understanding the difference in LPS sensitivity between the species.  Production of NO varies 
greatly between man and mice and there is some evidence this may be due to fundamental 
differences in the promoters (Taylor and Geller, 2000; Zhang et al., 1996; Yu et al., 2005).  
Chapter 3 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 52 
Figure 3.1 shows Pustell and ClustalW alignments of mouse, human and pig CD14 
promoters.  As has been noted previously when comparing genes which have differential 
expression between species (Perez et al., 2006; Yu et al., 2005), the mouse and human 
promoters for CD14 show little conservation.  By contrast the pig and human promoters are 
much more closely conserved.  This difference in promoter architecture could be responsible 
for the different expression patterns of CD14 between men and pigs, and mice which may be 
a contributing factor in the vast differences in LPS sensitivity between the species. 
 
3.1.1.2 CD16 
In man, CD16 (Fc gamma receptor type III, encoded by the FCGR3 gene) is found in two 
forms, a transmembrane form expressed on monocytes and NK cells and a 
phosphatidylinositol linked form expressed on neutrophils (Ravetch and Perussia, 1989). 
Copy number variation in FCGR3 has been linked to susceptibility to disease in humans and 
rats (Aitman et al., 2006; Willcocks et al., 2008) although humans appear to be the only 
animal to have two isoforms of the gene.  Previous studies in the pig found CD16 expression 
predominantly on NK cells, monocytes and macrophages and at lower levels on neutrophils 
and immature granulocytes (Chamorro et al., 2004).  CD16 was found at slightly higher 
levels on CD163+ cells (Sanchez et al., 1999). CD16 is perhaps most commonly used as a 
marker of monocyte differentiation in man.  CD14hiCD16- monocytes can be matured into 
CD14loCD16hi monocytes and MDMs generated in vitro increased expression of CD16 as 
they matured into macrophages (Ziegler-Heitbrock et al., 1993). Mouse monocyte subsets, 
previously categorised by the presence of Ly6C, can also be split on the basis of CD16 with 
the more mature Ly6Clo subset expressing higher levels of CD16 (Ingersoll et al., 2010), 
suggesting CD16 is also a marker of monocyte maturation in the mouse. 
 
3.1.1.3 CD163 
In man, CD163 has been identified as a receptor involved in clearance of hemoglobin-
haptoglobin-haptoglobin complexes by resident macrophages (Ritter et al., 1999). More 
recently identified functions include as a receptor for TNF-like weak inducer of apoptosis 
(TWEAK) (Bover et al., 2007), as an erythroblast adhesion receptor (Fabriek et al., 2007) and 
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as a bacterial innate immune sensor (Fabriek et al., 2009).  CD163 expressing human 
macrophages have also been shown to secrete anti-inflammatory cytokines (Philippidis et al., 
2004).  Like CD14, CD163 exists in a membrane bound and soluble form and pro-
inflammatory stimulation leads to shedding from the cell surface (Weaver et al., 2007; 
Sulahian et al., 2004). It is highly expressed on tissue macrophages and is considered a 
candidate innate immune sensor for bacteria, generating an anti-inflammatory signal (Fabriek 
et al., 2009; Weaver et al., 2007). CD163 expression is restricted to myeloid cells in man and 
is more strongly expressed by CD14hi CD16lo monocytes than by the CD14loCD16hisubset.  
However treatment of monocytes with CSF1 increased expression on all human subsets 
(Tippett et al., 2011).  Mouse Ly6C hi and Ly6C lo  subsets do not appear to have differential 
expression of CD163 (Ingersoll et al., 2010).   In rats, CD163 was originally detected with the 
ED2 monoclonal antibody, which recognises most tissue macrophages.  ED2 antigen has not 
been detected on rat monocytes (Polfliet et al., 2006; Dijkstra et al., 1985). As in man CD163 
expression in the pig is restricted to myeloid cells and is higher on tissue macrophages and a 
subset of blood monocytes which were considered more mature. CD163 hi  monocytes were 
claimed to express lower levels of CD16, converse to what was observed in man, (Sanchez et 
al., 1999; Ingersoll et al., 2010).  Like CD14 and CD16, CD163 is an import immune 
receptor.  CD163 is a receptor for Porcine Reproductive and Respiratory Virus Syndrome 
(PRRVS) (Duan et al., 1997) and African Swine Fever Virus (ASFV) (Sanchez-Torres et al., 
2003) and higher expression is associated with increased susceptibility to these viral 
pathogens (Calvert et al., 2007; Sanchez-Torres et al., 2003; Patton et al., 2009). In man HIV 
infected macrophages and microglia have been shown to up-regulate CD163 expression (Kim 
et al., 2006) and expression on blood monocytes was also increased in HIV infected patients 
(Tippett et al., 2011) 
 
3.1.2 Monocyte subsets 
The markers described above are commonly used to distinguish monocytes in humans, 
rodents and pigs and the current view of the most commonly used subsets are summarized in 
Figure 3.2.  More recently an intermediate subset of human monocytes has been identified 
which expressed intermediary levels of markers previously used to distinguish classical and 
non-classical monocytes.  Only a few markers have proven to be specific for intermediate 
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monocytes (e.g. GFRα2, CLEC10A) and these were expressed at low levels on these cells 
making isolation difficult (Wong et al., 2011).  A second Fc receptor, CD64,  has also been 
used to further sub-divide human CD16+ monocytes (Grage-Griebenow et al., 2001b; Grage-
Griebenow et al., 1993; Grage-Griebenow et al., 2000) while a Ly6C intermediate population 
of mouse monocytes has been reported (Sunderkotter et al., 2004).  Human CD16+ 
monocytes produced higher levels of TNFα and IL1β and low levels of IL10 while CD16- 
monocytes produced low levels of TNFα and appear to be the main producers of IL10 (Belge 
et al., 2002; Ziegler-Heitbrock et al., 1992; Ziegler-Heitbrock, 2007).  Mouse Ly6Clo 
monocytes resemble Human CD16+ monocytes based on surface marker expression and gene 
array studies (Ingersoll et al., 2010; Geissmann et al., 2003).  Distinct cytokine expression 
profiles give clues to the function of these subsets in vivo and will be discussed in more detail 
in Chapter 4, however the specific function of each monocyte subset has not yet been fully 
elucidated.  Murine Ly6Clo monocytes, which are defined by high expression of the 
fractalkine receptor CX3CR1 and absence of another chemokine receptor, CCR2, have been 
shown to have an LFA1 (CD11a/CD18) dependent patrolling function.  In response to tissue 
injury CX3CR1+ cells left the circulation and travel to the site of injury where they were 
responsible for the early inflammatory response. CX3CR1 was itself required for tissue 
invasion (Auffray et al., 2007).  CD14dimCD16hi monocytes which also lack CCR2 and have 
high expression of CX3CR1, appeared to fulfill this function in man (Cros et al., 2010).   
Human CD16+ monocytes also expressed CX3CR1 and migrate in response to CX3CL1 
expressed by inflamed endothelial cells.  CD16- monocytes expressed CCR2 and CD62L and 
responded to CCL2 which mediated migration from the bone marrow and to sites of 
inflammation, suggesting the different subsets are recruited into different sites during the 
inflammatory response (Ancuta et al., 2003). Relative numbers of the CD14loCD16hi subset 
varied in some forms of infection or inflammation.  Excessive exercise led to an increase in 
the CD14loCD16hi population, the infiltrating cells coming from the marginal pool rather than 
peripheral blood.  CD14loCD16hi   monocytes preferentially homed to the marginal pool due 
to high expression of adhesion molecules which were then down regulated by the exercise 
induced release of catecholamines which resulted in them moving back into the circulation 
(Steppich et al., 2000).  The CD16+ monocyte subset also increased in inflammatory disease 
such as rheumatoid arthritis (Baeten et al., 2000) and atherosclerosis (Wildgruber et al., 2009) 
and in bacterial and viral infections such as tuberculosis (Vanham et al., 1996) and HIV  
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Figure 3-2 Monocyte subsets in man, mouse and pig 
CD14 and CD16 are commonly used to define monocyte subsets in man (A) while Ly6C and 
CD14 and CD163 fulfill the same function in mice (B) and pigs (C) respectively.
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(Allen et al., 1991).  In sepsis as many as 50% of circulating blood monocytes were CD16+   
(Blumenstein et al., 1997; Fingerle et al., 1993).  The CD16+ monocyte subset also increased 
with age while total leukocyte and monocyte numbers remained static (Seidler et al., 2010). 
Different functions have not yet been ascribed to monocyte subsets in the pig although 
previous authors have described higher expression of CD16 (Sanchez et al., 1999) as well as 
high CX3CR1 and low levels of CCR2 (Moreno et al., 2010) on CD163hi pig monocytes 
which suggest they are therefore approximately equivalent to the human CD14loCD16hi  
monocyte subset (Ziegler-Heitbrock, 2007).   
It is not entirely clear that “subset” is an appropriate term, since the subdivisions of 
monocytes depend somewhat on exactly where one places gates on a flow cytometer.  The 
prevailing view is that the different subsets are maturation stages of the same cells and this 
has been backed-up by recent genetic studies (Wong et al., 2011). In vitro generated human 
MDM expressed lower levels of CD14 and high levels of CD16.  They also displayed 
increased MHC class II expression and decreased expression of CD11b and CD33, similar to 
the CD14loCD16hi subset.  Removal of all CD16+ cells, including the CD14loCD16hi subset, 
from PBMCs prior to cell culture did not affect the generation of CD16+ cells indicating that 
the CD14loCD16hi cells were derived from CD14+CD16- monocytes  (Ziegler-Heitbrock et 
al., 1993).   In the mouse, down-regulation of Ly6C on Ly6Chi circulating monocytes has 
been described, suggesting that as in man, the murine monocyte subsets represent a 
continuum of different stages of maturation (Sunderkotter et al., 2004). 
 
3.1.3 Expression of monocyte markers in the pig 
The proposed functional equivalence of the human CD16+ and mouse Ly6C- cells are mainly 
supported by the differential expression of a few key markers which are summarised in 
Appendix 3.  More recently, some groups have used microarray technology to acquire a 
global view of differences between monocyte subsets across different species (Ingersoll et al., 
2010; Cros et al., 2010) and this will be discussed with relevance to the pig in Chapter 4.  Of 
the markers that are differentially expressed between monocyte subsets in man and mouse, 
only a few have been studied in the pig. CD14 and CD16 were differentially expressed 
although the expression of CD16 has not been fully studied (Sanchez et al., 1999), most 
groups instead focused on differential expression of CD163 (Chamorro et al., 2004; 
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Chamorro et al., 2000; Chamorro et al., 2005).  CD11a had a similar expression pattern in the 
pig to that found in humans.  Human anti CD11b and CD11c antibodies recognise the porcine 
molecules wCD11R1 and wCD11R2 respectively although both had different expression 
patterns to that observed in humans.  wCD11R1 was expressed by 50% of granulocytes and  
was found on some blood monocytes,  alveolar macrophages, NK cells and DCs.  wCD11R2, 
the human counterpart of which is often used as a marker of DCs, was expressed on 
monocytes, DCs and AM but not granulocytes and was up-regulated following differentiation 
of PBMCs into tissue macrophages (Chamorro et al., 2000; Ezquerra et al., 2009).  As in 
humans and mice, expression of CX3CR1 was higher on CD163+ monocytes while CCR2 
expression was low and the converse was true for CD163-  monocytes (Moreno et al., 2010).  
Unfortunately the lack of commercially available anti-porcine antibodies means that 
expression of CCR2 and CX3CR1 have only been studied at the mRNA level and data on 
their expression at the protein level is not available.  Similarly expression of CD43, CD62L 
and CCR1 have not been studied in the pig, probably due to the lack of porcine specific 
antibodies. Studies looking at cytokine expression of pig monocyte subsets found all porcine 
monocytes produced TNF and IL1α after LPS stimulation, however CD163+ monocytes 
produce higher levels of these pro-inflammatory cytokines and only CD163- monocytes 
produced IL10, suggesting that, like human CD16- monocytes, CD163- monocytes have an 
anti-inflammatory role while CD163+ monocytes were more pro-inflammatory(Chamorro et 
al., 2005). 
 
3.1.4 Expression of porcine specific markers 
A number of pig specific myeloid cell markers have been studied by previous groups 
(Chamorro et al., 2005; Chamorro et al., 2004; Chamorro et al., 2000; Ezquerra et al., 2009).  
The most commonly used are swine workshop cluster (SWC) 1, 3, 8 and 9.  SWC1 was 
expressed on resting lymphocytes and myelomonocytic cells and was down-regulated as 
monocytes differentiate (Basta et al., 1999; Chamorro et al., 2004; Chamorro et al., 2000; 
Ezquerra et al., 2009).  SWC3 is the porcine homologue of the receptor-type transmembrane 
glycoprotein signal-regulatory protein alpha (SIRPα ,CD172a) and has a high degree of 
homology with the human protein (75% to 80%).   CD172a was expressed on every cell of 
myeloid origin from the earliest bone marrow pre-cursors (Summerfield and McCullough, 
Chapter 3 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 58 
1997). SWC8 is commonly used as a granulocyte marker. Myeloid cells from the jejunal 
lamina propria, blood and bone marrow granulocytes were SWC8+ while freshly isolated 
monocytes were negative (Thacker et al., 2001). SWC9 has 89% homology with human 
phosphodiesterase I / ecto-nucleotide pyrophosphatase 1 (NPP1/CD203a). The transcript was 
highly expressed in the thymus, pulmonary alveolar macrophages and lung tissues. 
Expression was up-regulated during monocyte differentiation into macrophages and its 
expression was restricted to mature macrophages (Petersen et al., 2007a).  CD14, CD163, 
SWC9, SWC3 and SLA DR were used to define multiple myeloid cell subsets and as in man, 
different subsets have been proposed to have different immune-regulatory roles (Chamorro et 
al., 2004; Chamorro et al., 2000; Chamorro et al., 2005). An excellent review of porcine 
monocyte markers is given by Ezquerra et al. (Ezquerra et al., 2009). 
 
3.1.5 CSF1 
Colony stimulating factor 1 (CSF1, MCSF)  was the first haemopoietic growth factor to be 
isolated and promotes the growth of mature macrophages from immature progenitors 
(Stanley et al., 1976).  The non-redundant functions of CSF1 have been studied in the 
osteopetrotic/osteopetrotic (op/op) mouse, which has a mutation in the Csf1 gene or an 
introduced mutation in the CSF1 receptor (CSF1R) gene (Csf1r).  Op/op mice have skeletal 
abnormalities, a shorter life span, a number of neurological and reproductive defects, and 
lower resistance to infection underlining the importance of macrophages in regulating 
development and homeostasis in a number of physiological systems.  They were not 
completely devoid of all macrophages but their numbers were substantially reduced (Ryan et 
al., 2001; Dai et al., 2002; Cecchini et al., 1994).  CSF1 has the ability to differentiate mouse 
BMC into mature macrophages in culture and this has been widely utilised in studies of 
myeloid cell development (Hume et al., 1987; Warren and Vogel, 1985; Hume and Gordon, 
1983).  The CSF1 gene has evolved rather rapidly across species (Garceau et al., 2010).  
Human CSF1 is active in mice, and indeed recombinant human CSF1 was used in the first in 
vivo studies (Hume et al., 1988).  Conversely, murine CSF1 does not act on the human 
CSF1R (Stanley, 2001).  The pig CSF1R binds both mouse and human CSF1 and both factors 
are able to stimulate pig macrophage differentiation and proliferation (Gow et al. manuscript 
in preparation).  The colony forming effects of CSF1 are increased when cells are cultured in 
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a combination of growth factors including GMCSF, IL3 and IFNγ (Breen et al., 1991; Breen 
et al., 1990; Miyauchi et al., 1988; Caracciolo et al., 1987). CSF1 has a number of 
immunological effects; it enhanced cytotoxicity, superoxide production, phagocytosis, 
chemotaxis and cytokine production in  monocytes and macrophages (Chitu and Stanley, 
2006).  Moreover the innate immune response can be affected by CSF1-dependent 
modulation of TLRs and CSF1 enhanced the cytokine response to LPS in the mouse (Sweet 
et al., 2002) although not in man (Irvine et al., 2009) or the pig (Kapetanovic et al. 
manuscript under review).  There are three isoforms of CSF1, the secreted proteoglycan, a 
secreted glycoprotein and a cell-surface membrane anchored form, all of which have different 
effects in immunity and inflammation (Chitu and Stanley, 2006).  In cancer  the different 
isoforms of CSF1 have been shown to have both pro (Aharinejad et al., 2002; Lin et al., 
2001; Pyonteck et al., 2011) and anti-tumour effects (Lu et al., 1991; Graf et al., 1999; Jadus 
et al., 0 AD; Hoa et al., 2007) although generally CSF1 is seen to have a cancer promoting 
role (Pollard, 2005).  CSF1 up-regulated expression of CD14 and CD16 on human monocytes 
(Ji et al., 2004; Li et al., 2004; Kawanaka et al., 2002) and elevated levels of this growth 
factor may lead to increased numbers of CD16+ monocytes which can worsen the pathology 
of rheumatoid arthritis among other diseases (Kawanaka et al., 2002).  Elevated numbers of 
CD16+ monocytes are also observed in cancer where treatment with recombinant human 
CSF1 (rhCSF1) further increased their numbers (Saleh et al., 1995).  Treatment with an anti-
CSF1 antibody caused a decrease in CD16+ monocytes in non-human primates (Radi et al., 
2011) suggesting blockade of CSF1 could improve the pathology of disease where an 
abnormally high number of CD16+ monocytes contribute to the pathology (Kawanaka et al., 
2002; Baeten et al., 2000; Wildgruber et al., 2009; Vanham et al., 1996; Allen et al., 1991; 
Blumenstein et al., 1997; Fingerle et al., 1993). 
 
It was originally hoped that CSF1 administration would improve the outcome of many 
disease such as cancer (Munn et al., 1990).  However much of the pathology of infectious or 
inflammatory diseases are macrophage mediated and increased levels of CSF1 led to 
increased numbers of macrophages (Weiner et al., 1994).  Interest has therefore turned to 
antagonists of CSF1.  There is some indication that blocking CSF1 may have a beneficial 
effect on some human pathologies (Macdonald et al., 2010; Hashimoto et al., 2011; Lenzo et 
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al., 2011; Hume and MacDonald, 2011).  The actions of CSF1 can be blocked by inhibitors 
against the protein tyrosine kinase activity of the receptor or by anti-CSF1R antibodies which 
block binding of the ligand(s) to the receptor.  In normal physiological conditions CSF1 is 
cleared from the circulation by receptor mediated endocytosis or by binding to CSF1R.  This 
ensures that monocytopoesis is linked to the immune state of the body (Shaposhnik et al., 
2010; Bartocci et al., 1987).  Blocking CSF1R therefore causes a huge increase in circulating 
CSF1; as the antibody dissipates and CSF1 begins to be cleared from the circulation a 
correspondingly large increase in monocyte numbers occurs.  This does not happen when 
CSF1R kinase inhibitors are used as they do not inhibit receptor-mediated endocytosis so 
some CSF1 will still be cleared from the circulation. They do however block autocrine CSF1 
which anti-CSF1R antibodies cannot do (Irvine et al., 2006; Hume and MacDonald, 2011). 
 
A recently developed anti-CSF1R antibody (M279) specifically depleted Ly6Clo monocytes 
in a mouse model.  A corresponding increase in Ly6Chi monocytes was observed although 
total monocyte numbers were not affected (Macdonald et al., 2010).  M279 selectively 
depleted several tissue macrophage populations including macrophages from established 
tumours but had no effect on macrophage numbers in inflammatory models of disease in the 
mouse.  These results have been partly replicated using a different anti-CSF1R antibody 
(AFS98) (Lenzo et al., 2011; Hashimoto et al., 2011).  These studies confirmed the CSF1-
dependant decrease in Ly6Clo cells which Macdonald et al. (2010) observed. They also report 
a decrease in total monocyte numbers.  Lenzo et al (2011) used AFS98 at lower doses than 
Hashimoto et al (2011) and correspondingly observed a more selective reduction in the 
mature monocyte subset.   The difference in total monocyte numbers when treated with M279 
versus AFS98 is probably due to intrinsic differences in the antibodies, since M279 has a 
much higher affinity for CSF1R than AFS98(Hume and MacDonald, 2011).  Additionally 
AFS98 is immunoglobulin IgG2a type and may bind to the Fc receptor CD64 which is 
constitutively expressed by macrophages.  This could lead to the death or removal of AFS98 
labelled monocytes by other CD64 expressing macrophage (Hume and MacDonald, 2011).  
All three studies demonstrated a loss of peritoneal macrophages after anti-CSF1R antibody 
administration, probably due to the reduced numbers of Ly6Clo circulating monocytes which 
are the precursors of mature tissue macrophages. The differentiation of Ly6Chi cells into the 
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more mature Ly6Clo subset and subsequent loss of selected tissue macrophage populations 
was the only non-redundant function of CSF1.  This suggests that, in the mouse at least, the 
two monocyte subsets are different maturation stages of the same cell and that CSF1 is 
essential for maturation of resident Ly6Chi cells into the more mature Ly6Clo subset and 
thence to tissue macrophages but not for generation of monocytes (Macdonald et al., 2010). 
 
There is a large body of work studying the heterogeneous expression of surface markers on 
human and mouse monocytes (Gordon and Taylor, 2005; Geissmann et al., 2003; Ziegler-
Heitbrock, 1996).  The expression of similarly heterogeneously expressed markers has been 
previously studied in the pig, mainly on blood monocytes (Chamorro et al., 2004; Chamorro 
et al., 2000; Chamorro et al., 2005; Gordon and Taylor, 2005; Sanchez et al., 1999).  One of 
the major advantages of the pig as a model for human immunity is the ability to compare 
MDM and BMDM with mature tissue macrophages from the same animal.  Tissue 
macrophages  are generally agreed to derive from circulating monocytes and are important 
for conservation of tissue homeostasis through the repair or remodelling of tissue after 
inflammation or injury (Gordon and Taylor, 2005).  They show a high degree of 
heterogeneity which is related to the specialised functions they fulfil in their particular 
anatomical niche. AMs are a mature tissue macrophage population, known to be dependent 
upon continuous CSF1 signaling, in both the steady state (Macdonald et al., 2010) and in an 
LPS-induced model of lung inflammation (Lenzo et al., 2011), in the mouse at least.  They 
are distinct from macrophages in other sites and play a central role in the innate immune 
system.  AMs are the first line of defense against inhaled pathogens and are involved in the 
pathology or control of diseases such as Pneumonia (Broug-Holub et al., 1997), Chronic 
Obstructive Pulmonary Disease (Hodge et al., 2003) and Legionnaires Disease (Shin and 
Roy, 2008).  AMs also function as an important link with the adaptive immune system as 
they function as antigen presenting cells (APC) (Vecchiarelli et al., 1994).  The numbers of 
alveolar macrophages isolated from a mouse are small and limit the scope of in vitro 
experiments.  Human AMs can only be isolated by bronchoalveolar lavage (BAL), an 
unpleasant procedure patients may be unwilling to undergo and are therefore also in short 
supply.  The large size of the pig will provide a unique resource permitting the isolation and 
analysis of a large number of alveolar macrophages from a single animal, enabling models of 
Chapter 3 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 62 
human lung pathology to be developed to a far greater degree than is possible with the 
mouse.  Many of the problems working with AMs described above also apply to the study of 
PMs.  Thioglycolate medium can be used to induce sterile peritoneal inflammation (Gallily et 
al., 1964) and  thioglycolate elicited mouse peritoneal macrophages (TEPMs) are a 
commonly used  model of inflammatory macrophages (Sester et al., 2005; Irvine et al., 2006; 
Halili et al., 2010).  The numbers of peritoneal macrophages isolated from a mouse without 
the use of thioglycolate is however very small, making the study of non-inflammatory PMs 
difficult.  Additionally the use of thioglycolate does not allow these elicited cells to be seen in 
any other role than as their classic function as APCs, murine PMs collected by peritoneal 
lavage have been shown to suppress T cell activation through IFNγ mediated catabolism of 
arginine (by iNOS) and tryptophan (by IDO) (Matlack et al., 2006).   Human PMs represent 
one of the few human resident macrophage populations that can be  
Chapter 3 




Figure 3-3 Cells were harvested from 4 different compartments in the pig.  
BMCs (A-C)  and PBMCs (D-F) treated with rhCSF1 for up to 7 days.  A and D freshly 
isolated cells, B and E grown in CSF1 for 3 days, C and F grown in CSF1 for 7 days.  G 
PBMCs grown in the absence of rhCSF1 for 3 days.
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easily isolated and studied (Xu et al., 2007; MacGowan et al., 1983) and there is a literature 
on their study (Jha et al., 1996; Chang et al., 2010; Peterson et al., 1983).  Unfortunately 
human AMs and BMC are not readily available limiting comparisons between macrophages 
from different anatomical niches in man.  The porcine peritoneal cavity is a sterile 
environment from which large numbers of macrophages can be easily isolated and will 
enable the comparison of macrophages from different anatomical locations (e.g. AMs versus 




3.2.1 Establishing a model of macrophage activation in large 
animals 
 
3.2.1.1 Isolation and cryopreservation of porcine macrophages from blood, 
bone marrow, lungs and peritoneal cavity 
As stated above, the ability to compare macrophages from different locations is one of the 
advantages of using the pig as a model.  A large number of cells were successfully isolated 
from the lungs, peritoneal cavity, bone marrow and blood of a pig (Figure 3.3B). The 
number of cells collected from one animal was very large, on average 1E+09 PBMCs, 9E+08 
BMCs, 8E+07 PMs and 1E+09 AM (n=5) (Figure 3.3B). Thus cells from one animal could 
be stored and used in many experiments without pooling samples from different animals as is 
common in the mouse.  The large number of cells obtained from one animal also allows 
repetition of experiments using the same cells. 
 
In order to best utilise the large number of cells isolated from the pig a cryopreservation 
protocol was optimised. Two different freezing media were assessed, FM1 and FM2 
(Chapter 2).  Viability after cryopreservation was above 80% for all cells using FM1 and 
higher in BMCs and PBMCs using FM1 (Figure 3.3A) therefore FM1 was used for all future 
work.   
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Figure 3-4 rhCSF1 caused BMCs and PBMCs to increase in granularity. 
BMCs (A-C) and PBMCs (D-F) treated with rhCSF1 for up to 7 days.  A and D freshly 
isolated cells, B and E grown in CSF1 for 3 days, C and F grown in CSF1 for 7 days.  G 
PBMCs grown in the absence of rhCSF1 for 3 days.
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3.2.1.2 Recombinant human CSF1 induces differentiation 
Previous authors have used mouse L929 conditioned medium as a source of mouse CSF1 to 
grow pig macrophages.  Recombinant human CSF1 potentially provides a more potent and 
reproducible system, as previously employed in studies of the mouse. Accordingly, pig bone 
marrow cells and PBMCs were cultured in rhCSF1 as described previously (Stacey et al., 
1993). Cells from both populations grown in  
 
rhCSF1 for 3 days at concentrations previously found to be maximally active for mouse,   
increased in size and granularity (Figure 3.4B, E) compared to freshly isolated cells (Figure 
3.4A, D).  After 7 days growth in rhCSF1 this population of larger, more granular cells 
increased further.  Expression of the maturation associated marker CD16 also increased on 
rhCSF1 cultured PBMCs.  Cells grown in normal media without the addition of rhCSF1 for 3 
days did not show this change in morphology or marker expression (Figure 3.4G).   
 
3.2.2 Characterisation of porcine BMCs 
 
3.2.2.1 Expression of CD14, CD16, CD163 and CD172a on BMC 
Murine BMDM are one of the most commonly used cells when modeling the human immune 
system.  They are often compared to human MDM as similarly immature 
macrophage/monocyte populations.  Blood and bone marrow monocytes are readily available 
in large quantities from the pig.  Examining the expression levels of key immune markers on 
porcine BMDM and MDM will allow a fuller characterisation of these immature cells from 
the same animal.  Previous studies have validated the use of Flow assisted cytometry (FACS) 
to study cell populations.  Forward scatter (FSC) vs. side scatter (SSC) plots have been 
shown to compare favourably to manual bone marrow differential counts in the dog, and 
distinct populations of erythroid and myeloid cells could be distinguished as well as 
megakaryocytes.  Cells of the same lineage but at different points of maturation were also 
detectable (Weiss et al., 2000).  Our freshly isolated porcine BMC showed heterogeneous cell 
populations as has been described for other species (Weiss et al., 2000; Lee, 1991; KOLLER 
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et al., 1996) when studied by FSC vs SSC FACS plots (Figure 3.5A) showing several 
populations of varying size and granularity.   
The expression of CD14 and CD16 has been studied extensively on immature monocytes 
(Ziegler-Heitbrock, 2007; Ziegler-Heitbrock, 1996; Ziegler-Heitbrock et al., 1993; Ziegler-
Heitbrock and Ulevitch, 1993).  Likewise CD163 has been used as a monocyte marker in pig 
blood derived monocytes (Chamorro et al., 2005; Chamorro et al., 2004; Chamorro et al., 
2000).  The expression of these surface markers was therefore studied on BMCs to enable 
comparisons of these two undifferentiated monocyte populations in the same animal.  
Approximately half of the BMCs were CD14+ CD16+ and this large double positive 
population was composed of two distinct smaller populations (Figure 3.4C, D).  One 
population expressed higher levels of both CD14 and CD16 while the second population had 
lower levels of both molecules and some CD14- CD16 lo cells.  Just over half of CD14+ 
BMCs expressed CD163 (Figure 3.4E, F) and only 6% of CD163+cells were CD14-, 
showing CD163 to be a good marker of a subset of monocytes from the bone marrow as well 
as its previous use as a marker of blood monocyte subsets.  By contrast CD172a was 
expressed by all CD14+ cells at high levels (56% of total gated cells).  Gating on the larger, 
more granular cells of this population showed they had a higher expression of all the markers 
studied suggesting expression increased as the cells matured 
 
3.2.2.2 Effects of CSF1 on expression of CD14, CD16, CD163 and CD172a 
As discussed previously (Figure 3.4), addition of rhCSF1 caused an increase in the average 
size and granularity of bone marrow cells with time (Figure 3.4A-C).  It also caused an 
increase in auto-fluorescence which is typical of differentiated macrophages and can be seen 
in the isotype control for BMCs cultured for 3 (Figure 3.6G-J) and 7 days (Figure 3.6L-O).  
Increased auto-fluorescence is probably due to increased numbers of lipid droplets in the 
mature macrophages and/or uptake of phenol red from culture medium.  The increased 
number of mature, differentiated cells was reflected in the FSC vs. SSC plots (Figure 3.6A, 
F, K) where a new population of cells could be seen which was larger, more granular and 
more auto-fluorescent than the original population of BMCs.   
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Figure 3-5 Cytometry characterization of freshly harvested BMCs. 
Freshly harvested BMCs from young male Large-White x Landrace pigs were analysed by 
forward-scatter (FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or 
antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (D, F, 








Figure 3-6 Cytometry characterization of BMCs grown in rhCSF1. 
Freshly harvested BMCs (A-E), 3 day old (F-J) and 7 day old (K-O) MDM  from young 
male Large-White x Landrace pigs were analysed by forward-scatter (FS Lin) and side-
scatter (SS Log), and stained with an isotype control or antibodies CD14-FITC (B, G, L), 
CD16-PE (C, H, M), CD163-PE (D, I, N) or CD172a-PE (E, J, O) . 
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The increases in apparent cell size and granularity in response to rhCSF1 were associated 
with altered expression of cell surface markers detected by FACS.  The classical monocyte 
marker CD14 increased after 3 days culture in rhCSF1 with the CD14hi population in 
particular increasing.  This increase was associated with the appearance of larger cells after 
culture in rhCSF1 (Figure 3.6G).  Furthermore additional culture in rhCSF1 increased the 
number of larger more granular cells (Figure 3.6 k) which corresponded to a further increase 
in CD14hi cells (Figure 3.6L).   Expression of the Fc receptor CD16, which is increased on 
mature human monocytes, was also increased by culture in rhCSF1.  Freshly isolated bone 
marrow contained two populations of CD16+ cells and a distinct population of CD16- cells 
(Figure 3.6C).  As with CD14 culture in rhCSF1 increased the number of CD16hi cells 
(Figure 3.6I, M).  As described above, CD163 is used as a marker of monocyte maturation, it 
is also expressed by some mature macrophages.  Nevertheless culturing BMCs in rhCSF1 for 
up to 7 days did not greatly alter levels of expression of this marker.  The proportion of 
CD163+ cells at day 7 was very similar to what was observed in freshly isolated BMC 
(Figure 3.6D, I, N).  As described above, CD172a is expressed by all myeloid cells.  Some 
freshly isolated BMC were CD172a- although the majority of cells expressed high levels 
(Figure 3.6E).  Culture with rhCSF1 increased levels of this marker (Figure 3.6) until after 7 
days culture all cells were CD172a+ (Figure 3.6O). Culturing pig BMC in rhCSF increased 
the expression of CD14, CD16 and CD172a and perhaps surprisingly did not increase levels 
of CD163 which has been noted by others to increase on blood derived monocytes as they 
mature (Chamorro et al., 2005; Sanchez et al., 1999).   As discussed above, CD16 is seen as a 
marker of macrophage differentiation in humans and mice, it would appear that it can also be 
used as a marker of macrophage maturation in the pig.   
 
3.2.3 Characterisation of porcine AMs 
3.2.3.1 Expression of CD14, CD16, CD163, CD172a on AMs 
Analysis of AMs isolated from rodents and humans has shown that lung macrophages are not 
a homogeneous cell population (Nicod et al., 1987; Shellito and Kaltreider, 1984).  
Subpopulations have been characterized by the use of density separation techniques in 
combination with mAb staining with different immunological functions assigned to these 
subpopulations (Spiteri and Poulter, 1991). Previous experiments have divided pig AMs by 
density (Zeidler et al., 1987).   Expression of the scavenger receptor CD163 has been shown  
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Figure 3-7 Cytometry characterization of freshly harvested AMs. 
AMs, from young male Large-White x Landrace pigs were analysed by forward-scatter (FS 
Lin) and side-scatter (SS Log; A, I), stained with an isotype control (B, J) or antibodies 
CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C&K, D&L, and E&M, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (F&N, 
G&O, and H&P, respectively). 
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Figure 3-8 Effects of CSF1 on pig AMs. 
Freshly harvested AMs (A-E), 3 day old (F-J) and 7 day old (K-O) AMs grown with rhCSF1  
from young male Large-White x Landrace pigs were analysed by forward-scatter (FS Lin) 
and side-scatter (SS Log), and stained with an isotype control or antibodies CD14-FITC (B, 
G, L), CD16-PE (C, H, M), CD163-PE (D, I, N) or CD172a-PE (E, J, O) .  
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Figure 3-9 Effects of CSF1 inhibitor on pig AMs – day 3. 
3 day old AMs grown in the absence of CSF1 (A-E), with CSF1 and inhibitor (F-J) without 
CSF1 and with inhibitor (K-O) from young male Large-White x Landrace pigs were analysed 
by forward-scatter (FS Lin) and side-scatter (SS Log), and stained with an isotype control or 
antibodies CD14-FITC (B, G, L), CD16-PE (C, H, M), CD163-PE (D, I, N) or CD172a-PE 
(E, J, O) .  
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Figure 3-10 Effects of CSF1 inhibitor on pig AMs - day 7. 
7 day old AMs grown in the absence of CSF1 (A-E), with CSF1 and inhibitor(F-J) without 
CSF1 and with inhibitor (K-O) from young male Large-White x Landrace pigs were analysed 
by forward-scatter (FS Lin) and side-scatter (SS Log), and stained with an isotype control or 
antibodies CD14-FITC (B, G, L), CD16-PE (C, H, M), CD163-PE (D, I, N) or CD172a-PE 
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to correlate with permissiveness to infection as discussed above (Sanchez-Torres et al., 2003; 
Calvert et al., 2007).  To determine whether pig AMs showed similar heterogeneity to that 
observed in human and mice the expression of the immune markers CD14, CD16, CD163 
and CD172a was analysed by FACS.   
 
Freshly isolated AMs were composed of at least 2 populations when looking at FSC versus 
SSC plots.  When looking at the porcine lung macrophages as a whole (Figure 3.7A) the 
majority of cells were CD14+ CD16+ CD163+ CD172a+ (Figure 3.7C-E). As with the 
differentiated BMCs, many of the cells were highly auto-fluorescent, as these cells were 
freshly isolated and had not been cultured it must be assumed this was due to increased lipid 
droplets within the cytoplasm of the macrophages.  All of the CD14+ AMs were also positive 
for CD16, CD163 and CD172a (Figure 3.7F-H).  Like the BMC, it was the larger, more 
granular cells (Figure 3.7I) which were CD14+ CD16+ CD163+ CD172+ (Figure 3.7K-P). 
These are the mature tissue macrophages, the smaller CD14-CD16-CD163-CD172a- were 
likely to be B-cells due to the absence of either CD14 or CD172a.  This confirmed that 
porcine AMs are composed of two populations of cells although it seems unlikely the smaller 
population belongs to the macrophage lineage. The CD14+ cells were relatively 
homogeneous for marker expression suggesting that if there is two populations of AMs in the 
porcine lung then the expression of the immune markers studied is not sufficient to 
differentiate them 
 
3.2.3.2 Effects of CSF1 on expression of CD14, CD16, CD163 and CD172a 
As described in Chapter 1, GMCSF is necessary for the production or maintenance of 
alveolar macrophages. Although superficially healthy, the lungs of Gmcsf deficient mice do 
not develop normally (Stanley et al., 1994) ensuring that the mice suffer from a pathology 
very similar to that displayed by human patients suffering from alveolar proteinosis, a disease 
of the lungs caused by accumulation of surfactant proteins in the lungs, (Carey and Trapnell, 
2010; Hibbs et al., 2007).    Mice deficient in both Gmcsf and Csf1 have a more severe 
phenotype than Gmcsf deficient mice alone  suggesting an important relationship between 
these two growth factors in lung development (Lieschke et al., 1994). The CSF1 deficient  
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op/op mouse has a severe reduction in the numbers of macrophages in the lung although they 
are not completely absent (5-15% of normal lung macrophage numbers) (Wiktor-Jedrzejczak 
et al., 1992) Therefore to determine whether alveolar macrophage function in the pig was 
regulated by CSF1, expression of surface markers was examined on cells grown in the 
presence or absence of CSF1 and the selective CSF1R kinase inhibitor GW2580.   
 
 Culture of porcine AMs in rhCSF1 for up to 7 days increased their size and granularity but 
did not greatly alter the expression of CD14 (Figure 3.8B, G, L)  or CD16 (Figure 3.8C, H, 
M).  Expression of CD163 (Figure 3.8D, I, N) and CD172 (Figure 3.8E, J, O) decreased 
slightly. In particular the number of CD163lo cells increased.  Suggesting CSF1 did not 
further differentiate porcine AMs 
 
Mouse macrophages require CSF1 for survival.  To assess the effects of rhCSF1 on survival 
of porcine AMs cells were grown in the presence of the selective CSF1R kinase inhibitor 
GW2580.   After 3 days in rhCSF1 52% of cells analysed were alive while only 39% of cells 
grown with rhCSF1 plus GW2580 and 29% of cells grown without rhCSF1 and with 
GW2580 were alive showing rhCSF1 promoted survival of porcine AM.  AMs would be 
expected to continue replicating in culture so these numbers refelect not just decreased 
survival but presumably decreased replication in the absence of CSF1. The inhibitor did not 
kill all the cells, suggesting either CSF1 is not the only signal that keeping porcine AMs alive 
or that the inhibitor did not completely inhibit the receptor.   Cells grown without rhCSF1 
(Figure 3.9A) or in the presence of the inhibitor GW2580 (Figure 3.9F, K) were smaller and 
less granular than cells grown with CSF1 (Figure 3.8F) after 3 days (Figure 3.9A, F, K). 
The effect was more marked after 7 days deprivation (Figure 3.10A, F, K) versus 7 days 
culture with rhCSF1 (Figure 3.8K).  The expression of CD14 was lower in rhCSF1 deprived 
cells after 3 days (Figure 3.9B, G, L) as was CD16 (Figure 3.9C, H, M) and CD163 (Figure 
3.9D, I, N) suggesting CSF1 promoted their expression.  The effects on CD172a expression 
were not as marked (Figure 3.9E, J, O).  Staining patterns for AMs grown in rhCSF1 for 7 
days (Figure 3.8K-O) were very similar to those seen after 3 days growth indicating that 
additional culture did not lead to a further differentiated phenotype.  Cells grown without 
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rhCSF1 expressed CD14, CD16, CD163 and CD172a although the population of CD14hi 
(Figure 3.10B), CD16hi (Figure 3.10C), CD163hi (Figure 3.10D) and CD172ahi (Figure 
3.10E) cells was less than those grown with rhCSF1 (Figure 3.8L-O).  AMs grown with the 
inhibitor for 7 days expressed CD14 (Figure 3.10G), CD163 (Figure 3.10 I) and CD172a 
(Figure 3.10J), albeit at lower levels, but CD16 expression had almost completely 
disappeared suggesting CD16 expression is CSF1 dependent (Figure 3.10H).  CD16 is 
commonly used as a marker of mature macrophages and its loss may suggest a loss of the 
mature macrophage phenotype.  The most marked phenotypic change was seen with cells 
grown in the absence of rhCSF1 and with the inhibitor for 7 days (Figure 3.10L-O).  The 
majority of cells died and the ones that remained were CD14- CD16- CD163- and largely 
CD172a- .These cells were unlikely to be macrophages, since CD172a is expressed on all 
cells of myeloid origin.  This also suggested that the inhibitor did not completely block all 
CSF1R activity as the presence of exogenous rhCSF1 led to a less severe phenotype.  These 
results suggest that although porcine AMs are a fully differentiated cell type, mature AMs 
may require continuous CSF1 signaling.  The inhibitor used in these experiments may also 
have off target effects therefore the reduced cell viability seen in AMs grown in the presence 
of GW2580 may have been due to blockade of growth factors other than CSF1.  The use of 
further controls such as AMs grown in the presence of a range of inhibitor which target 
alternative receptors would have provided a clearer answer to which growth factors are 
necessary for survival of AMs. The presence of CSF1 did not alter the expression of the 
surface markers studied, nevertheless cells gown without an exogenous source of CSF1 or in 
the presence of a CSF1 inhibitor showed lower expression of all marker studied.  The 
expression of these markers is likely to have functional significance therefore loss of markers 
can most likely be related to loss of function suggesting CSF1 would be required to maintain 
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3.2.4 Characterisation of porcine PM 
 
3.2.4.1 Expression of CD14, CD16, CD163, CD172a on PMs 
In this study, large numbers of PMs were isolated from the pig without the use of an eliciting 
stimulus (Figure 3.11B) enabling a model of non-inflammatory differentiated macrophages 
to be studied.    
Freshly isolated PM expressed uniformly high levels of all markers examined.   90% of PMs 
were positive for both CD14 and CD16 (Figure 3.11C), 80% were CD14+ CD163+ (Figure 
3.11E) and 91% were CD14+ CD172a+ (Figure 3.11G).  This confirmed the presence of 
CD14, CD16, CD163 and CD172a on mature porcine PMs in addition to the AMs examined 
suggesting these markers may be present on many mature porcine macrophage populations.  
As with the AMs examined, this population was relatively homogeneous and phenotypically 
similar to AMs.  Microscopic examination of porcine AMs and PMs showed visible 
differences in cell morphology however examination of surface marker expression showed 
striking similarity between these two tissue macrophage populations and further surface 
markers will be needed to differentiate the two populations by FACS. 
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Figure 3-11 Cytometry characterization of pig PMs. 
Freshly harvested PMs from young male Large-White x Landrace pigs were analysed by 
forward-scatter (FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or 
antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (D, F, 
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3.2.5 Characterisation of porcine MDMs  
 
3.2.5.1 Expression of CD14, CD16, CD163 and CD172a on pPBMCs from six 
different breeds 
The level of CD16+ monocytes varies considerably in man, whether due to ill health or 
natural variation between subjects.  There is also considerable interest in humans in the 
association between genetic variation at the CD14 (Yu et al., 2011; Mason et al., 2010) and 
CD16 loci (Molokhia et al., 2011; Aitman et al., 2006; Fanciulli et al., 2007) and 
susceptibility to a wide range of inflammatory and infectious diseases.   
 
Particular pig breeds are more sensitive to some viral and bacterial pathogens (Wang et al., 
2011b; Reiner et al., 2010; Ait-ali et al., 2007), for instance pigs from the Landrace line are 
less susceptible to PRRVS and ASF.  AMs are the primary cell target of PRRVS in vivo and 
expression of CD163 has been shown to confer susceptibility to PRRVS (Calvert et al., 2007) 
and to ASFV (Sanchez-Torres et al., 2003).  AMs from  the more resistant Landrace pigs 
showed no difference in the expression of the PRRVS receptor CD163 (Ait-ali et al., 2007)  
 
To survey for possible genetic variation in these key receptors in pigs, PBMCs were isolated 
from at least two individual animals from 6 different breeds (animals detailed in appendix 3).  
This small number of animals precludes any conclusions being drawn from this experiment 
as true species variation could not be assessed.  It was hoped however that any large 
differences between breeds would be picked up by this small sample  All of the breeds 
studied had populations which were CD14- CD16+ (presumed to be NK cells or immature 
monocytes), CD14+CD16+, CD14+ CD163+ and CD14+ CD172a+ although there was subtle 
variation between breeds.  The percentage of cells in each population is summarized in 
Appendix 3.  All animals showed differential expression of CD16 versus CD14 (Figure  
3.12C, 3.13C, 3.14C, 3.15C, 3.16C, 3.17C), having a population which expressed high levels 
of CD14 and lower levels of CD16, hereafter called CD14hi CD16lo, and another population  
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Figure 33-12 Cytometry characterization of freshly harvested PBMCs - Large-White x Landrace. 
Freshly harvested PBMCs from young male Large-White x Landrace pigs were analyzed by 
forward-scatter (FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or 
antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (D, F, 








Figure 33-13 Cytometry characterization of pig PBMCs - Hamshire. 
Freshly harvested PBMCs from young male Hampshire pigs were analyzed by forward-
scatter (FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or 
antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (D, F, 








Figure 3-14 Cytometry characterization of pig PBMCs - Duroc. 
Freshly harvested PBMCs from young male Duroc pigs were analyzed by forward-scatter (FS 
Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or antibodies CD14-
FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). Graphs show CD16, 








Figure 3-15 Cytometry characterization of pig PBMCs - Large White 
Freshly harvested PBMCs from young male Large-White pigs were analyzed by forward-
scatter (FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or 
antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). 
Graphs show CD16, CD163, or CD172a cells gated on the CD14 population isolated (D, F, 








Figure 3-16 Cytometry characterization of pig PBMCs – Pietrain 
Freshly harvested PBMCs from young male Pietrain pigs were analyzed by forward-scatter 
(FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or antibodies 
CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). Graphs show 









Figure 3-17 Cytometry characterization of pig PBMCs – Landrace 
Freshly harvested PBMCs from young male Landrace pigs were analyzed by forward-scatter 
(FS Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or antibodies 
CD14-FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). Graphs show 
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which expressed lower levels of CD14 and higher levels of CD16, CD14lo CD16hi.  With 
some breeds e.g. Hampshire, there appeared to be more distinct populations (Figure 3.13C) 
while other breeds e.g. Pietrain (Figure 3.16C), had more of a continuum of cells with the 
extremes of the population expressing different levels of CD14 and CD16.  Unlike humans, 
the CD16+ population represented around half of the CD14+ monocytes (Appendix 3).  
Similar variation was seen in CD163 staining as previously reported (Chamorro et al., 2000; 
Chamorro et al., 2004; Chamorro et al., 2005) (Figure 3.12E, 3.13E, 3.14E, 3.15E, 3.16C, 
3.17C).  CD172a expression showed little variation, all CD14+ monocytes also expressed 
high levels of CD172a (Figure  3.12G, 3.13G, 3.14G, 3.15G, 3.16C, 3.17C).  The variation 
in expression of CD163 on CD14+ monocytes confirmed previous work in this field 
(Chamorro et al., 2004; Chamorro et al., 2000; Chamorro et al., 2005).  Furthermore, in 
common with human and mice, this study showed pig monocytes can be divided into 
populations based on differential expression of CD16 by CD14+ monocytes although how 
these populations relate to each other is unknown. 
 
3.2.5.2 Effects of CSF1 on expression of CD14, CD16, CD163, CD172a 
Like BMCs, PBMCs are a heterogeneous population of immature cells.  Culture with growth 
factors such as CSF1 can cause the cells to differentiate into a mature macrophage 
population.  As with BMCs, rhCSF1 caused PBMCs to increase in size and granularity 
(Figure 3.18A, F, K) and as previously an increase in auto-fluorescence was also observed 
(Figure 3.18L-O) compared to freshly isolated PBMCs (Figure 3.18B-E).  The increase in 
apparent cell size and granularity in response to rhCSF-1 was also associated with altered 
expression of cell surface markers.  The new population of larger cells was predominantly 
CD14+. (Figure 3.18 A, B, G, L).  These cells also increased expression of CD16 (Figure 
3.18 C, H, M).  CD172a was expressed at high levels by a small proportion of freshly 
isolated  
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Figure 3-18 Effects of CSF1 on PBMCs. 
Freshly harvested PBMCs (A-E), 3 day old (F-J) and 7 day old (K-O) MDM  from young 
male Large-White x Landrace pigs were analysed by forward-scatter (FS Lin) and side-
scatter (SS Log), and stained with an isotype control or antibodies CD14-FITC (B, G, L), 
CD16-PE (C, H, M), CD163-PE (D, I, N) or CD172a-PE (E, J, O) . 
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PBMCs (Figure 3.18 E), culture with CSF1 did not increase the intensity of expression but 
did however increase the proportion of the cells expressing CD172a (Figure 3.18 O).  
Perhaps most surprisingly given its use as a marker of maturation previously, CD163 
expression decreased with culture in the growth factor CSF1 (Figure 3.18 D, I, N).  CSF1 
marginally increased CD14 expression in human monocytes (Asakura et al., 1996) but it 
appears to have had a more marked effect on CD14 expression on pig monocytes and also 
increased expression of the maturation marker CD16.   
 
3.2.6 Expression of surface markers on PBMCs from pigs with 
severe sepsis 
PBMCs from pigs infected with  Actinobacillus pleuropneumoniae that later developed 
severe sepsis were anlaysed for the expression of CD14, CD16, CD163 and CD172a to see 
whether, as in humans, there was a major change in the monocyte subpopulations in response 
to infectious challenge.  This was an opportunistic experiment due to a mistake by another 
laboratory.  A sample was obtained before the pigs developed sepsis but after surgical 
intervention (to fit monitoring devices).  Ideally a sample would have been obtained when the 
pigs were healthy before any surgical intervention.  Further control animals would have been 
desirable to assess the inflammatory effects of surgical intervention and the infection process, 
for example animals fitted with telemetry devices and not infected, animals undergoing mock 
infection with for instance heat killed bacteria and animals infected with gram negative 
bacteria whch are commonly found as commensal bacteria in the gut.  Unfortunately the 
unplanned nature of this experiment meant these controls were not available.  The number of 
CD14+ monocytes which were negative for CD16, CD163 or CD172a was increased in 
freshly harvested PBMCs from minipigs compared to other breeds studied.  The pigs had 
already undergone surgical intervention which may have changed the cellular composition of 
the blood, for instance by recruiting immature CD14+ monocytes.  Nevertheless, as 
previously (Figures 3.12, 3.13, 3.14, 3.15, 3.16, 3.17), a CD14-CD16+ NK or immature 
monocyte population was present and CD14+ cells exhibited heterogeneous expression of 
CD16 and CD163.  A  more homogenous population of CD14hi or CD14lo and CD172a+ cells 
(Figure 3.19C-H) was also present as observed in the healthy pigs from the 6 other breeds  
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Figure 3-19 Cytometry characterization of pig PBMCs – minipigs 
Freshly harvested PBMCs from young male minipigs were analysed by forward-scatter (FS 
Lin) and side-scatter (SS Log; A), stained with an isotype control (B) or antibodies CD14-
FITC and CD16-PE/CD163-PE/CD172a-PE (C, E, and G, respectively). Graphs show CD16, 








Figure 3-20 Cytometry characterization of PBMCs from minipigs suffering from Septic Shock. 
Freshly harvested PBMCs from young male minipigs, infected with AP for 12 hours then 
euthanised, were analysed by forward-scatter (FS Lin) and side-scatter (SS Log; A), stained 
with an isotype control (B) or antibodies CD14-FITC and CD16-PE/CD163-PE/CD172a-PE 
(C, E, and G, respectively). Graphs show CD16, CD163, or CD172a cells gated on the CD14 
population isolated (D, F, and H, respectively).
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examined (Section 3.2.5.1).  As expected the pigs were severely leukopenic after 
septic shock (Figure 3.20C-H).  This experiment was only carried out once, on two 
animals without adequate controls meaning conclusions cannot be drawn, 
nevertheless the drop in circulating leukocytes serves as a good indication of the 
severity of septic shock against which to measure changes in gene expression 
(Chapter 5). 
 
3.3  Discussion 
The pig is an ideal animal for modelling human innate immunity.  There are many 
benefits to using the pig as a model over the more commonly used rodent models, 
not least the large numbers of cells available from one animal (Figure 3.3).   Mouse 
cells have been frozen previously to more easily enable the transportation of knock-
out animals, derived from the transported cells, between research groups (Lattin et 
al., 2009).  This study utilised a similar protocol to store porcine cells from blood, 
bone marrow, lungs and peritoneal cavity.  Cells were frozen and stored at -80˚C 
enabling multiple experiments from the same animal to be carried out over a long 
period of time.  This will enable inter-animal variability to be studied, something 
more difficult in the mouse due to the small number of cells harvested from each 
animal.  Genes that vary between animals of the same species often rapidly evolve 
between species and may be important immune effectors (Murphy, 1993).  Analysing 
gene expression from a single animal rather than pooled samples, as may occur with 
murine samples, will more readily allow the discovery of such inter-animal 
variability.  It is important to note that generally speaking, pooling murine samples is 
not desirable as this will mask any inter-animal variation and make it impossible to 
spot any outliers which may skew results for the whole population.  Research on 
primary human cells has often utilised blood derived monocytes or MDMs (Irvine et 
al., 2009).  Research on these cells in the mouse is hampered by technical difficulties 
and the extremely small amount of blood available from a single animal.  Mouse 
BMDMs are therefore frequently used (Sester et al., 2005) and although a useful tool 
they introduce another variable when trying to apply knowledge from animal studies 
to humans; comparing pig and human MDM  removes any differences which may be 
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due to cell type rather than species.   This study showed that cells can be harvested 
from the lung, peritoneal cavity, blood and bone marrow in the pig.    Like for like 
comparisons can be made between porcine and human monocytes and monocyte 
derived macrophages in order to develop a better model for studying the human 
innate immune system.  Thus the pig provides an ideal model for studying innate 
immunity in man.  Immature monocytes and mature macrophages are readily 
harvested and available in large numbers facilitating the study of multiple human 
pathologies and will allow differences between monocytes/macrophages from 
different anatomical niches and in different states of activation to be studied in more 
detail. 
 
3.3.1  Pig monocytes can be divided into subsets 
As discussed previously, porcine blood monocytes can be split into subsets, previous 
groups have used differential expression of CD14 and CD163 to do so (Chamorro et 
al., 2000).  Heterogeneous expression of CD16 has been noted but not studied in 
detail (Sanchez et al., 1999).  This study showed that the differential expression of 
CD16 observed in both man and mice (Ingersoll et al., 2010) was conserved in pigs 
(Figure 3.12-17) although the proportion of CD16+ monocytes was far greater in pig 
(Appendix 3) than in man where only around 10% of CD14+ monocytes express 
CD16 (Passlick et al., 1989).  In this aspect pigs appear more like mice having a near 
even number of CD14hi and CD14lo monocytes.  There was also a population of 
monocytes which expressed very low levels of CD14 and did not express CD163 or 
CD16 (this can be seen most clearly in the Hampshire and Duroc, Figures 313E & 
3.14E).  It is not entirely clear how these monocyte populations relate to similar 
populations in man or mice, if at all. PBMCs from 6 different breeds of pig were 
examined for expression of CD14, CD16, CD163 and CD172a to detect possible 
genetic variation in these key immune receptors.  As discussed above, variation in 
humans in CD14 (Mason et al., 2010; Yu et al., 2011) and CD16 (Fanciulli et al., 
2007; Molokhia et al., 2011; Aitman et al., 2006) has been linked to susceptibility to 
disease.  All breeds examined had variable expression of CD16 and CD163 and high 
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expression of CD172a on CD14 positive cells.  As with CD14+CD16+ monocytes, 
the number of CD14+CD163+ cells was approximately half the total number of 
CD14+ monocytes.  The similar expression of these key immune markers between 
different pig breeds confirmed similar studies looking at monocyte markers in 
Meishan and Large White pigs (Clapperton et al., 2005).  Moreover the slight 
heterogeneity between individual pigs  was similar to the variation observed between 
humans (Passlick et al., 1989). There were no major differences in expression of any 
of the molecules examined although there was some variation, for example 
Hampshires and Durocs had a larger population of monocytes expressing very low 
levels of CD14.  The small number of animals in this study limits any conclusions 
which may be drawn about breed specific genetic variation at any loci.  A larger 
study may pick up individual variation at one or more of these loci which would 
almost certainly affect susceptibility to disease, as has been discovered in man 
(Aitman et al., 2006; Fanciulli et al., 2007; Molokhia et al., 2011; Yu et al., 2011).  
The number of CD16+CD14- cells, which were presumed to be NK cells or possibly 
immature monocytes, also differed between animals. Like the expression of CD14 
and CD16, this varied by animal rather than breed.  NK cell phenotype in humans 
has previously been correlated to age, older subjects had lower levels of the more 
mature CD3- CD56dim NK cells which expressed only low levels of CD16 (Hayhoe et 
al., 2010).  Expression of Killer cell Ig-like receptors (KIR), which inhibit and 
activate NK cell functions, has also been shown to be controlled at the genome level 
and varies between individuals (Shilling et al., 2002; Guinan et al., 2009).  This 
ensures that the repertoire of NK cells is slightly different for each individual which 
will likely affect NK-cell mediated immunity.  It appears there is similar variation in 
the NK cell population among pigs.  In humans the CD16+ population of monocytes 
can vary with health  (Baeten et al., 2000; Blumenstein et al., 1997; Fingerle et al., 
1993; Steppich et al., 2000; Ziegler-Heitbrock, 2007; Zimmermann et al., 2010; 
Allen et al., 1991).  Unfortunately the number of pigs examined was too low to 
assess if the relative levels of each population, whether studied with CD16 or 
CD163, changed in the minipigs with the onset of sepsis.  Severe leucopenia was 
present in the post-septic samples suggesting the samples were collected too close to 
natural death to assess relative levels of monocytes. Samples taken at an earlier time 
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point may have shown some differences in relative numbers of monocytes.  The 
CD14loCD16hi population (Figure 3.19C) appeared larger in the minipigs prior to the 
development of sepsis.  This initial sample was obtained after these animals had 
already undergone surgery to insert telemetry devices which itself would have caused 
an inflammatory response.  This may suggest that the CD14loCD16hi population 
increases in an inflammatory response in the pig.  The relative numbers of CD14 and 
CD163 positive cells appeared closer to what was observed in the additional breeds 
studied.  Of the other pigs studied (Figure 3.12-17), all appeared healthy although 
post-mortem examination showed several had lesions on the lungs.  Rather than 
showing an increase or decrease in one particular subset these pigs had less 
CD14+CD16+, CD14+ CD163+ and CD14+ CD172a+ cells overall.  Unfortunately 
again the number of animals was too small to determine if the relative numbers of the 
monocyte subsets vary with disease in the pig and data on the health of the animals 
was not collected as they all appeared healthy pre-mortem.  Monocyte subsets have 
also been shown to vary with age (Tacke and Randolph, 2006) and health in mice 
(Tacke et al., 2007) therefore it seems likely that a more detailed study may show 
variation in relative monocyte numbers in pigs. 
 
3.3.2 Markers of monocyte maturation are common to 
humans, mice and pigs 
 CD163 was expressed selectively on CD14lo monocytes. These cells also expressed 
marginally higher levels of CD16.  As discussed above, others have reported that 
CD163+ pig monocytes were heterogeneous, with mainly low CD14 expression and 
high MHC II expression, similar to human CD14loCD16+ human monocytes.  
CD163+ cells expressed adhesion molecules, CD11a, wCD11c, wCD29 and CD49d, 
and co-stimulatory molecules, such as B7, at higher levels than CD163- cells 
(Chamorro et al., 2005; Chamorro et al., 2004; Ezquerra et al., 2009). This may have 
accounted for their strong antigen presenting ability and higher allostimulatory 
capacity, and could lead to differences in the ability of the cells to migrate to tissues.  
By contrast to humans, these “resident” type monocytes in the pig were 
approximately 50% of total monocytes (Appendix 3).  Taken together, the data 
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suggest that by contrast to human and in common with mice, pig monocytes mature 
towards a “resident” phenotype to a greater extent in the circulation.  Previously 
surface CD163 has been reported to be more highly-expressed in the CD14loCD16hi 
“resident” monocyte subset in human blood, and inducible in the CD14hi monocytes 
during CSF1-induced differentiation in vitro (Buechler et al., 2000).  However recent 
studies have shown CD163 to be more highly expressed in the CD14 hiCD16- 
populations (Ingersoll et al., 2010; Cros et al., 2010) and expression can be induced 
in human CD16+ monocytes by CSF1 (Tippett et al., 2011).  As in humans, 
expression of CD163 in pigs is restricted to monocytes and macrophages and clearly 
defines a monocyte subset.   
 
3.3.3 rhCSF1 induced differentiation of pig monocytes 
Like mouse (Hume et al., 1987; Warren and Vogel, 1985; Hume and Gordon, 1983), 
pig monocytes could be differentiated into macrophages using rhCSF1 (Figure 3.4).  
As described above, CSF1 is present in the circulation and is important for 
macrophage differentiation, growth and survival.  It is also induced in inflammatory 
states and has a key role in regulating macrophage activation (Sweet and Hume, 
2003) therefore CSF1 differentiated macrophages are a good model for studying in 
vivo process in vitro (Pollard, 2009).  Exogenous CSF1 was required for survival of 
mouse macrophages in culture although TEPMs, an inflammatory macrophage type, 
expressed Csf1 mRNA and survived without a source of exogenous CSF1 (Irvine et 
al., 2006).  In vitro human macrophages did not require CSF1 for survival due to 
autocrine production of CSF1 (Becker et al., 1987) although freshly-isolated 
monocytes did not express CSF1, (Biogps.org.info; (Hume and MacDonald, 2011)) 
suggesting expression was induced by culture conditions.    rhCSF1 induced 
differentiation and promoted proliferation in pig monocytes but was not essential for 
survival once the cells had differentiated, suggestive of autocrine production by 
mature porcine macrophages (Kapetanovic  et al, 2011, in press).  In both mouse and 
human, culture in CSF1 alone promoted an immunosuppressive role for 
macrophages.  However continuous exposure in humans drove macrophages towards 
a pro-atherogenic phenotype which was not replicated in mouse macrophages (Irvine 
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et al., 2009).  CSF1 primed mouse macrophages to respond to LPS stimulation with a 
pro-inflammatory response but had no effect on the production of TNFα and IL6 by 
human macrophages.  Instead it induced a set of pro-atherogenic genes including 
CXCL10, CCL2 and CCL7 and repressed the anti-atherogenic chemokine CXCR4 
(Irvine et al., 2009).  Similarly rhCSF1 did not increase LPS-induced TNFα 
production by pig (Kapetanovic et al. manuscript under review) suggesting like 
humans, CSF1 did not prime for a pro-inflammatory response in the pig.  It should 
also be remembered that CSF1 is not present in the circulation in isolation so in vivo 
other factors may modify the extremes of phenotypes seen in vitro.   
 
Culture with rhCSF1 caused porcine BMCs and PBMCs to increase in size and 
granularity which had a corresponding increase in expression of surface markers. 
Imature bone marrow progenitors expressed only low levels of CD14 and CD16 
(Figure 3.6B, C)  which confirmed findings in human (Passlick et al., 1989; Lee, 
1991) and bovine  bone marrow (Adler et al., 1994).  Studies on human monocytes  
likewise reported an increase in CD14 expression as cells matured (Rigby et al., 
1984), consistent with the findings of this study in the pig (Figure 3.6B, G, L).  
Furthermore CD14 was absent from monocyte precursor cell lines (Rigby et al., 
1984) but found on more mature monocytic cell lines such as monomac 6 (Ziegler-
Heitbrock et al., 1988) in agreement with its role as a marker of macrophage 
maturation.  Macrophages derived in vitro from blood or bone marrow progenitors 
are frequently used to simulate the responses of tissue macrophages in vivo.  The 
increase in expression of CD14, CD16 and CD172a suggests that rhCSF1 matured t 
pig monocytes into a more differentiated cell type, similar to AMs or PMs.  One of 
the major benefits of pig over the more commonly used rodent models is the ability 
to compare macrophages/monocytes from different locations from the same animal.   
Pigs will allow us to more easily determine differences between immature 
monocytes, in vitro generated macrophages and mature tissue macrophages.  Freshly 
isolated BMC did not express high levels of CD163 (Figure 3.6D) in common with 
previous findings (Sanchez et al., 1999).  Furthermore rhCSF1-matured bone marrow 
or blood derived macrophages did not express high levels of CD163 (Figure 3.6D, I, 
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N and 3.18D, I, N) when compared to AMs (Figure 3.8B) or PMs (Figure 3.11F).  
CD163 has been used as a marker of monocyte maturation in the pig (Chamorro et 
al., 2005) is expressed on mature human macrophages (Fabriek et al., 2005) and was 
highly expressed by mature macrophages in this study and previous studies (Sanchez 
et al., 1999).  The lack of CD163 on CSF1-derived macrophages is therefore 
surprising and highlights an important difference between in vitro generated pig 
BMDMs or MDMs and the naturally occurring tissue macrophages in this study.  
CD163 is expressed on a large number of macrophages, although not all tissue 
macrophages express CD163, for example macrophages from the marginal zone and 
white pulp of the spleen and those found in lymph node follicles are CD163 negative 
(Ezquerra et al., 2009) 
There was an obvious difference in the size of immature and mature monocytes in 
men and pigs.  Contrary to our study, where CD16+ monocytes were larger and more 
granular than CD16- monocytes, human CD16+ monocytes were smaller than their 
CD16- counterparts (Passlick et al., 1989) though like our cells they were more 
granular.  This is not altogether surprising in man as promonocytes are larger than 
CD14++ circulating blood monocytes which in turn are larger than the more 
differentiated CD14+ CD16+ blood monocytes (van Furth et al., 1979).  It is uncertain 
why human monocytes should decrease in size as they differentiate while pig 
monocytes increase although it is clear that monocytes from both species undergo 
CSF1-driven differentiation which results in increased expression of the maturation 
markers CD14 and CD16.  
 
3.3.4 Porcine AMs and PMs expressed high levels of CD14, 
CD16, CD163 and CD172a 
The expression of CD14, CD16, CD163 and CD172a was universally high among 
porcine PMs and AMs.  Previous investigations detected only low levels of CD16 in 
human PMs, differing from the high CD16 expression previously reported on human 
AMs (Passlick et al., 1989).  Human peritoneal macrophages have been compared to 
CSF1-derived anti-inflammatory type II macrophages.  Among other characteristics 
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they both expressed CD163 and lacked CD16,  and after stimulation with LPS both 
macrophage types produced IL10 and down-regulated the co-stimulatory molecule 
CD86 (Xu et al., 2007). Human AMs also expressed CD163 as do most other 
differentiated macrophage populations (ZENG et al., 1996; Van den Heuvel et al., 
1999; Fabriek et al., 2005) and high expression has previously been reported on AMs 
in the pig (Sanchez et al., 1999).  Human PMs have been shown to phagocytose 
opsonized cells (MacGowan et al., 1983) although they are also able to phagocytose 
non-opsonized bacteria (Boner et al., 1989).  Resident mouse PMs expressed low 
levels of the β-glucan receptor dectin1 which is important for the non-opsonic 
recognition of fungal derived β-glucans.  In contrast mouse AMs expressed high 
levels of dectin1 (Taylor et al., 2002).  The expression of CD16 by porcine PMs 
suggests that unlike human PMs they may phagocytose opsonized cells.  
Alternatively opsonized cells in the human peritoneal cavity may be cleared by other 
cells or the equivalent cells may not be opsonized at all and dealt with in a non Fc 
receptor-mediated manner.  Pig PMs and AMs appeared relatively homogeneous, at 
least when comparing expression of surface markers.  Nevertheless previous 
investigations have identified different pathways of immune activation.  Porcine 
AMs stimulated with double stranded RNA (dsRNA) expressed high levels of type I 
IFNs, TNFα and RANTES.  By contrast PMs stimulated with dsRNA expressed 
lower levels of type I IFNs but higher levels of the antiviral mediators protein kinase 
receptor (PKR) and myxovirus resistant, IFN-inducible GTPase (Mx) mRNA.  The 
authors suggested AMs respond to dsRNA through a TLR3 dependent pathway while 
PMs respond through a PKR mediated pathway (Loving et al., 2006).  Further 
studies using a broader array of surface markers may detect molecules specific to one 
type of macrophage and analysis at the genome level would almost certainly increase 
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3.3.5 Porcine AMs produce CSF1 
Porcine AMs, a mature macrophage cell type, were largely positive for CD14, CD16, 
CD163 and CD172a upon isolation (Figure 3.7) and retained these markers up to 7 
days in culture with rhCSF (Figure 3.8).  Human AMs were reported to have much 
lower levels of CD14 but similar levels of CD16 (Passlick et al., 1989).  As 
described above, mice deficient in Gmcsf did not show normal lung development 
(Stanley et al., 1994) while Csf1 deficient mice have reduced numbers of lung 
macrophages (Wiktor-Jedrzejczak et al., 1992).  Mice deficient in both Gmcsf and 
Csf1 show a more severe phenotype than knockouts of either growth factor alone 
(Lieschke et al., 1994) demonstrating that both GMCSF and CSF1 have non 
redundant functions, in mice at least.   AMs are a differentiated cell type and 
culturing them in the presence of rhCSF1 did not affect expression of surface 
markers to the extent that was seen with undifferentiated monocytes from bone 
marrow and blood suggesting that CSF1 did not regulate the function of already 
differentiated pig AMs.  The loss of CD14 and CD16, and to a lesser extent CD163 
and CD172a on AMs grown without CSF1 (Figure 3.9A-E, Figure 3.10A-E) or 
with a CSF1 inhibitor (Figure 3.9F-J, Figure 3.10F-J) suggested that although 
CSF1 did not change surface marker expression on already differentiated AMs it was 
necessary for maintenance of the differentiated phenotype.  The expression of the 
surface markers was most reduced in AMs grown without rhCSF1 and with the 
inhibitor suggesting autocrine production of CSF1 was able to partially save the 
differentiated phenotype.  This was validated by the increased rate of death among 
cells grown in the presence of the selective CSF1R kinase inhibitor GW2580 which 
blocked autocrine and exogenous CSF1(Irvine et al., 2006) although the survival of 
some AMs after 7 days culture in the presence of the inhibitor suggests it did not 
fully block CSF1R.  As described above AMs would have been expected to continue 
replicating in culture so the increased cell numbers in the presence of CSF1 could 
also indicate replication that did not occur in the absence of CSF1.  RNASeq data 
(unpublished, Dario Beraldi) showed constitutive expression of CSF1 at very low 
levels by AMs.  The absence of an external source of CSF1 may have triggered a 
mechanism for increased expression in the AMs.    The CSF1 inhibitor used in this 
study also inhibited FLT3. However it was likely that the effects reported here were 
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due to inhibition of CSF1, as FLT3L was expressed only at very low levels by AMs 
although it is possible that cells grown in the absence of CSF1 could have increased 
expression of FLT3L and quantification of FLT3L expression in the presence and 
absence of CSF1 would have answered this question.  The AMs also failed to 
produce the alternative ligand for the CSF1R, IL34 (unpublished, Dario Beraldi).  
These findings suggest that porcine AMs can produce autocrine CSF1 and it may be 
required for maintenance of a mature phenotype.  As stated above further 
experiments using additional inhibitors may have given a clearer picture of the 
requirements for AMs, for instance the Gmcsf  knockout mouse has shown the 
importance of GMCSF in the developing lung so it would have been interesting to 
block the GMCSF receptor.  It would also be interesting to determine if cells grown 
in the presence of an inhibitor could be rescued (ie. display the same phenotype as 
cells in normal culture conditions) by the addition of growth factors after a period of 
starvation or whether the addition of a GMCSF could rescue CSF1 starved cells and 
vice versa.   The mechanism of renewal of AMs is not fully understood (Gordon and 
Taylor, 2005).  AMs  have been shown to be both self-renewing locally (Tarling et 
al., 1987) and to be replenished from the bone marrow (Thomas et al., 1976). It may 
be that the two populations of macrophages found in the lung fulfill different 
functions with one population proliferating to provide new cells while the others 
“mature” into the resident macrophages.  Pulmonary macrophages obtained by 
enzymatic digestion of murine lungs could be divided into loosely adherent (LAMS) 
and firmly adherent mononuclear cells (FAMS).  LAMs were more effective at 
stimulating allogeneic mixed lymphocyte reactions (MLR) than FAMs, AMs 
obtained by BAL or blood monocytes.  LAMS were Fc receptor negative and poorly 
phagocytic (Nicod et al., 1987).  These experiments showed that adherence to plastic 
can be a useful method of differentiation macrophage populations from the lung.  
More recent studies have assigned different immunological functions to different 
subpopulations separated by density, staining and adherence.  Non-adherent cells had 
APC capacity while adherent cells expressed C3b and Fc receptors and were strongly 
phagocytic (Spiteri and Poulter, 1991).  The AMs isolated from this study had 
remarkably similar expression of surface markers and FACS analysis did not show 
two clear populations of macrophages.  The population of cells which were CD14+ 
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was remarkably homogeneous with regards to expression of CD16, CD163 and 
CD172a.  Additional experiments in this laboratory utilizing differential adherence to 
plastic as previously described (Nicod et al., 1987)  identified loosely adherent and 
firmly adherent macrophages  and confirmed that expression of the markers studied 
are similar for both populations (unpublished, Ronan Kapetanovic).  These 
differences in adherence are likely to relate to functional differences not reflected in 
the surface markers examined suggesting that as described in mice and humans, pig 
AMs are composed of two populations of cells. 
 
Expression was examined for a few key molecules commonly used to study human 
monocytes which may also be used to differentiate mouse monocytes into subsets 
(Ingersoll et al., 2010).  The work presented in this chapter shows that pig monocytes 
can be classified on the basis of CD14 and CD163 or CD16 expression.  Work on 
phenotyping pig monocytes and macrophages is still in its infancy compared to what 
is known about human and mouse cells.  Further studies are needed to increase our 
knowledge of monocyte subsets in the pig. The phagocytic ability of the different 
subsets is as yet unknown, as is the expression of other molecules found to have 
heterogeneous expression in human and mouse monocyte subsets, the lack of 
suitable antibodies makes this difficult for now.  For instance previous work on 
CCR2 did not use specific anti-CCR2 antibodies but chemokine binding assay 
instead  and RT qPCR  was used to show differential expression of CCR2 and 
CX3CR1 rather than examination of expression at the protein level (Moreno et al., 
2010).  Previous work has shown variation between mRNA levels and protein 
expression (Ingersoll et al., 2010; Zhao et al., 2009) specific antibodies would enable 
differences identified at the mRNA level to be confirmed at the protein level.  
Genetic studies may identify new markers which could be useful for further 
phenotyping macrophage populations from different site within the pig.  AMs, 
PBMCs and BMCs were differentiated with CSF1 for 7 days.  However only AMS 
were cultured without rhCSF1 and in the presence of a CSF1 inhibitor.  It would be 
interesting to study the effects of a lack of CSF1 on the other cell types.  Production 
of a pig specific CSF1 antibody is also required before the importance of CSF1 in 
Chapter 3 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 103 
monocyte maturation can be assessed in the pig.  The rest of this thesis will focus on 
MDM and BMDM as these are the commonly used cells from man and mouse 
respectively.
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Until recently the proposed homology between human CD16hi and mouse Ly6Clo 
monocytes was based mainly on the surface expression of a few molecules as 
described in Chapter 3.  More recent research using a microarray approach to fully 
investigate the extent of any similarities has shown that a core set of genes is 
expressed selectively in the same pattern in the homologous subsets in both species 
(Ingersoll et al., 2010; Cros et al., 2010). The discovery of differential gene 
expression between the subsets lends credence to the hypothesis that distinct 
monocyte subsets may have conserved functions as has already been established with 
lymphocytes (e.g. Th1, Th2). Many human diseases involve alterations in either total 
or relative monocyte numbers (Baeten et al., 2000; Blumenstein et al., 1997; Ellery et 
al., 2007; Fingerle et al., 1993; Moniuszko et al., 2009).  Discoveries of differences 
between monocyte subsets at the gene level provide possible targets for manipulating 
disease outcome or alternatively identify genes which may function as markers of 
disease progression.  Studies on mice or other laboratory animals are therefore 
necessary to determine if the expression of genes which are selectively expressed in 
human monocytes are conserved in other species.  Examination of monocyte gene 
expression in other species will therefore provide useful information which will 
enable better modelling of human inflammatory diseases.  
 
4.1.1 Differentially expressed genes 
The first efforts to dissect the functions of monocyte subsets looked for genes which 
were differentially expressed. Two studies from 2009 (Zhao et al., 2009; Ancuta et 
al., 2009) found clear differences in the gene expression profiles of human monocyte 
subsets and reported a whole host of enriched functions or pathways in each subset.  
Functions consistently assigned to human monocyte subsets are summarised in  
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Figure 4-1 A core set of genes were consistently expressed preferentially by one monocyte subset 
Data from Ancuta et al. (2009), Ingersoll et al. (2010) and Zhao et al. (2009) was re-
analysed to find genes which were preferentially expressed in the same pattern in all 
studies.  
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Table  4.1.   Among other functions Zhao et al. suggested that CD16+ monocytes 
were enriched for genes involved in FcγR-mediated phagocytosis, B cell receptor 
signalling and apoptosis signalling while CD16- monocytes expressed genes 
associated with antimicrobial function and IL8 signalling.  Ancuta et al. found 
similar differential expression including the granulocyte colony-stimulating factor 
receptor (CSF3R, GCSFR, CD114) which was expressed more highly by CD16- 
monocytes, and CSF1R which was more highly expressed by CD16+ monocytes.  
They suggested that CD16+ monocytes expressed higher levels of genes related to 
NK cell mediated toxicity, actin binding and oxidative stress.  CD16- monocytes 
were enriched in genes relating to hematopoietic cell lineage, receptor mediated 
endocytosis and lipid binding molecules.  Re-analysis of data from Ancuta et al., 
Zhao  et al., and Ingersoll et al. identified 140 genes which were preferentially 
expressed by CD14loCD16+ monocytes and 196 which were more highly expressed 
by CD14hiCD16- monocytes in all three studies (Figure 4.1).  Use of the online 
bioinformatics resource DAVID (the Database for Annotation, Visualization and 
Integrated Discovery) (Huang et al., 2008; Andersson et al., 2000; Huang et al., 
2009)  showed CD14loCD16+ were enriched for genes involved in negative 
regulation of immune functions, regulation of apoptosis, the inflammatory response, 
regulation of cytokine production and the complement pathway.  CD14hiCD16- 
monocytes were enriched in genes involved in signalling, wound healing and 
chemotaxis (Table 4.1).  The full gene lists can be found in Appendix 5.  
Interestingly Ancuta et al. also identified a third, intermediate phenotype of 
CD14+CD16+ monocytes which expressed both CD14 and CD16 and intermediate 
levels of many other surface markers such as CSF1R and CSF3R.  These 
“intermediate” monocytes have become part of the accepted nomenclature of human 
monocyte subsets (Ziegler-Heitbrock et al., 2010) and corresponding subsets have 
been identified in macaques (Kim et al., 2010).  The most recent studies have 
therefore examined gene expression between all three subsets of human monocytes; 
classical CD14hiCD16-, non-classical CD14loCD16hi and intermediate CD14+CD16+ 
monocytes (Wong et al., 2011; Cros et al., 2010).  Like the gene expression data 
examined above, Wong et al. found classical monocytes to be enriched for genes 
associated with wound healing and coagulation, response to stimuli and  
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Wound healing, coagulation, 
response to infectious 
stimuli, angiogenesis 
(Wong et al., 2011; Ingersoll 
et al., 2010; Ancuta et al., 







MHC Class II processing and 
presentation 







Cell movement, Fc receptor 
mediated phagocytosis, 
complement components 
(Wong et al., 2011; Ingersoll 
et al., 2010; Ancuta et al., 
2009; Zhao et al., 2009) 
Table 4.1 Suggested functions of human monocyte subsets 
Adapted from (Wong et al., 2011) 
angiogenesis; intermediate monocytes were enriched for genes associated with MHC 
class II processing and presentation and non-classical monocytes expressed genes 
associated with cell movement, Fc receptor mediated phagocytosis and complement 
components (Table 4.1).  All four microarray approaches (Wong et al., 2011; 
Ingersoll et al., 2010; Ancuta et al., 2009; Zhao et al., 2009) found broad similarities 
between genes preferentially expressed by classical monocytes.  Wong et al. 
suggested the broad range of genes associated with classical monocytes showed they 
were highly versatile cells capable of responding to a variety of external cues while 
non-classical monocytes expressed many genes involved in cytoskeletal 
rearrangement which may explain their patrolling function described previously 
(Cros et al., 2010).  There was however more disagreement in genes preferentially 
expressed by CD16+ monocytes, Wong et al. (2011) subdivided this group into non 
classical CD14lo and intermediate CD14+ monocytes making comparisons between 
previous studies difficult; it is not clear with previous reports whether intermediate 
monocytes would have fallen into the classical or non-classical subsets. Wong et al. 
also found evidence for the maturation of monocytes as they moved from expressing 
high levels of CD14 and low levels of CD16 through intermediate expression and 
thence to high CD16 and low CD14 expression they also modulated expression of 
genes.  Classical monocytes expressed anti-apoptotic genes and genes associated 
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with proliferation while non-classical monocytes displayed a pro-apoptotic and anti-
proliferative expression profile. 
 
4.1.2 Conservation of gene expression differences between 
monocyte subsets in men and mice 
More recent studies have compared gene expression between human and mouse 
monocyte subsets to determine if the phenotypic similarities observed in man were 
conserved at a genomic level in the mouse.  Ingersoll et al. discovered 269 genes in 
humans and 561 in mice which were differentially expressed between monocytes 
subsets.  Of these 132 were differentially expressed in the same pattern between the 
species; 69 were more  highly-expressed in Ly6c+ and CD16- monocytes and 63 in 
CD16+ and Ly6Clo monocytes.  The array data confirmed functional differences 
which had been observed at the protein level such as comparatively restricted 
expression of CCR2, CD62L and CD64 by CD16- and Ly6C+ monocytes and of 
CD43, CD11a and CD11c by CD16+ and Ly6Clo monocytes.  Genes where 
differential expression in the subsets was reversed between the species were also 
discovered.  CXCR4, TREM1 and CD36 were more highly expressed by CD16- 
human monocytes and Ly6Clo mouse monocytes while CD9 was more highly 
expressed by CD16+ and Ly6C+ monocytes. Finally, some differentially-expressed 
genes were unique to one species or the other.  Mouse Ly6Clo monocytes were 
identifiable by higher expression of genes related to the transcription factor 
peroxisome proliferator-activated receptor γ (Pparg) such as fatty acid binding 
protein 4 (Fabp4) which is regulated at the transcriptional level by Pparg along with 
other associated genes including Cd36, Hsd11b1 and G0s2. This signature was not 
conserved in human CD16+ monocytes.  Ly6Clo mouse monocytes were also 
enriched for genes involved in recognition and engulfment of apoptotic cells 
including Cd36, Tgm2, Treml4 and Itgav.  The authors concluded that the major 
difference between monocyte subsets in man and mouse was a higher expression of 
classical scavenger receptors and apoptotic cell recognition molecules on Ly6Clo 
monocytes which was not found on human CD16+ monocytes and the strong Pparg 
signature found in murine Ly6Clo monocytes alone.   Both human and mouse 
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monocytes shared differential expression of the macrophage-specific transcription 
factor EC (Tcfec/TFEC) (Rehli et al., 1999) which was more highly expressed by 
human CD16- and murine Ly6C+ monocytes and TCF7l2 (TCF4) and Pou2f2/Oct2 
which were both elevated in CD16+ and Ly6Clo monocytes. 
 
Similarly Cros et al. (2010) compared gene expression in human and mouse subsets 
and divided human monocytes into three populations which were broadly similar to 
those proposed by Ancuta et al. (2009) and Wong et al. (2011).  Hierarchical 
clustering split the samples into two main groups both of which included human and 
mouse samples.  The CD14dim subset, called non-classical subset by Wong and 
Ancuta, was proposed to be the closest homologue to mouse Ly6C- cells.  This 
contrasted with previous studies which suggested the expression or absence of CD16 
should be used to differentiate human monocytes into subsets and that mouse Ly6C- 
monocytes were the closest homologs (Ingersoll et al., 2010; Ziegler-Heitbrock, 
2007; Geissmann et al., 2003).  Array data since has not agreed with the findings of 
Cros et al. and has concluded that human CD16hi and mouse Ly6Clo monocytes are 
most probably the nearest homologous cell types (Wong et al., 2011). The data 
presented by Cros et al.  does however raise the question of whether mouse 
monocytes might also be subdivided further, and whether there is any rational basis 
for the setting of gates that distinguish the different subsets.   
 
4.1.3 Functional differences 
In addition to groups of functionally-related differentially-expressed genes, in vivo or 
in vitro functional differences between monocyte subsets have been described.   
Expression of specific surface molecules suggests that particular subsets will be 
trafficked to distinct sites of inflammation or injury in response to their specific 
ligands.  Human CD16- and mouse Ly6C+ monocytes express CCR2 and so respond 
to secretion of the CCR2 chemokine ligand, CCL2, at sites of infection.  Similarly, 
the expression of CX3CR1 by CD16+ or Ly6C- monocytes results in trafficking in 
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response to CX3CL1 (Serbina et al., 2008). Ly6C+ monocytes were recruited to 
peripheral tissue in response to inflammation and can migrate to draining lymph 
nodes where they have been shown to promote T cell proliferation (Geissmann et al., 
2003). In the absence of inflammation they were not found in peripheral tissues and 
homed to the bone marrow when injected into the circulation (Varol et al., 2007).  
Conversely Ly6C- cells were recruited to peripheral tissue under non-inflammatory 
conditions where they may renew local tissue macrophage populations (Geissmann 
et al., 2003). Cros et al.  (2010) proposed that human CD14dim and mouse Ly6C- 
monocytes were most closely related due to their similar response to bacterial and 
viral stimuli.  Studies carried out in different laboratories have provided differing 
results on cytokine response of various subsets, summarised in Table 4.2.  Cros et al. 
provided some functional evidence of the similarity of human CD14dim and mouse 
Ly6C- monocytes; fluorescently labelled CD14dim monocytes exhibited LFA1-
dependent patrolling behaviour in a transgenic mouse model similar to what had 
previously been ascribed to mouse Ly6C- monocytes (Cros et al., 2010; Auffray et 
al., 2007).  
 
Cros et al. (2010) described how in their hands CD14dim monocytes responded 
primarily to whole virus or TLR7 or TLR8 agonists with production of the pro-
inflammatory cytokines TNFα and IL1β in a MyD88 dependent pathway which led 
to phosphorylation of p42 mitogen-activated protein kinase 1 (MEK1) and Jun N-
terminal kinases (JNK).  Production of the “lymphocyte helper” cytokines and 
chemokines IL6 and IL8 by CD14+CD16- monocytes was also MyD88 dependent but 
led to phosphorylation of p38 mitogen-activated protein kinase (MAPK) suggesting 
different signalling pathways were active in the different subsets.  Similarly mouse 
Ly6C- monocytes responded strongly to TLR7 agonists but not LPS suggesting they 
were like human CD14dim monocytes in their strong response to virus and weak 
response to bacterial products.  More recent analysis of the cytokine profiles of 
human monocyte subsets tended to support the traditional view of the non-classical  
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Subset Function References 
Human CD14hiCD16- Inhibit fungal germination (Serbina et al., 2009) 
 Produced high levels of 
CCL2, CCL3, Il6,IL10 and 
IL8 after LPS stimulation 
(Cros et al., 2010) 
 High TNFα production 
after LPS, zymosan and 
S.aureus stimulation 
(Skrzeczynska-Moncznik 
et al., 2008) 




phagocytes, did not 
produce ROS, MPO or 
lysozyme.  Produced little 
cytokines in response to 
LPS, exhibited patrolling 
behaviour 
(Cros et al., 2010) 
 High TNFα production 
after LPS, zymosan and 
S.aureus stimulation 
(Skrzeczynska-Moncznik 
et al., 2008) 
Human CD14+CD16+ Produced high levels of 
TNFα and IL1β after LPS 
stimulation 
(Cros et al., 2010) 
 Produced high levels of 
IL10 after LPS stimulation 
(Skrzeczynska-Moncznik 
et al., 2008) 
Mouse Ly6Chi Control fungal infections (Traynor et al., 2000; 
Traynor et al., 2002) 
 Respond to viral ligands 
with production of type I 
IFNs through TLR2 
(Barbalat et al., 2009) 
Mouse Ly6Clo Patrolling behaviour (Auffray et al., 2007) 
 responded strongly to 
TLR7 agonists but not 
LPS 
(Cros et al., 2010) 
Table 4.2 Proposed roles in infection of human and mouse monocyte subsets 
CD16hi monocytes as being the main producers of pro-inflammatory cytokines in 
response to LPS (Wong et al., 2011). The studies summarised in Table 4.2 
demonstrate the variable results achieved in studies of monocyte subsets from 
different laboratories.  This could be due to several reasons; different isolation 
methods are often employed meaning CD14hiCD16- monocytes could be composed 
of slightly different cells depending on the laboratory the experiment is conducted in.  
Furthermore some of the anti-CD14 antibodies used to isolate the subsets have been 
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described to have a blocking action (Power et al., 2004) which would affect 
subsequent studies on response to TLR4 ligands.   
The differential expression of CD14 and CD163 on pig monocyte subsets has been 
demonstrated previously by others (Chamorro et al., 2004; Chamorro et al., 2000; 
Chamorro et al., 2005) and this thesis also clearly showed differential expression of 
CD16 in the pig, as in man and mouse (Chapter 3).  Unfortunately there are many 
problems associated with cross-species comparisons, for instance the same markers 
often cannot be used across species.  In the pig CD163 is differentially expressed by 
CD14 positive monocytes with those cells that express highest levels of CD14 
expressing lower levels of CD163.  CD163 is also differentially expressed by human 
CD14 positive monocytes but in the converse pattern to in pig and it is not 
differentially expressed in the mouse at all (Ingersoll et al., 2010).  Furthermore in 
humans CD16 is a duplicated gene which shows copy number variation amongst 
individuals (Zhou et al., 2010), and although it is also differentially expressed in both 
pig and mouse monocytes, it is not useful as a marker.  CD14 also differs amongst 
species, in that it is an acute phase protein expressed by the liver in humans but not 
in mice (Hetherington et al., 1999; Pan et al., 2000) and finally, Ly6C is a marker 
only in mice.  Despite these problems there are likely to be homologous cell 
populations across species, particularly in those as closely related as humans and 
pigs.  There has been no previous analysis of the gene expression profiles of pig 
monocyte subsets therefore the aim of this chapter was to determine if the recently 
reported differences between monocyte subsets in mouse and human were conserved 
in the pig.  The pig may function as good model for many inflammatory human 
conditions.  The identification of shared differential gene expression between human 
and pig monocyte subsets may assist in finding targets for disease or markers of 








Figure 4-2 Monocytes were FACS sorted on CD163. 
Monocytes were gated (A), dead cells excluded (B) and cells sorted on expression of 














4.2.1 Microarray analysis of porcine monocyte subsets 
Pig monocytes were stained with CD14 and CD163 and FACS sorted (FACS Aria) 
into two populations of CD14hiCD163lo and CD14loCD163hi monocytes (Figure 4.2).  
RNA was extracted and analysed by microarray and normalization and statistical 
analysis was performed by Fios Genomics. Figure 4.3 shows a workflow diagram 
for the analysis of the microarray data.  Three animals were examined separately. 
Statistical analysis of the microarray showed many probes were differentially 
expressed between the CD14hiCD163lo and CD14loCD163hi populations.  Probes 
were sorted and only those which were differentially expressed by ≥ 1.5 or ≤ 0.67 
fold change between the monocyte subsets were included.  This normalised and 
filtered dataset was then analysed using Biolayout Express3D (Freeman et al., 2007) 
with an MCL of 1.7, R=0.95, smallest cluster = 3.  This generated 69 clusters which 
were grouped into two distinct shapes, one of which was composed of clusters of 
probes which were expressed more highly in CD14hiCD163lo monocytes and one 
composed of clusters which were more highly expressed in CD14loCD163hi 
monocytes (Figure 4.4).  The expression profiles of CD163, CD16 and CD14 shown 
in Figure 4.4 confirmed the successful separation based upon the markers and the 
differential expression of CD16 seen previously (Chapter 3).  CCR2 and CX3CR1 
are differentially expressed on mouse and human monocytes and so far only limited 
studies have investigated their expression in the pig (Moreno et al., 2010).  Probes 
for CX3CR1 were not included in this array but CCR2 was expressed more highly by 
CD14loCD163hi monocytes which is the converse to what is seen in human and mice 
and what has been reported previously in the pig (Moreno et al., 2010; Ingersoll et 
al., 2010).  Data from Biolayout can more easily be represented in a 2D format using 
the graph editor yEd (Figure 4.5).  In addition to the variation between the monocyte 
subsets that was reproducible amongst each of the animals, Figure 4.5 also shows 
that there was variation between the individual animals.  For example genes in 
cluster 6 were most highly segregated between monocyte subsets in pig 3, similar 
distinct expression can be seen for pig 2 in cluster 3.  The three animals used for this
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Figure 4-3 Work flow for studying genes which were differentially expressed in porcine monocte 
subsets. PBMCs isolated from blood of pigs 8-12 week old LW x Landrace F1 cross 
(2 males 1 female), stained with anti-CD14 and anti-CD163 antibodies and FACS 
sorted into subsets to obtain RNA for analysis by Affymetrix array. 
Isolate PBMCs from  pigs (one female, two males, 8-
12wks) 
Stain with anti CD14 and  anti CD163 antibodies  and 
appropriate  isotype  controls 
FACS sort into subsets on basis of expression 






Cell harvest, extract 
RNA, analyse gene 
expression with 
Affymetrix Gene Arrays 
 Probe set expressions normalized using the RMA 
algorithm  as implemented in the Bioconductor 
package affy 
Data sorted to extract all genes differentially 
expressed between subsets (> 1.5 fold change or 
<0,67 fold change) Normalized, sorted array data 
was uploaded to the software Biolayout 
Express(3D) (http://www.biolayout.org/) and a 
graph was created using parameters of R mean 
0.95, Markov clustering algorithm of 2.2, and a 
minimum number of 6 nodes per cluster 
Genes which were differentially expressed 
in mouse and human monocyte subsets 
identified (Ingersoll et al 2010) and 
expression levels of these genes analysed 










Figure 4-4 Micro-array data clustered into two distinct groups containing genes which were 
more highly expressed by CD163hi or CD163lo monocytes. 
Expression of the surface markers CD163, CD14 and CD16 are shown to verify 
successful sorting of monocytes. 
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Figure 4-5 Clusters of co-expressed genes were more highly expressed by CD163hi or CD163lo 
monocytes 
Data also showed some variation between individual animals.
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study were from different genetic backgrounds and clusters such as these may highlight 
variation between breeds which may results in differential response to infection.  
Alternatively variation between samples may be due technical or biological variation and has 
been reported to be common in clinical data (Theocharidis et al., 2009).  
 
To highlight the most robust differences between CD163hi and CD163lo pig monocytes, the 
top 50 most differentially expressed genes were identified (Figure 4.6).  CD163lo monocytes 
expressed higher levels of the neutrophil chemotactant chemokine IL8 and its receptors IL8 
receptor 2 fragment and IL8 receptor β (IL8RB, CXCR2) as well as the tetraspanin CD82 
which is involved in T cell activation.  The IFN inducing cytokine IL18 was also more highly 
expressed in CD163lo monocytes as were the pro-inflammatory genes S100A8 and 
prostaglandin-endoperoxide synthase 2 (PTGS2, COX2) .  CD163hi monocytes expressed 
high levels of legumain (LGMN) which is essential for antigen presentation.  The class II 
genes of the swine leukocyte antigen (SLA) genes, like human MHC class II genes, are 
involved in control of immune response to foreign antigen.  SLA-DRB1 was one of the most 
highly expressed genes on CD163hi pig monocytes suggesting they may have a higher antigen 
presenting role than CD163lo monocytes.  Other immune genes preferentially expressed by 
CD163hi monocytes included the C-type lectin CLEC7A (dectin1) which recognises a variety 
of beta glucans from fungi and plants and kynurenine 3-monooxygenase (KMO) which the 
catalyses the metabolism of kynurenine to 3-hydroxykynurenine in the IDO mediated 
metabolism of tryptophan to kynurenine which is discussed in more length in Chapter 5.  
Dectin1 has also been described to function as a co-receptor for recognition of various 
microbial products (Yadav and Schorey, 2006; Dillon et al., 2006; Ferwerda et al., 2008b).   
The miRNA mir-29c (ssc-mir-29c) was also up-regulated in CD163hi monocytes as was the 
receptor for angiopoeitin-1 (TEK). The differential expression of key immune response genes 
suggests specialised functions for monocyte subsets in the pig as has been reported 
previously in other species (Zhao et al., 2009; Wong et al., 2011; Ingersoll et al., 2010; 
Ancuta et al., 2009).  For instance CD163lo monocytes 
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Figure 4-6 The top 50 most differentially expressed genes between pig monocyte subsets. 
Genes were sorted by fold change and the 50 most differentially expressed genes ( by fold 
change, average across all three samples, (p>0.01) )  are shown. 
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expressed many genes involved with recruitment of other immune cells while CD163hi 
monocytes appeared specialised for antigen presentation.  To enable a better understanding of 
any functional differences between the subsets all probes which were more highly expressed 
in CD163hi monocytes by at least 1.5 fold change were identified (2082 individual genes).  
Analysis of these genes using DAVID (Huang et al., 2008; Huang et al., 2009) showed 
enrichment for mitochondrial components, translation, cellular metabolic processes, 
intracellular protein transport, localization and binding, nuclear parts, cytoplasmic membrane 
bound vesicles and RNA processing.  This suggests CD163hi monocytes are more 
metabolically active so are actively growing unlike CD163lo monocytes.  They are 
responding to growth factors by increasing protein synthesis and RNA synthesis and were 
enriched for genes involved in anabolic metabolism, the TCA cycle and respiration.  The top 
ten clusters of GO terms which were enriched in CD163hi monocytes can be found in 
Appendix 6.  Similar analysis of probes which were expressed more highly in CD163lo 
monocytes provided 1485 unique genes.  Analysis with DAVID showed enrichment for 
genes involved in leukocyte activation and differentiation such as CSF2, CSF3R, CXCR2,  
IL8, TGFB1, TLR2, TNF (Figure 4.7A-G)  and the inflammatory response and response to 
wounding including CCL5, CCR1, CD14, CXCR2, IL1B, TGFB1, THBS1, TLR2, TLR9,TNF, 
IL8, CSF3R (Figure 4.7H-L).  This suggests that CD163lo monocytes are the immune 
effector cells and that this function is switched off as the cells mature to CD163hi monocytes.  
The full list of genes found in the top ten clusters can be found in Appendix 6. 
 
As with previous studies in human and mouse (Ingersoll et al., 2010; Cros et al., 2010) there 
did appear to be some lymphocyte contamination, KLRG1 which is mainly expressed on T 
cells was in cluster 6 and BANK1 and BCL7A which are expressed by B cells were in cluster 
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4.2.2 Analysis of human and mouse data sets 
To compare gene expression of pig monocytes to the better characterised human and mouse 
monocyte subsets, microarray data comparing human and mouse monocytes was downloaded 
from the Gene Expression Omnibus (GEO) database (ncbi.nlm.nih.gov/gds) (GSE16836, E-
MEXP-2544, E-MEXP-2545, GSE18565, GSE17256, GSE17256). Probes were sorted and 
only those which were differentially expressed by ≥ 1.5 or ≤ 0.67 fold change between the 
monocyte subsets were included.  This data was analysed using Biolayout Express3D 
(Freeman et al., 2007) with an MCL of 1.7, R=0.95, smallest cluster = 3 
 
4.2.2.1 Human monocyte subsets 
There have been several studies comparing gene expression of the traditional monocyte 
subsets in man (Zhao et al., 2009) and more recent studies have examined differences 
between three human monocyte subsets (Wong et al., 2011).  Cros et al. (2010) examined 
how differences between these three monocyte subsets could relate to differentially expressed 
genes in the mouse.  In other studies, Mabbott et al. (Mabbott et al., 2010) have taken 
microarray datasets from multiple laboratories and analysed them using Biolayout to identify 
clusters of genes that track together consistently. Analysis of this human monocyte 
microarray data highlights many sample specific rather than cell type specific clusters, 
suggesting that the different datasets from different labs are not strictly comparable.  For 
example the largest cluster of co-expressed probes, cluster 1 was composed of genes which 
were expressed more highly in one sample (CD14_s32) (Figure 4.8).  This is common when 
there is technical or biological variation between samples and as discussed above may be 
observed with clinical data (Theocharidis et al., 2009).  Two samples appeared to have been 
switched at some stage as sample CD1416_s38 was labelled as CD14hiCD16hi although the 
gene expression pattern more closely resembled the other 4 CD14+CD16- samples.  
Correspondingly the expression pattern of sample CD14_s37 more closely fit the other 
CD14hiCD16hi  samples (Figure 4.8, cluster 4, 9 and 17).  Cluster 1 contained some B-cell 
associated genes (BANK1, BCL7A, CD22, CD72) which as above may suggest 
contamination.  The interferon regulated  
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Figure 4-8 Human monocyte subset array data from Cros et al. was re-analysed using Biolayout Express. 
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gene SIGLEC1 was highly expressed in this cluster as was CD22 which belongs to the siglec 
family of lectins.  SIGLEC1 was highly expressed on CD14hi monocytes from patients with 
systemic sclerosis (York et al., 2007).  Cluster 4, 9, 12, 15, 16, 17 and 19 (Figure 4.8) 
contained genes which were highly expressed in the CD14+CD16- samples and which were 
only expressed at low levels by the CD14dim monocytes, these include CCR2, IL1RN, CD163, 
TREM1, FOS, S100A8 and S100A12.  Many of the clusters containing genes which were 
highly expressed by CD14+CD16- monocytes (Clusters 4, 9, 12, 15, 17 and 19) contained 
genes which were expressed at intermediate levels by CD14+CD16+ monocytes (Figure 4.8).  
Genes in these clusters included CCR2, IL1RN, CD163, S100A8 and S100A12.  Unlike more 
recent analysis of the proposed three human monocyte subsets (Wong et al., 2011) there were 
no clusters in this dataset which were specific for genes which were expressed more highly 
by CD14dimCD16hi or CD14 hi CD16 hi monocytes. 
 
Similar studies comparing differences between the two traditional monocyte subsets have 
also been carried out (Ingersoll et al., 2010; Ancuta et al., 2009).  As these may be more 
comparable to the two monocyte subsets in the pig, genes which were differentially expressed 
in these studies were identified.  Comparison of data from Ingersoll et al. (2010) did not show 
the sample specific variation seen in the Cros et al. data, instead it clustered into genes which 
were more highly expressed in specific subsets (Figure 4.9).  The majority of genes clustered 
into two main clusters.  The largest cluster, cluster 1, contained 1819 probes for genes which 
were expressed at higher levels in CD16+ monocytes (including CD16) such as, CX3CR1, 
CD11a, CD11c, CD43 and CSF1R.  Similarly Cluster 2 contained 1447 probes for genes 
which were expressed more highly in CD16- monocytes (including CD14) such as CCR2, 
CD163, CCR1, CD62L, CSF3R, CSF2RA, FCGR1B, CD64, CD36.  Analysis of gene 
expression data from Ancuta et al. was examined in a similar manner and clustered into two 
main groups which were differentially expressed between the monocyte subsets (Figure 
4.10) again as reported with other data above there were some sample specific clusters 
(Figure 4.10, cluster 1, cluster 5). The largest cluster, cluster 1 contained 3211 probes which 
were more highly expressed in one sample,  
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CD43 was included in this cluster. Genes which were more highly expressed by CD16+ 
monocytes, in all data examined (Ingersoll et al., 2010; Zhao et al., 2009; Ancuta et al., 2009) 
included CD62L, CX3CR1, CSF1R, TNF, FCGR3B (CD16) and ITGAL (CD11a) while 
probes for genes such as CCR1, CD9, CD36, IL8, CD163, CSF3R, S100A8, S100A9  and 
CCR2 were expressed more highly by CD16-monocytes (Figure 4.1).  Data from Cros et al. 




Until recently the proposed homology between human CD16+ and mouse Ly6clo monocytes 
mainly rested on the expression of a few key surface markers (detailed in Appendix 3).  
Recently several groups have compared gene expression data from human and mouse 
monocyte subsets to determine if the similarities extend beyond expression of a few key 
molecules.  The array data from these studies was downloaded from GEO and analysed as 
above.  Gene expression levels for mouse monocytes from Cros et al. (Cros et al., 2010) and 
Ingersoll et al. (Ingersoll et al., 2010) clearly clustered into cell type specific clusters (Figure 
4.11  and Figure 4.12).  Genes which were more highly expressed in Ly6C- monocytes in 
both studies included Ccl5, Pparg, Tlr8, Il1rn, Il18bp, Il9r, Irf6, Sirpα, Csf1r, Csf2rb1, 
Clec4e, Serpinb2, Smurf2, Pde4b, Rtn1, Jag1, Ear3, Cd36 and Trem1.  Similarly both studies 
discovered genes which were more highly expressed in Ly6C+ cells such as Ifngr2, Il11ra1, 
Tgfbi, Tgfb1, S100a13, Traf5, Ccl9, Cd92, Ccr2, Icam1, Casp2, Usp18 and Oas2.  There 
were some genes which were shown to be differentially expressed between the subsets in a 
converse manner between the two studies.  For instance the transcription factor Tcfec was 
only highly expressed by one Ly6C+ sample in the study by Cros et al. while Ingersoll et al. 
found it increased in all samples.  Cros et al. found high expression of the transcription factor 
Tcf4 and Cd9 in Ly6C+ samples while Ingersoll et al. found it to be more highly expressed by 
Ly6C- cells.  Similarly Cros found higher expression of Ifit2, C3 and Msr in Ly6C- 
monocytes while Ingersoll et al. found higher expression in Ly6C+ monocytes.  Differences 
in gene expression levels between the studies could be down to the different isolation  
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methods used or the different platforms used to analyse gene expression however this data 
provides a list of genes which are consistently expressed by one specific monocyte 
population in the mouse and which will prove useful for future mouse models of human 
disease. 
 
4.2.3 Comparison of human, mouse and pig monocyte subsets. 
Ingersoll et al. (2010) previously identified 132 genes which were differentially expressed in 
the same subsets in both human and mice monocytes and 33 genes which were differentially 
expressed but in a converse pattern between the two species (Ingersoll et al., 2010).  To 
determine if the differential expression of these genes was also conserved in pig monocyte 
subsets expression was examined in monocytes FACS sorted on the basis of CD14 and 
CD163 expression.  Figure 4.13 shows genes where the differential expression was 
conserved between human and pig (80 genes) and Figure 4.14 shows genes which were 
differentially expressed in pig and human but in a converse manner to each other (44 genes), 
43 genes which were identified by Ingersoll et al. were not in the pig array.  Among those 
genes more highly expressed on CD14hi human (CD14hiCD16-), pig (CD14hiCD163lo) and 
mouse (Ly6Chi), monocyte subsets was CD14, S100A8, CCR1, IL18, LBR and CSF3R.  The 
expression of JAG1, TREM1 SGK1, PDE4B, SERBINB2, CLEC4E and CD36 was conserved 
in human and pig but not mouse, these genes were more highly expressed by human and pig 
CD14hi monocytes and CD14lo mouse monocytes.  CD14lo human (CD14loCD16+), pig 
(CD14loCD163hi) and mouse (Ly6Clo) monocyte subsets expressed higher levels of  CD16, 
ICAM2, TGFBR3, ITGAL, LTB.  Human and pig CD14lo monocytes shared high expression 
of interferon-induced proteins with tetratricopeptide repeats 2 and 3 (IFIT2, IFIT3) and the 
scavenger receptor MSR1 which were all more highly expressed on mouse CD14hi 
monocytes. Although expression was conserved between the three species the degrees of 
differential expression was often different between the species, for instance CD14 was more 
highly expressed by Human CD16- monocytes compared to CD16+ monocytes than when 
comparing the two subsets in pig or mouse and although CD16 was differentially expressed 
by CD14 positive pig monocytes, both populations expressed it at relatively high levels 
compared to human CD16lo monocytes.  Differential gene expression can help identify 
functions which are specific to one monocyte subset.  Mouse Ly6Clo and human CD16+ 
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monocytes have been described as better stimulators of mixed lymphocyte reactions.  The 
finding that genes encoding MHC class II molecules were enriched in mouse Ly6Clo and 
human CD16+ monocytes  
validated this (Ingersoll et al., 2010). Similarly others have reported pig CD163hi monocytes 
as better accessory cells  (Sanchez et al., 1999) and this study showed that SLA-DQ and DR 
were expressed more highly on CD163hi monocytes (SLA-DQA, SLA-DQB1, SLA-DRA, SLA-
DRB1, SLA-DRB2). 
 
Ingersoll et al. (2010) found expression of phagocytic and scavenger receptors to differ 
between human and mouse monocyte subsets.  Generally these were more highly expressed 
on mouse Ly6Clo and human CD16- monocytes suggesting different roles for the monocyte 
subsets in human and mice.  The expression of these receptors was therefore examined in the 
pig monocyte subsets to determine if a specific subset appeared to be better adapted for 
recognition and engulfment of apoptotic cells.  The expression of the adhesion molecule 
thrombospondin 1 (THBS1) and the thrombospondin receptor CD36 was higher on CD163lo 
monocytes as was expression of triggering receptor expressed on myeloid cells 1 (TREM1) 
(Figure 4.13).  Expression of similar adhesion molecules or scavenger receptors such as the 
αv integrin (ITGAV, CD51) did not differ between the subsets and mRNA levels of the 
apoptotic cell recognition molecule SIRPA were varied, expression was high on CD163hi 
monocytes from pig 2, slightly high on CD163hi monocytes from pig 1 but there was no 
difference in expression between monocyte subsets in pig three.  Furthermore expression of 
SIRPA at the protein level (Chapter 3) showed homogeneous expression on all CD14+ 
monocytes.  Expression of some scavenger receptors and receptors for apoptotic cells does 
seem to be differentially expressed as in humans although analysis with DAVID (Huang et 
al., 2008) did not find enrichment of either cluster for genes relating to phagocytosis 
suggesting that the  
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Figure 4-13 Genes which were differentially expressed in the same pattern between human and pig 
monocyte subsets. 
Mouse and human data from Ingersoll et al. (2010). 
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Figure 4-14 Genes which were differentially expressed in the converse pattern between human and pig 
monocyte subsets. 
Mouse and human data from Ingersoll et al. (2010). 
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specialisation of one subset that was observed in man and mouse does not happen to such an 
extent in the pig. 
 
Surprisingly CCR2 was shown to be on average more highly expressed by CD14lo pig 
monocytes in contrast to the high expression on CD14hi human and mouse monocytes 
(Figure 4.14) and to previous reports (Moreno et al., 2010).  Analysis of the array data show 
there were two probes for CCR2 (SNOWBALL_014576.1_st, SNOWBALL_014576.2_st) 
one of which was more highly expressed by CD163hi monocytes and one by CD163lo 
monocytes.  Again contrary to previous reports (Chamorro et al., 2005) TNF was more highly 
expressed by pig CD14hi monocytes converse to the high expression by human and mouse 
CD14lo monocytes.  The transcription factor TFEC was also more highly expressed on 
CD14lo pig monocytes and CD14hi human and mouse monocytes.  Ingersoll et al. have 
reported differential expression of CD9 between human and mouse monocyte subsets and this 
array showed that like mice, it was pig CD14lo monocytes which expressed higher levels of 
this adhesion molecule.  The transcription factor POU2F2 was also differentially expressed 
between pig versus human and mouse.  CD64 has been used to divide human monocytes into 
subsets (Grage-Griebenow et al., 1993; Grage-Griebenow et al., 2000; Grage-Griebenow et 
al., 2001b) and differential expression has been shown between murine monocytes however 
differential expression was not seen in the pig.  Finally Ingersoll et al. also noted a PPARγ 
signature in mouse Ly6Clo monocytes, PPARG was expressed only at very low levels 
suggesting that pig monocytes were like human monocytes in this aspect too. 
 
This data suggests CD14hi monocytes are perhaps the most closely conserved between 
different species.  The porcine CD163hiCD14lo monocyte may not be the functional 
equivalent of human CD14lo population.  Examination of porcine monocyte FACs plots show 
that the expression of CD14 on CD163hi monocytes is still relatively high compared to that 
seen on CD16hi human monocytes, these cells may be better termed as intermediate 
expressers of CD14.    Examination of FACS plots from Chapter 3 and Figure 4.2 show 
there is a true CD14lo population which is also negative for CD163.  CD163 may be better 
utilised to simply subdivide the CD14hi population in the pig.  One of the biggest differences 
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between monocyte subsets in humans and other species examined is the relative numbers of 
each subset; in man around 90% of monocytes are classical CD14hi and only 10% express 
low levels of CD14.  The CD14loCD163- porcine monocyte population identified in Chapter 
3 may be more similar to human CD14lo monocytes and the numbers of porcine CD14lo 
monocytes may be closer to the percentages in humans.  Previous investigations have so far 
focussed on subdivisions of CD14lo populations in man, subdivision of the CD14hi population 
has not been examined in humans and the use of further antibodies may show a sub-
populations of CD14hi monocytes.  CD14hi monocytes they make up 90% of circulating 
monocytes and heterogeneity in this population does not seem unlikely.   
 
4.3 Discussion 
Previous groups have used the LPS receptor CD14 and the scavenger receptor CD163 to 
divide pig monocytes into subsets.  As with similar work in humans and rodents the 
assumption is that differing surface expression of such key immune molecules results in 
functional differences such as inflammatory role, cytokine production and pathogen 
recognition.  Work on monocyte subsets in the pig has so far been limited to analyses of 
surface markers (Chamorro et al., 2004; Chamorro et al., 2000; Chamorro et al., 2005) or 
smaller studies looking at expression of specific genes (Moreno et al., 2010).  This chapter 
aimed to identify differences at the genomic level between monocyte subsets in the pig and 
hypothesise how they may relate to functional differences between the cells in vivo. 
 
4.3.1 Gene expression differences between pig monocyte subsets 
In order to determine possible functions of pig monocytes, the 50 most differentially 
expressed genes were identified (Figure 4.5).  CD163lo monocytes expressed between 6-12 
fold higher levels of the chemokine IL8 and its receptors (IL8RB, IL8R2, CXCR2) than 
CD163hi monocytes. IL8 was first identified as a powerful neutrophil chemoattractant 
(Yoshimura et al., 1987) and has been demonstrated to have similar effects in several species 
(Beaubien et al., 1990; Hassfurther et al., 1994; Lindley et al., 1988; Caswell et al., 1999; 
Seow et al., 1994). IL8 has been shown to have a wide variety of effects on neutrophils 
(Mukaida et al., 1998) including increasing expression of the adhesion molecules 
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CD11b/CD18, CD11c/CD18 and CR1 (Detmers et al., 1990), and  induction of superoxide 
and hydrogen peroxide and release of granule enzymes (Walz et al., 1987).  Neutrophil 
infiltration is one of the hallmarks of acute inflammation and injection of IL8 resulted in 
rapid neutrophilia (Larsen et al., 1989; Laterveer et al., 1996).  The relatively high expression 
of IL8 by CD163lo monocytes suggests they may have an important role in recruiting 
neutrophils to sites of inflammation or infection.  Moreover increased expression of IL8 
receptors suggests IL8 may have an auto-stimulatory or regulatory role in CD163lo 
monocytes as has previously been described in T cells (Gesser et al., 1996).   The recruitment 
of neutrophils to sites of inflammation is also of therapeutic interest as it is common in 
ischemia reperfusion injury (IRI) which can lead to complications in organ transplantation, 
cerebral stroke, myocardial infarction and bowel surgery (Litt et al., 1989).  Depletion of 
neutrophils resulted in attenuation of IRI in an animal model (Korthuis et al., 1988).  
Identification of the CD163lo subset as important mediators of neutrophil influx may provide 
new therapeutic targets.  IL8 also induced angiogenesis (Koch et al., 1992) although it has 
been suggested this was through the recruitment of leukocytes rather than direct actions of 
IL8 (Petzelbauer et al., 1995).  Nevertheless IL8 production at sites of inflammation may lead 
to increased wound healing whether through direct or indirect formation of new blood 
vessels.  In addition to its many effects on neutrophils, IL8 has also been shown to inhibit IgE 
production by B cells (Kimata et al., 1992), stimulate release of histamine from basophils 
(White et al., 1989) and to be chemotactic for T cells (Larsen et al., 1989).  IL8 has been 
particularly implicated in Th1 responses; Th1 cytokines up-regulated IL8R expression on T 
cells in vitro while Th2 cytokines inhibited T cell chemotaxis to IL8 (Jinquan et al., 1995).  
Moreover IL8 has been shown to be involved in regulation of T helper cell activities, 
suppressing IL4 and up-regulating its own production by CD4 T cells (Gesser et al., 1996).  
Expression of the IL8 receptor CCR1 has also been shown to define a subset of highly 
cytotoxic CD8 T cells with high levels of perforin, granzyme B and IFNγ which were primed 
to hone for early recruitment into sites of infection or inflammation (Hess et al., 2004).  
Expression of IL8 by CD163lo monocytes could provide an important link between the innate 
and acquired immune system through regulation of T cell function in addition to its 
neutrophil attracting properties.  At present no direct murine homolog of IL8 has been 
identified and mice appear to lack the IL8 receptor CXCR1.  Nevertheless the murine 
chemokines CXCL1 (KC), CXCL2 (MIP2) and CXCL5 (LIX) signal through a receptor 
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homologous to human CXCR2 and mediate neutrophil chemotaxis (Bozic et al., 1994; Lee et 
al., 1995) suggesting a similar mechanism for neutrophil recruitment also exists in the mouse 
despite the lack of a direct homolog of IL8.  In man CD16- monocytes have previously been 
reported to be enriched for genes involved in production of IL8 (Ancuta et al., 2009; Zhao et 
al., 2009; Ingersoll et al., 2010) and Figure 4.1) and to respond to LPS with production of 
IL8 (Cros et al., 2010).  A recent study examining gene expression differences between three 
monocyte subsets (classical CD14hiCD16-, non-classical CD14loCD16hi and intermediate 
CD14+CD16+) found IL8 to among one of the most differentially expressed genes, being 
strongly expressed by the classical human subsets (Wong et al., 2011)  suggesting that in men 
and pigs at least CD14hi monocytes are important mediators of the immune response by 
influencing neutrophil and T cell response to infection. 
 
CD163lo monocytes also expressed higher levels of the cytokine IL18.  IL18 is a member of 
the IL1 family, is structurally related to IL1β  and was originally described as an inducer of 
IFNγ (Okamura et al., 1995).  Like IL8, IL18 can regulate the adaptive immune response 
functioning as a regulator of both Th1 and in the absence of IL12, Th2 responses (Nakanishi 
et al., 2001).  Autocrine IL18 has been shown to have pro-inflammatory functions by 
enhancing production of IL1β and TNFα and up-regulating expression of the adhesion 
molecules VCAM1 and ICAM1 on monocytes (Dai et al., 2004).  IL18 has also been shown 
to have a role in resolution of the inflammatory immune response by preventing monocyte 
apoptosis and promoting differentiation into macrophages.  IL18 increased production of the 
angiogenesis-regulating and immune cell chemotactic chemokines CXCL8, CXCL9 and 
CXCL10 (Coma et al., 2006) again suggesting CD163lo monocytes may serve as a link 
between the innate and adaptive immune system.  Similarly the co-stimulatory molecule 
CD82 was more highly expressed by CD163lo monocytes.  CD82 has been shown to function 
as an accessory molecule in T cell activation by associating with CD4 or CD8 to deliver co-
stimulatory signals for the T cell receptor (TCR)/ CD3 pathway (Imai and Yoshie, 1993; 
Nojima et al., 1993).  Signalling through CD82 links to the actin cytoskeleton, so may have a 
particular role in T cell co-stimulation through induction of morphological changes 
(Lagaudriere-Gesbert et al., 1998; Delaguillaumie et al., 2004). CD163lo monocytes 
expressed a large number of genes associated with control of the adaptive immune response 
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suggesting they may serve as an important bridge between the innate and acquired immune 
system. 
 
A pro-inflammatory role was also suggested for CD163lo monocytes due to high expression 
of the pro-inflammatory genes PTGS2 and S100A8.  PTGS1 and PTGS2 catalyze the first step 
in the synthesis of the fatty acid derivatives prostaglandins, thromboxanes and prostacyclins 
(KOSAKA et al., 1994).  Prostaglandins play key roles in regulation of immune function, 
angiogenesis and kidney development (Williams et al., 1999) and contribute to T cell 
development (Rocca et al., 1999).  PTGS2 is generally seen as pro-inflammatory and is a 
major target for the treatment of inflammatory disease (Willoughby et al., 2000).  S100A8 
has also been implicated in inflammation (Odink et al., 1987; Roth et al., 2003; Goyette and 
Geczy, 2010; Perera et al., 2009; Ravasi et al., 2004) and excessively high levels have been 
associated with recurrent infections and inflammation (Sampson et al., 2002).  S100A8 has 
also been shown to modulate cystoskeletal-membrane interactions during macrophage 
activation and to be involved in phagocyte migration (Roth et al., 1993).  Similar high 
expression of genes of the S100 family has been described in human CD14hiCD16- 
monocytes (Wong et al., 2011) suggesting the proposed pig and human “classical” monocytes 
share a similar pro-inflammatory role. 
  
The lysosomal asparaginyl endopeptidase legumain (LGMN) was the most highly expressed 
gene in CD163hi pig monocytes. LGMN can be found in lysosomes and degrades antigenic 
proteins for presentation to CD4+ cells so is responsible for a key step in antigen presentation 
(Manoury et al., 1998; Antoniou et al., 2000).  CD163hi monocytes also expressed the highest 
levels of the SLA class II gene SLA-DRB1, levels of other SLA genes were also higher in 
CD163hi monocytes (SLA-DQA, SLA-DQB1, SLA-DRA, SLA-DRB1, SLA-DRB2) suggesting a 
role for porcine CD163hi monocytes in class II processing and presentation.  A similar role in 
MHC processing has been described for human “intermediate” CD14+ CD16+  monocytes 
(Wong et al., 2011). 
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Research in the last 10 years has revealed that Micro RNAs (miRNAs) control gene 
expression at several different levels including mRNA stability and translation. miRNAs are 
a class of non-coding, single stranded RNA molecules of around 19-25 nucleotides; each 
targets a spectrum  of target genes at a post-transcriptional level  by imperfect base-pairing 
with the 3’-UTR (David, 2004).  Distinct miRNAs control several steps within the acquired 
and innate immune responses, development of disease and immune cell differentiation 
(Baltimore et al., 2008; O'Connell et al., 2010).  The miRNA miR-29c was highly expressed 
in pig CD163hi monocytes.  miR-29c has been shown to suppress responses to intra-cellular 
pathogens by targeting expression of the archetypal Th1 cytokine, IFNγ.  Mice infected with 
intracellular bacteria down-regulated miR-29 expression in NK cells, and CD4+ and CD8+ T 
cells which enabled these cells to produce higher levels of IFNγ.  miR-29 also directly 
targeted IFNγ mRNA which suppressed production of IFNγ (Ma et al., 2011).  The miR-29 
family have also been shown to target the zinc finger protein TNFα-induced protein 3 
(TNFAIP3) (Wang et al., 2011a).  TNFAIP3 inhibits NFκB activation and TNF-mediated 
apoptosis (Vereecke et al., 2009).  Such negative regulation of the immune response is an 
import method of limiting inflammation.  Expression of miR-29c has been shown to inversely 
correlate with TNFAIP3 in hepatocellular carcinoma cell lines and clinical samples and over-
expression of miR-29c was shown to suppress TNFAIP3, inhibit cell proliferation and induce 
apoptosis in a hepatitis B virus-related hepatocellular carcinoma cell line.  miR-29 family 
members may also target genes involved in fibrosis in organs such as the lungs (Cushing et 
al., 2011).  CD163hi monocytes are thought to mature from CD163lo monocytes therefore 
high expression of miR-29c by CD163hi monocytes may inhibit monocyte proliferation as the 
cells mature to eventually become tissue macrophages. 
 
CD163hi monocytes also expressed higher levels of kynurenine 3-monooxygenase (KMO) 
which is involved in the IDO mediated metabolism of kynurenine to 3-hydroxykynurenine 
(Figure 5.1).  IDO1 was also expressed at higher levels in CD163hi monocytes.  IDO1 is 
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4.3.2 Differences between human and mice monocyte subsets 
Many diseases are associated with monocytosis or alterations in the proportions of the 
monocyte subsets, increases in the CD16+ subset is particularly associated with inflammatory 
disease (Baeten et al., 2000; Blumenstein et al., 1997; Ellery et al., 2007; Fingerle et al., 
1993; Kawanaka et al., 2002; Mosig et al., 2009).  Increases in the intermediate subset have 
also been reported in asthmatic patients (Moniuszko et al., 2009) and CD14+CD16+ 
“intermediate” monocytes have been shown to be most permissive to infection with HIV 
(Kim et al., 2010; Ellery et al., 2007). Mice are often used to model human inflammatory 
disorders therefore there is great interest in determining any similarities or differences 
between monocyte subsets in the two species in order to better model human conditions 
which affect relative monocyte numbers or which may result from alternations in a particular 
subset of monocytes.  
 
Human CD14+CD16- monocytes produced a broad range of cytokines including IL10 and IL6 
but little TNFα after stimulation with LPS while CD14+CD16+ monocytes were the main 
producers of the inflammatory cytokines TNFα and IL1β (Belge et al., 2002; Wong et al., 
2011).  TNFα production has also been shown to be higher in a CD43hi subset of Ly6Clo 
mouse monocytes (Burke et al., 2008) although recruited Ly6Chi monocytes have also been 
shown to produce TNFα (O'Dea et al., 2011; Serbina et al., 2008).  While the role of Ly6C- 
monocytes in infection is unclear they have been ascribed a patrolling behaviour (Auffray et 
al., 2007) which has been mirrored by human CD16+ monocytes (Cros et al., 2010) giving 
important clues about their functions in vivo.  As described previously new classification 
divides the continuum of CD14 and CD16 expressing monocytes seen in a FACS plot into 
three monocyte subsets with cells at either end of the spectrum being the most diverse in 
terms of expression of surface markers, gene expression, cytokine profiles and maturation 
state (Wong et al., 2011).   It is also not yet clear how this new classification will transfer to 
other species where the number of “non-classical” monocytes are far higher than in humans.  
The high TNFα production by murine CD43hi monocytes does however raise the possibility 
that further subdivisions of the established monocyte subsets may be possible in species other 
than humans.  Cros et al. (2010) analysed mouse and human monocyte subsets using 
microarray technology and segregated the data into three clusters corresponding to the 
Chapter 4 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 141 
subsets they identified.  They proposed that human CD14hiCD16- and CD14+CD16+ 
monocytes were most closely related to each other and mouse Ly6Clo monocytes in contrast 
to previous reports (Ingersoll et al., 2010).  Reanalysis of the data of Cros et al. using 
Biolayout Express3D (Freeman et al., 2007) showed many genes that were expressed at high 
levels in CD14hiCD16- monocytes were expressed at intermediary levels in CD14+CD16+ and 
expressed only at low levels or not at all in CD14loCD16hi monocytes suggesting that this 
really is a continuum.  This included genes such as CCR2, IL1RN, CD163, TREM1, S100A8 
and S100A12. These genes have consistently been shown to be selectively expressed by 
CD14hi monocytes (Figure 4.1). There were no clusters which contained genes which were 
most highly expressed by CD14+CD16+ or CD14loCD16hi monocytes.  By contrast Ingersoll 
et al. (2010) determined human CD14hiCD16- monocytes to be most closely related to mouse 
Ly6Chi monocytes.  In agreement with Ingersoll et al.  Wong et al. (2011) determined the 
closest relationship to be between classical CD14loCD16hi and intermediate CD14+CD16+  
monocytes.  Additionally, unlike the gene expression studies by Cros et al., array data from 
Wong et al. showed genes which were specifically expressed by both CD16+ subsets.  They 
also found CD14loCD16hi monocytes to respond to LPS with induction of pro-inflammatory 
cytokines, in contrast to Cros et al. and in agreement with many previous studies 
(Skrzeczynska-Moncznik et al., 2008; Belge et al., 2002).  Skrzeczynska-Moncznik et al. 
(2008) and Cros et al. both claim differences in the expression of TLRs between 
CD14hiCD16+ and CD14dimCD16+ subsets but it is unclear from the data presented by Cros et 
al. whether this was significant for all differences claimed, Skrzeczynska-Moncznik et al. did 
however show significance for TLR2 and TLR4 expression suggesting different monocyte 
subsets would respond to different infectious stimuli. 
 
Cros et al.  (2010) and Ingersoll et al. (2010) compared gene expression between human and 
mouse monocyte subsets but came to different conclusions about the relationship between 
them.  Some of the differences between the data from both studies could lie in the isolation 
methods used.  Cros et al. isolated monocytes based on expression of CSF1R (CD115) 
positive cells while Ingersoll et al. purified on size/density and then removed NK cells using 
anti-CD56, they then positively enriched using magnetic beads.  This may have resulted in 
Ingersoll et al. failing to purify the CD14dimCD16+ cells that Cros et al. emphasised.  
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Additionally the anti-CD14 antibody used by Cros et al, M5E2, has been show to block LPS 
activity (Power et al., 2004) explaining the differences in cytokine profiles reported by Cros 
et al. compared to previous studies (Belge et al., 2002; Wong et al., 2011; Skrzeczynska-
Moncznik et al., 2008).  This suggests that contrary to the findings by Cros et al. human 
CD14hiCD16lo and mouse Ly6Chi monocytes are most probably the closest comparable cell 
types between the two species.  Furthermore the differences between these two papers show 
that experimental data from different laboratories is not strictly comparable, differences in 
isolation methods, antibodies used and the rather arbitrarily defined gates used to separate 
populations can all lead to different results. 
 
4.3.3 A core set of genes is conserved in human, mouse and pig 
monocyte subsets 
Monocytosis or alterations in relative numbers of monocytes are features of a many 
inflammatory conditions (Ancuta et al., 2009; Blumenstein et al., 1997; Ellery et al., 2007; 
Fingerle et al., 1993; Kawanaka et al., 2002; Moniuszko et al., 2009; Steppich et al., 2000). 
As discussed at length in the introduction to this thesis, pigs may function as a better model 
for many inflammatory human conditions than many of the more commonly used rodent 
models.  The comparison of pig and human monocytes on a genome wide scale may therefore 
provide targets to manipulate or markers to affect disease outcome.  Differential expression 
of CD14 and CD16, which have traditionally been used to divide human monocytes into 
subsets (Ziegler-Heitbrock et al., 1993; Ziegler-Heitbrock, 1996), was somewhat conserved 
between human, mouse and pigs (Figure 4.13).  However, CD16 has not been used as a 
subset marker in other species, so the subpopulations defined by this marker may not be 
strictly comparable.  It is worth recalling that whereas CD16+ monocytes account for only 
10% of human monocytes, CD14 low populations (with differential expression of Ly6C or 
CD163) are more like 50% of monocytes in mice and pigs.  There is however another 
population of CD14lo monocytes in the pig which did not express CD163 or CD16.  If this 
population was viewed as the “true” CD14lo population and CD163 seen merely as a further 
marker to differentiate CD14hi monocytes then the numbers of CD14hi and CD14lo monocytes 
between pigs and humans may be more comparable. 
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As discussed above, expression of many genes which control interactions with the adaptive 
immune system (IL8, IL18) were conserved between human and pig CD14hi monocytes.  
Expression of granulocyte-colony stimulating factor (GCSF, CSF3) receptor was also higher 
on human, pig and mouse CD14hi monocytes (Figures 4.1, 4.13).  CSF3 controls the 
production, differentiation and function of granulocytes (Avalos, 1996) and has been 
described as a maturation factor for monocytes as well (Jiang and Schwarz, 2010; Rossetti et 
al., 2010).  Higher expression of CSF3R on CD14hiCD16- monocytes has been previously 
reported (Figure 4.1) and may suggest that production of this monocyte subset in the bone 
marrow is co-ordinated with granulocytes (Ingersoll et al., 2010; Mobley et al., 2007).  
Moreover IL8 is a powerful neutrophil chemotactant produced by CD14hi monocytes in 
humans and pigs suggesting an important relationship between CD14hi monocytes and 
neutrophils.  Mobely et al. suggested numbers of CD14hiCD16- monocytes may be correlated 
to numbers of granulocytes in order to ensure sufficient numbers were available to clear 
apoptotic neutrophils.  Tying the production of these immature monocytes with the 
production of neutrophils by co-expression of CSF3R would appear to be a mechanism to do 
so.  There appears to be a clear immune function for   CD14hi monocytes in humans and pigs 
and this subset perhaps appears to be the most consistent across the species.  This suggests 
immature monocytes can be compared between species but markers in use at present do not 
allow strict comparisons between the more mature CD14lo subsets.  CD163 may function 
better as a differentiator of CD14hi monocytes in the pig, this would be more comparable with 
its role in man where it has been described to define a subset of CD14hi monocytes (reports 
suggest between 7-20% of monocytes expressed CD163) (Asleh et al., 2003; Zwadlo et al., 
1987) 
 
One of the archetypal features of blood monocytes is their phagocytic ability.  Studies have 
suggested mouse Ly6Clo monocytes were more efficient phagocytes (Tacke et al., 2006; 
Randolph et al., 2008) and gene expression differences suggested a similar role for human 
CD16+ monocytes as discussed in the introduction (Zhao et al., 2009).  Functional studies 
have provided conflicting results, these are largely summarised in Table 4.1.  Experiments 
using latex beads suggested  human CD16+ monocytes possessed greater phagocytic ability 
(Mosig et al., 2009) while comparing the ability to phagocytose Aspergillus fumigate found 
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both CD16+ and CD16- monocytes had similar phagocytic ability although only CD16- 
monocytes inhibited germination (Serbina et al., 2009).  Similarly earlier reports ascribed 
higher phagocytic capacity to human CD64+ monocytes which were either CD16+or CD16- 
(Grage-Griebenow et al., 2000; Grage-Griebenow et al., 1993).  More recent studies using 
latex beads showed both subsets were able to phagocytose the beads but CD16- monocytes 
had higher uptake of the beads (Wildgruber et al., 2009).  These sometimes conflicting 
reports suggest that both subsets have some phagocytic ability depending on the stimuli.  One 
of the main differences noted by others between human and mouse monocyte subsets was 
relative expression of phagocytic and scavenger receptors. In mice these were found on 
Ly6Clo monocytes (SIRPA, MSR1, CD36, THBS1) while in humans they were expressed 
more highly on CD16- monocytes, or were not differentially expressed at all, again 
suggesting that in man neither subset preferentially functions as phagocytes  (Ingersoll et al., 
2010).  The scavenger receptors MSR1 and CD36 are involved in clearance of apoptotic cells 
(Erwig and Henson, 2007) and expression  was conserved in human and pig but not mouse.  
CD36  has a role as scavenger receptor for oxidised low-density lipoproteins and CD36 
deficiency is frequently associated with atherosclerotic cardiovascular disease (Hirano et al., 
2003).  Although expression of these molecules was conserved between humans and pigs 
CD36 was more highly expressed by CD14hi monocytes while MSR1 was expressed by 
CD14lo monocytes in both species, again suggesting that one subset is not specialized for 
phagocytic ability in humans or pigs as appeared to be the case in the mouse (Ingersoll et al., 
2010). Similarly TREM1 was more highly expressed by human and pig CD14hi monocytes 
and by mouse CD14lo monocytes.  TREM1 activates cells for pro-inflammatory cytokine 
release and is a crucial mediator of septic shock (Bouchon et al., 2001).  Expression of the 
notch 2 ligand jagged 1 (JAG1) was also conserved in human and pig CD14hi monocytes but 
expressed more highly by mouse CD14lo monocytes.  JAG1 has been shown to promote cell 
survival (Choi et al., 2009) and has been described as a potential Th2-promoting factor (Goh 
et al., 2009).  Expression of JAG1 on APC promoted Th2 development through a STAT6-
independent pathway (Amsen et al., 2004).  The conservation of gene expression between 
human and pig CD14hi monocytes noted above may suggest these subsets are specialized for 
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Conservation of gene expression in CD14lo human (CD14loCD16+), pig (CD14loCD163hi) and 
mouse (Ly6Clo) monocyte subsets was seen for  CD16, ICAM2, TGFBR3, ITGAL and LTB.  
Human and pig CD14lo monocytes alone shared high expression of the complement 
component 3 (C3).  The C3 receptor 1 (C3AR1) has previously been reported to be more 
highly expressed by CD14lo monocytes (Mobley et al., 2007; Ancuta et al., 2009).  C3 is an 
ancient molecule being found in sea urchins and may have a role outside of the immune 
system (Al-Sharif et al., 1998).  In the immune system, C3 contributes to innate immunity by 
promoting phagocytosis and supporting local inflammatory responses.  It also provides an 
important link to the acquired immune system by modulating complement-dependent 
leukocyte functions and enhancing the humoral response to antigen (Sahu and Lambris, 
2001). Naturally occurring C3 deficiency leads to increased susceptibility to bacterial 
infections (Lachmann, 1975) and certain immune disorders such as systemic erythematosus 
(SLE) (Matsuyama et al., 2001).  
 
Previous reports have described  mouse Ly6Clo and human CD16+ monocytes as better 
stimulators of mixed lymphocyte reactions moreover both  mouse Ly6Clo and human CD16+ 
monocytes expressed higher levels of genes encoding MHC class II molecules than Ly6Clo 
and CD16- monocytes respectively (Ingersoll et al., 2010; Wong et al., 2011). Similar reports 
have been published describing better T cell stimulating ability of  pig CD163hi monocytes 
(Sanchez et al., 1999) and the increased class II gene expression (SLA-DQ and DB ) on 
CD163hi monocytes is consistent with this view.  
 
Gene expression data also identified some transcription factors which were differentially 
expressed between monocyte subsets in the pig.  The macrophage specific transcription factor 
TFEC (Rehli et al., 1999) was more highly expressed on CD14loCD163hi pig monocytes, 
expression of TFEC was converse to what was observed in human and mouse monocytes 
where it was more highly expressed by CD14hi monocytes in both species.  TFEC has been 
shown to be induced upon stimulation of macrophages with LPS or Th2 cytokines in a 
STAT6 dependent manner.  Interestingly Tfec mutant mice had much lower induction of 
Csf3r after stimulation with IL4 (Rehli et al., 2005). Additionally ETS2 was more highly 
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expressed on CD14loCD163hi pig monocytes.  ETS2 has been shown to be involved in 
expression of the macrophage scavenger receptor gene (Wu et al., 1994). CD14hi CD163lo 
monocytes expressed higher levels of the transcription factors IRF5 and POU2F2, POU2F2 
expression was converse to what was reported in human and mice monocytes (Ingersoll et al., 
2010).  IRF5 has been shown to promote polarization of macrophages towards an 
inflammatory phenotype with high expression of IL12 genes and repression of IL10 
(Krausgruber et al., 2011).  POU2F2  has been described to act as a cell survival factor by 
directly activating BCL2 (Heckman et al., 2005).  Differential expression of transcription 
factors has not been described in porcine monocyte subsets before. 
 
Perhaps the most unexpected finding of this study was the higher mRNA levels of CCR2 on 
CD14loCD163hi pig monocytes.  This contradicts previous reports (Moreno et al., 2010) and 
is in contrast to the low expression of CCR2 on human and mouse  CD14lo monocytes and 
high expression on CD14hi monocytes from both species (Figure 4.14). High expression of 
CCR2 is one of the defining features of CD14hi monocytes in both mice and man and CCR2 
was one of the most differentially expressed genes between human monocyte subsets 
(Ingersoll et al., 2010). Porcine expression of CCR2 converse to what has been described in 
human and mice would have important consequences for homing in response to CCL2 
expression at site of infection or inflammation.  For instance CCR2+ monocytes are 
preferentially recruited in atherosclerosis (Veillard et al., 2005).  However the array probes 
for CCR2 did not show consistent expression, one was more highly expressed by CD163hi 
monocytes and one by CD163lo monocytes.  CCR2 is not annotated on the pig genome and 
porcine specific anti-CCR2 antibodies are not available, previous studies have relied on 
indirect methods to assess its expression (Moreno).  Correct identification of the porcine 
CCR2 gene or development of porcine specific anti-CCR2 antibodies are essential.   Similarly 
previous reports (Chamorro et al., 2005) identified porcine CD14loCD163hi monocytes as 
being the main producers of TNFα (Chamorro et al., 2005). This study found higher levels of 
TNF mRNA produced by the CD14hi CD163lo subset.  Previous reports have described 
increased TNFα production from a subset of mouse monocytes expressing high levels of 
CD43 and low levels of Ly6C (Burke et al., 2008) suggesting TNFα production may be 
limited to a smaller subset of monocytes.  Furthermore Cros et al.  found intermediate 
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CD14+CD16+ monocytes to be the main producers of TNFα in response to LPS while non-
classical CD16hi monocytes produced TNFα only in response to virus (Cros et al., 2010).  
This study suggests that monocytes previously referred to as CD14loCD163hi may in fact be 
more similar to human intermediate monocytes and the higher levels of TNFα produced may 
support this view.  Finally it is unclear whether these differences at the mRNA level are 
reflected at the protein level. Previous studies have shown discrepancies between mRNA and 
protein levels (Zhao et al., 2009). Moreover this study analysed monocytes in their resting 
state, stimulation with LPS may results in higher induction of TNFα by a different population 
of monocytes altogether.
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Mice and humans diverged approximately 70 million years ago (Waterston et al., 
2002) therefore as discussed at length in Chapter 1, it is unsurprising that their 
response to infectious stimuli often differs dramatically (Fairbairn et al., 2011; 
Mestas and Hughes, 2004).  Nevertheless rodents are widely used to model the 
human immune system.  Many important immune effectors are differentially 
expressed between human and mouse e.g. Indoleamine 2, 3-dioxygenase (IDO), 
inducible nitric oxide synthase (iNOS, NOS2), this means that despite their 
widespread use, mice may not always function as the best animal to model the 
human immune response.  Indeed the literature is full of animal trials which have 
appeared promising in rodents only to fail to translate to meaningful improvements 
for human patients; Cancer and Alzheimer’s are just two of the diseases which have 
been cured in mice (Harris, 1999) and multiple murine trials for sepsis spectacularly 
failed to reduce the death rate among human patients (Poli-de-Figueiredo et al., 
2008; Lopez et al., 2004).  Mice challenged with either live bacteria or a non-
infectious molecule, such as LPS, react in a very different way to the heterogeneous 
group of patients classified as having sepsis: they are relatively resistant to LPS 
mediated toxicity (Copeland et al., 2005).  Mice treated with LPS fail to develop the 
organ failure commonly seen in humans and die quite suddenly.  Indeed mice are 
much more resistant to LPS than humans, commonly used doses (1-25mg/kg) are 
1000 to 10,000 times what is needed to induce severe septic shock in humans 
(Warren, 2009; Munford, 2010).  It has been suggested that the differences in 
sensitivity to LPS between man and mouse is due to proteins found in serum rather 
than differing responses of immune effector cells (Warren et al., 2010).    Some 
researchers have produced “humanised” mice which may function as a better model 
than many commonly used non transgenic mice (Shultz et al., 2007).  This provides a 
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solution to some of the issues associated with working on rodents although there may 
be many as yet unknown differences between man and mouse. 
 
5.1.1 Murine production of nitric oxide 
Mice respond to microbial challenge with robust production of nitric oxide (NO).  
Macrophages are the principal effector cell for the production of NO in the mouse 
(Stuehr and Marletta, 1985) and the cytotoxic effects of NO have been well 
documented in rodents (Bogdan, 2001; MacMicking et al., 1997).  As discussed in 
Chapter 1, NOS mediates the production of NO from arginine.  Alternatively 
arginase-1 (ARG1) metabolises arginine generating ornithine.  This is a classic 
pathway of M2 or alternatively activated macrophages as opposed to the NOS2 
mediated metabolism of arginine to NO that predominates in M1 or classically 
activated macrophages (Hassanzadeh Ghassabeh et al., 2006; Munder et al., 1998; 
Martinez et al., 2006).  In  addition to the extensively studied anti-microbial effects 
of NO (Nathan and Hibbs Jr, 1991), anti-tumour (Xie et al., 1996; Brantley et al., 
2010) and immunosuppressive (DAI and GOTTSTEIN, 1999) effects have been 
described.  Nos2 -/- mice failed to clear Listeria monocytogenes infection illustrating 
the importance of NO in clearance of intracellular pathogens.  Furthermore 
macrophages from these animals failed to suppress lymphoma replication in vitro 
showing the important anti-tumour effects of NO (MacMicking et al., 1995). NOS 
inhibitors have had adverse effects on disease outcome in the majority of mouse 
models tested.  In tuberculosis (Chan et al., 1995), malaria (Nussler et al., 1993), 
herpes simplex (Croen, 1993), and Cryptococcus neoformans infections (Lovchik et 
al., 1995) NOS inhibitors worsened disease outcome demonstrating the importance 
of NO in the immune response of the mouse to a wide range of pathogens.  The 
effects of NO in the mouse are however double edged.  NO defends the host against 
bacterial infection at the risk of damage to tissues or induction of shock.  It is 
therefore not entirely surprising that NO inhibitors have also had protective effects in 
some mouse models for instance  Nos2 -/- mice did not experience hypotension in a 
model of endotoxemia (MacMicking et al., 1995).  Similarly protective effects have 
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been observed with NO inhibitors in murine models of septic shock (Bahar Tunctan 
et al., 1998).  Unfortunately these promising results in the mouse have not translated 
into benefits for man.  Hypotension is one of the most serious clinical symptoms of 
septic shock.  NO has vasodilating effects, researchers have therefore tried to block 
NO production by inhibiting NOS2 as a possible treatment for sepsis in humans, 
unfortunately inhibiting NOS2 did not improve patient survival in clinical trials and 
in some cases even worsened the outcome (Bakker et al., 2004; Lopez et al., 2004; 
Poli-de-Figueiredo et al., 2008).  It is likely NO inhibitors in humans inhibited eNOS 
instead of iNOS which could interfere with vasodilation leading to an increase in 
hypotension instead of the desired decrease.   
 
There is a large amount of evidence for the importance of NO as an immune effector 
in the mouse but the evidence for its importance in man is less compelling.  
Experiments detecting NO from human macrophages were often unable to be 
replicated in other laboratories (MacMicking et al., 1997) although some laboratories 
have reported NOS2 expression in directly isolated macrophages from patients 
suffering from inflammatory disorders (Nicholson et al., 1996; Hunt and Goldin, 
1992; Anstey et al., 1996; St Clair et al., 1996).  It appears that some of the 
divergence between production of NO in man and mice may be due to differential 
control of transcription (Taylor and Geller, 2000).  Transcription of Nos2 in mouse 
macrophages is controlled by a basal promoter and an enhancer element.  Both 
regions are LPS responsive and the enhancer region is also responsive to IFNγ.  A 
series of inactivating nucleotide changes in the enhancer element in human 
macrophages resulted in failure to initiate transcription.  Furthermore κB binding 
sites in both regions of the mouse Nos2 gene have previously been shown to be 
important in regulation of expression.  The comparative κB binding site in the basal 
promoter region of the human NOS2 gene did not bind to NFκB/Rel complexes with 
the same specificity as mouse macrophages while the κB binding site in the enhancer 
region failed completely to bind NFκB/Rel complexes (Zhang et al., 1996). 
Additional experiments in transgenic mice carrying an insertional human NOS2 
promoter-reporter gene construct showed differing endogenous and LPS induced 
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expression of the transgene when compared to murine Nos2.  This suggests many of 
the differences between NOS2 expression in man and mouse may be due to 
differential regulation of the promoters in the different species  (Yu et al., 2005).  
What is clear is there is an intrinsic difference in mouse and human macrophages.  In 
culture mouse macrophages produce Nos2 mediated NO which human macrophages 
fail to do.  It appears that whatever is “different” about human macrophages is also 
“different” in pig macrophages; they too failed to produce NO in culture (Figure 
5.15).  
 
5.1.2 Human production of Indoleamine 2, 3-dioxygenase 
As discussed above the classic murine response to infectious stimuli involves 
metabolism of arginine to produce NO.  By contrast to murine macrophages, human 
macrophages preferentially metabolize tryptophan.  Indoleamine 2, 3-dioxygenase-1 
(IDO1) is a heme-containing enzyme which catalyses the degradation of tryptophan 
through the kynurenine pathway (Figure 5.1) (Taylor and Feng, 1991).  Activated 
human macrophages internalise tryptophan and metabolise it via IDO to kynurenine 
and thence to several metabolites that have been implicated in regulation of immune 
cell function and antimicrobial actions.  Interestingly tryptophan is the only amino 
acid which is specifically regulated in response to signals from the immune system. 
For tryptophan to be metabolized in macrophages by IDO it must first enter the cell 
by means of a solute carrier although the specific transporter for tryptophan has not 
yet been identified.  System L is a widely expressed transport system which accepts 
tryptophan, among other amino acids, however system L is not specific enough to 
explain the level of tryptophan depletion by MDM in culture.  It appears likely there 
may be two different tryptophan transport systems.  One low affinity system (System 
L) and another as yet unidentified system with 100-fold higher affinity which is 
specific for tryptophan and up-regulated during MDM differentiation (Seymour et 
al., 2006).  
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Figure 5-1 The Indoleamine 2,3-dioxygenase pathway. 
The Indoleamine 2, 3-dioxygenase mediate catabolism of tryptophan to Kynurenine 
and its metabolites.  IDO; indoleamine 2, 3-dioxygenase, KYNU; kynureninase, 




Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 153 
The enzyme IDO1 and the metabolism of tryptophan can have immune regulatory 
properties; this pathway is involved in suppression of T-cell responses, activation of 
regulatory T cells and inhibition of natural killer cells (Mellor and Munn, 2004; 
Mellor et al., 2002).  It is not clear exactly how the IDO mediated metabolism of 
tryptophan effects the immune response, whether  depletion of tryptophan suppresses 
T cell proliferation (Mellor and Munn, 2004) or the kynurenine metabolites have a 
suppressive function (Moffett and Namboodiri, 2003) has yet to be proven.  
Certainly  the kynurenine metabolites 3-hydroxyanthranilic acid (3-HAA) and 
quiniloinic acid (QUIN) have been shown to induce apoptosis specifically in Th1 
cells (Fallarino et al., 2002), effects have also been shown on NK cells (Frumento et 
al., 2002; Song et al., 2011) and possibly B cells (Terness et al., 2002).  The IDO1 
pathway has been implicated in many diseased states.  IDO1  is expressed by most 
human tumours and has tumour promoting properties in mice (Uyttenhove et al., 
2003).  Lower levels of tryptophan in the serum of cancer patients suggests IDO may 
be chronically active in some cancers.  It was also suggested that constitutive 
expression of IDO by these patients may contribute to depression through disruption 
of serotonin metabolism (Schroecksnadel et al., 2007).   The IDO1 pathway has also 
been implicated in sepsis, increased kynurenine levels in plasma after trauma were 
indicative for the later development of sepsis (Logters et al., 2009) and the ratio of 
quinolinic acid to tryptophan (Zeden et al., 2010) or kynurenine to tryptophan  
(Logters et al., 2009) have been used to discriminate between non septic and pre 
septic patients.  Patients already suffering from septic shock have also shown good 
correlation between plasma kynurenine to tryptophan ratios and plasma IFNγ, IL10 
and lymphopenia (Darcy et al., 2011).  IDO1 activity can lead to increased 
vasodilation which may cause the drop in blood pressure which often leads to organ 
dysfunction and death for many septic patients.  Additionally the tryptophan 
metabolite kynurenic acid had an inhibitory effect on TNFα and the DNA-binding 
protein high-mobility group box protein1 (HMGB1) production by monocytes in 
vitro (Wang et al., 2006; Tiszlavicz et al., 2011).  HMGB1 can function as a positive 
control of pro-inflammatory cytokine production (Andersson et al., 2000) and high 
levels have also been found in septic patients suggesting the kynurenine produced by 
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the IDO pathway is not being further metabolised to kynurenic acid (Wang et al., 
1999).   
 
 Recent studies have focused on the vasodilatory effects of kynurenine. Wang et al. 
showed systemic inflammation induced tryptophan metabolism which led to 
endothelial expression of Ido1 in mice after infection or treatment with LPS.   Ido1 
expression resulted in kynurenine dependent vasodilation and hypotension and 
inhibition of Ido1 led to an increase in blood pressure (Wang et al., 2010).  Ido1 was 
not routinely expressed by mouse macrophages after stimulation with LPS or IFNγ 
(biogps.gnf.org) although there is some evidence that it can be induced in murine 
macrophages when NO synthesis is inhibited using arginine free medium (Thomas et 
al., 1994; Alberati-Giani et al., 1997). Any vasodilating effects reported by Wang et 
al. must therefore have been due to endothelial Ido1 expression as they did not 
inhibit NO production.  They also found that Ido1-/-  mice were less hypotensive than 
wild type mice but that Nos2a -/- mice were even less hypotensive.  This illustrates 
one of the issues of using mice as a model for sepsis, not only are mice far more 
resistant to endotoxin than man but any response involves the NO pathway, a 
pathway not active in human macrophages. The same authors showed that 
tryptophan and kynurenine also had IDO1 dependent vasodilatory effects on pig 
arteries and as pigs do not produce NO (Figure 5.15) it seems clear that they can 
provide a better model to study the complicated immune interactions that result in 
sepsis in man.      
 
A major aim of this thesis was to examine the pig response to LPS under similar 
conditions to those used in mouse and human studies. Affymetrix array chips were 
used to analyse the gene expression profile of LPS stimulated pig BMDMs with 
regard to differentially expressed genes in human and mouse.  There are many genes 
which are known to be differentially regulated but which were not detected by the 
Affymetrix array, a selection of these were investigated with RT qPCR (IDO1, 
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CCL20).  The nitric oxide pathway and IDO mediated catabolism of tryptophan are 
LPS inducible pathways in mice and men respectively and the activation of these 
pathways in the pig was examined in more detail and possible implications of 
blocking IDO as treatment for sepsis in man were investigated. 
 
5.2 Results 
Figure 5.2 shows a workflow diagram for the analysis of microarray data presented 
in this chapter 
5.2.1 Microarray analysis of Porcine BMDM 
 
5.2.1.1 Gene expression after LPS stimulation in porcine BMDM – 
analysis by microarray 
Changes in gene expression at the transcript level were examined using RNA from 
BMDM stimulated with LPS for up to 24 hours (0, 2, 7 and 24h) from 3  Large 
White x Landrace F1 cross (1 female, 2 males) and Affymetrix porcine microarrays.  
As previously observed in humans and mice (Wells et al., 2003; Hume et al., 2007; 
Nilsson et al., 2006) the expression of a large number of genes was affected.  Genes 
that were initially expressed at high levels were mainly repressed by LPS, while 
transcription of other genes was initiated or increased in response.  LPS stimulation 
induced the expression of a very large number of genes – 3,343 probesets 
corresponding to 2,159 genes -  peaking at 7 hours with 70.3 % of the total up-
regulated genes (2,340 probesets corresponding to 1,518 up-regulated genes) 
including numerous known LPS-responsive cytokines and chemokines. The LPS 
response was very well regulated; 30% of the probesets were up-regulated at 7 hours 
alone, 25.7% were up-regulated only at 24 hours and 26.4% remained up-regulated 
between 7 and 24 hours.    The software package BioLayout ExpressTM (Freeman et 
al., 2007) was used to analyse genes that were co-expressed across the three 
individual pigs examined.  Data was normalised as described in Chapter 2 then were 
clustered using a correlation of R=0.95 and MCL of 1.7, generating 99 distinct  
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Figure 5-2 Work flow for studying the response of porcine BMDM to LPS.  
Bone marrow derived macrophages were cultured by obtaining cells from 8-12 week 
old LW x Landrace F1 cross (2 males 1 female) and differentiated using rhCSF1. 
Following 7 days of differentiation cells were stimulated with 100ng/mL LPS then 
harvested at 0, 2, 7 or 24 hours post treatment to obtain RNA for analysis by 
Affymetrix array. 
Isolate bone marrow from  pigs (one female, two males, 
F
1
 cross Landrace × Large White, 8-12wks) 
Differentiate with rhCSF1 for 7 days (cells from 3 animals, in 
duplicate) 






Cell harvest, extract RNA, 
analyse gene expression 
with Affymetrix Gene 
Arrays 
 Probe set expressions normalized using the RMA 
algorithm  as implemented in the Bioconductor package 
affy 
Normalized array data were uploaded to the 
software Biolayout Express(3D) 
(http://www.biolayout.org/) and a graph was 
created using parameters of R mean 0.95, 
Markov clustering algorithm of 2.2, and a 
minimum number of 6 nodes per cluster 
500 most inducible probesets 
identified using fold change (p<0.01) 
then compared to available array data 
from mouse and human macrophages 
treated in exactly the same manner 











Figure 5-3 LPS regulated genes were clustered using BioLayout Express. 
This generated 99 distinct clusters (A). Genes which were up-regulated in response 
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clusters (Figure 5.3A). In keeping with the view that negative regulation and 
feedback control is a critical determinant of the duration and magnitude of LPS 
responses (Coll and O'Neill, 2010), LPS stimulation of pig BMDM triggered even 
more down-regulation of genes than up-regulation (a total of 5721 down-regulated 
probesets, corresponding to 4258 genes) (Figure 5.3B).  The two largest clusters 
were one group of down-regulated genes (Figure 5.3B) and one group of up-
regulated genes (Figure 5.3C).  Genes clustered using Biolayout Express can be 
represented in a 2D format (Figure 5.4) using the graph editor yEd (yWorks.com) 
which allows the relationship between clusters to be more easily visualised.  The 
largest cluster in this graph, Cluster 1 (Figure 5.4D) consisted of 699 probes which 
were down-regulated after 7 hours LPS stimulation.  The third largest cluster, Cluster 
3 (Figure 5.4C) contained 182 genes which were also down-regulated after 7 hours 
LPS stimulation but which returned to base levels by 24 hours. At 2 h, 14.3% of the 
probesets (609 genes) were already down-regulated, including the top down-
regulated Hairy/Enhancer of Split 1 (HES1) a transcriptional repressor/activator, the 
Growth-Arrest and DNA damage-inducible gene alpha (GADD45A) and the 
oncogene MYC. Down-regulated genes from the 2 largest clusters included the 
TGFβ receptor 2 (TGFBR2), the angiogenic regulator vascular endothelial growth 
factor B (VEGFB) and the regulator of MAPK1/ERK2 kinase, suppression of 
tumorigenicity 5 (ST5). The multidrug resistance associated protein, ABCC5 and 
several heat shock proteins (HSPD1, HSP90, HSPA4) were also down-regulated by 
LPS in the pig.  TLR8 was down-regulated while TLR2 and TLR6 were induced by 
LPS.  The modification of TLRs in the porcine macrophages after activation with 
LPS demonstrates the modification of regulatory networks in response to PAMPS 
which has previously been reported in the mouse (Nilsson et al., 2006).   
 
Cluster 2 (Figure 5.4B) contained 481 probes which were up-regulated by 7 hours 
LPS stimulation.  A large number of these genes are associated with apoptosis and 
programmed cell death such as the ubiquitin specific peptidase and proteases and 
several caspases (CASP3, CASP4, CASP7 and CASP8).  There were also a number of  
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Figure 5-4 The three largest clusters of LPS regulated genes. 
Cluster 1 (A) consisted of 193 genes (B) which were down-regulated by LPS after 7 
hrs. 19 un-annotated genes were present.  
Chapter 5 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 160 
transcription factors or genes associated with control of transcription such as STAT1, 
STAT2, ETV6, ETV7, IFI16, IRF2 and SP100. Immune response associated genes 
included the thrombospondin receptor CD47.   As discussed by Wells et al. (Wells et 
al., 2005), a major component of the inducible genes in mice comprised feedback 
repressors.  In the pig such genes included inhibitory transcription factors (NFkBI) 
and co-repressors (NCOR), members of the SOCS family, dual specificity 
phosphatase 1 (DUSP1), ATF3, tristetraprolin (TTP, ZFP36) and several inhibitory 
cytokines (IL1RA (IL1RN), TGFB, IL10).  IL1RN inhibits the activities of IL1α and 
IL1β both of which peaked after 2hrs LPS stimulation of the pig BMDM and 
declined thereafter.  There were also a number of genes associated with control of 
lymphocyte function such as IL27RA which regulates Th1 type immune responses 
through a system involving STAT1; IL7R which is involved with lymphocyte 
development, and the positive regulator of Th1 type cytokine gene expression 
PHF11.  TGFB1 and TGFB3 which are involved in cell differentiation were also 
found in cluster 2.  Up-regulated genes from other clusters included many 
components of the TLR and other signalling pathways, including multiple 
transcription factors as NFkB1, the IRF family (IRF1, 2, 3, 5, 7, 8 and 9), CEBPβ 
(CEBPB) and delta (CEBPD)  and PU.1 (SPI1) and co-regulatory factors such as 
JMJD3 (KDM6B), and demethylase 6B (Satoh et al., 2010).   
 
Interestingly, two hours stimulation with LPS produced a relatively small number of 
probes affected by LPS; however, proportionally more genes had a larger fold 
change at this time point than at seven or 24 hours. After 2 hours of LPS treatment 
not many genes were affected, but those that were up-regulated, changed their 
expression to a large extent, thus suggesting a particularly crucial role for these 
genes.  Figure 5.5 shows the early response clusters, genes which were induced by 2 
hours of LPS stimulation.  There were three clusters of early response genes which 
clustered together (Figure 5.5A&B).  The expression profile of the largest of these 
clusters (cluster 15) is shown  along with the most related probes which consisted of 
two additional clusters (cluster 60 & 81) and some genes which did not fall into any  
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Figure 5-5 LPS early response genes. 
Cluster 1 (A) consisted of 193 genes (B) which were down-regulated by LPS after 7 
hrs. 19 un-annotated genes were present.
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of the clusters but which were also induced by 2 hours LPS stimulation (Figure 
5.5C).  Many early response genes known to be LPS inducible in the mouse were in 
this group including the archetypal LPS response gene TNF, Interferon β (IFNΒΙ), 
interferon regulatory factor 3 (IRF3), the interferon receptor (IFNAR2), and Jagged 1 
(JAG1) – a molecule that is known to be a Notch ligand and a potential Th2-
promoting factor.  The Growth-Arrest and DNA damage-inducible gene beta 
(GADD45B) was also up-regulated by 2 hours. GADD45B was shown to inhibit the 
apoptosis signal of TNF by interfering with the JNK cascade (De Smaele et al., 
2001).  Up-regulation of GADD45B may allow the macrophages to release TNF 
without themselves undergoing apoptosis.   
 
5.2.1.2 The pig response to LPS was similar to man 
To compare the responses of  pig BMDM to mouse BMDM, a list of the 500 most 
induced probe sets (comprising 174 gene names) in porcine BMDM (at any time 
point) was compiled and the regulation of these genes was examined in mouse 
BMDM or TEPM from earlier studies now displayed on biogps.gnf.org. From this 
list, 200 probes (63 genes) were identified that were not significantly regulated by 
LPS in mouse BMDM at any time point.  The list of discordantly-regulated genes 
was then compared to publicly available similar human data sets (GSE8608 and 
GSE5099).  Of those 63 genes, 29 were highly induced in activated human 
monocyte-derived macrophages (Figure 5.6).  Some of them are related to the IDO 
and vitamin D3 pathway (KYNU and CYP27B1), active pathways in human but not 
in mouse. The heparin-binding EGF-like growth factor (HBEGF) was also up-
regulated in human and pig but not in mouse. HBEGF is also known as the 
diphtheria toxin receptor (DTR) and interestingly human and pig are sensitive to the 
toxin whereas mouse are more resistant (Mitamura et al., 1995).  Figure 5.7A & B 
show RT qPCR validation of the microarray data for the differentially expressed 
genes IL7R and CXCL13.  To determine if the expression of these genes was cell 
type specific rather than species specific, expression was also examined in LPS 
activated porcine MDM. Figure 5.7C & D shows that IL7R and CXCL13 were also 
LPS inducible in porcine MDM.  This strongly suggests that the differing expression  
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Figure 5-6 The pig response to LPS was similar to human. 
Expression of genes was compared between pig, human MDM +LPS (GSE5099 and 
GSE8608) and mouse BMDM + LPS (unpublished data and biogps.gnf.org). Genes 
up-regulated in pig and human but not in mouse are shown. 
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Figure 5-7 IL7R and CXCL13 were LPS inducible in BMDM and MDM 
BMCs and PBMCs were treated with rhCSF1 for 7 days to differentiate them into 
macrophages.  BMDM (A & B) and MDM (C & D) were then activated with LPS 
(100ng/ml) for 2, 7 or 24 hours.  RNA was extracted and reverse transcribed.  
mRNAs for  (A & C) IL7R, (B & D) CXCL13 and (C) CYP27B1 were measured by 
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between human MDM and mouse BMDM is due to species specific rather than cell 
type specific differences. 
 
5.2.2 Analysis of gene expression profile in pig with regard to 
differentially expressed genes in human and mouse 
 
5.2.2.1 LPS induced STAT4, IDO1 and CCL20 in BMDM 
The Affymetrix array provided a large scale overview of porcine BMDM response to 
LPS which can be used to compare gene expression across species.  Nevertheless 
there are some genes which are known to be differentially expressed between man 
and mouse which are not present in the microarray.  Previous work in our laboratory 
had identified IDO1, the chemokine CCL20 (also known as MIP-3-alpha) and the 
transcription factor signal transducer and activator of transcription (STAT) 4 as being 
up-regulated in human monocyte-derived macrophages but not in mouse in response 
to LPS (Schroder et al., 2012) ;www.biogps.gnf.org;(Martinez et al., 2006; Nilsson et 
al., 2006)). The lack of induction of these genes in mouse BMDM responding to LPS 
is also evident from genome-scale 5’RACE (CAGE) expression profile in the 
FANTOM project (Carninci et al., 2006) and in expression profiling of the RAW264 
macrophage cell line (Murray et al., 2005).  The mRNA expression of these genes 
was therefore investigated in porcine BMDM after LPS stimulation using RT qPCR 
(Figure 5.8). IDO1 expression was massively up-regulated after 7h and slowly 
decreased by 24h. The expression of CCL20 and STAT4 were also substantially 
induced after LPS stimulation continuing to increase up to 24 hours.  The PCR 
products for IDO1, STAT4, CCL20 and HPRT were cloned and sequenced and 
blasted against the pig genome to ensure the correct gene product was detected by 
the primers.  In addition, the innate immune effector lipocalin-2 (LCN2, also known 
as NGAL) has been shown previously to be highly LPS inducible in mouse but not 
human macrophages (Schroder et al., 2012). LCN2 was not induced in porcine 
BMDM by RT qPCR (data not shown). 
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Figure 5-8 LPS induced STAT4, IDO and CCL20 in porcine BMDM. 
BMCs were treated with rhCSF1 for 7 days then activated with LPS (100ng/ml) for 
2, 7 or 24 hours.  RNA was extracted and reverse transcribed.  mRNAs for  (A) 
STAT4, (B) IDO and (C) CCL20 were measured by quantitative PCR.  Results are 








Figure 5-9 LPS induced STAT4, IDO and CCL20 in porcine MDM. 
PBMCs were treated with rhCSF1 for 7 days then activated with LPS (100ng/ml) for 
2, 7 or 24 hours.  RNA was extracted and reverse transcribed.  mRNAs for  (A) 
STAT4, (B) IDO and (C) CCL20 were measured by quantitative PCR.  Results are 
representative of four experiments using RNA from different animals 
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Figure 5-10 LPS induces STAT4, IDO and CCL20 in BMDM from pigs with severe sepsis. 
PBMCs were harvested from minipigs with severe sepsis.  RNA was extracted and 
reverse transcribed.  mRNAs for  (A) STAT4, (B) IDO and (C) CCL20 were 
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5.2.2.2 LPS induced STAT4, IDO1 and CCL20 in MDM 
One difficulty when examining the immune response of mice and men is that 
comparisons must frequently be made between macrophages from different 
anatomical locations.  The expression of IDO1, STAT4 and CCL20 in porcine MDM 
was examined by RT qPCR to investigate if the expression of genes identified as 
being differentially regulated between human and mouse macrophages could be due 
to cell specific rather than species specific differences as discussed above.  All three 
genes were up-regulated in MDM although expression was lower than in BMDM 
(Figure 5.9), this may have been due to higher constitutive expression of these genes 
in MDM (relative to HPRT).  This laboratory has also identified IDO1 as one of the 
most LPS inducible transcripts in pig AMs using RNA-seq, CCL20 was also LPS 
inducible (unpublished, Dario Beraldi).  This provides further evidence that the 
reported differences between LPS inducible genes in human and mice are species 
specific rather than cell specific. 
 
5.2.2.3 STAT4, IDO1 and CCL20 were up-regulated in pigs with severe 
sepsis  
In vitro experiments are only ever an approximation of what is occurring in vivo.  
What happens under real inflammatory conditions is often far more complicated than 
anything that can be simulated in the laboratory environment.  Samples from genuine 
patients or animals are therefore important to validate experimental hypothesis. Pre 
and post mortem samples from minipigs which were euthanized due to developing 
severe sepsis were collected and the expression of genes which were highly LPS 
inducible in vitro was examined.  Expression of IDO1, STAT4 and CCL20 was 
increased in MDM from these pigs by RT qPCR (Figure 5.10) suggesting that the in 
vitro model of macrophage inflammation established is a good model for studying 
what occurs in the whole animal in an inflammatory state. 
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5.2.2.4 The promoters of LPS regulated genes were more closely 
conserved in pig and human 
As described in the introduction, there is some evidence that the differential 
expression of immune genes in humans and mice may be controlled at the level of 
transcription.  The promoters of such genes (such as NOS2) have therefore been 
examined for men and mice and differences which could be responsible for the 
divergent expression of such genes identified (Taylor and Geller, 2000; Zhang et al., 
1996; Yu et al., 2005).   The microarray data presented in this thesis suggested that 
many genes which are LPS inducible in man but not mice are also regulated by LPS 
in the pig, irrespective of cell type studied (Figures 5.6-10).  The CYP27B1 
promoter, which is LPS inducible in men and pigs but not mice, was therefore 
analysed in MacVector (MacVector Inc., Cary, NC, USA).  The protein product of 
this gene was conserved 81% in mice and 87% in pigs (www.ensembl.org), but the 
promoter region was considerably more divergent.  All sequences were extracted 
from the Ensembl database and Pustell DNA matrix alignments were constructed for 
human v mouse and human v pig, ClustalW alignment of the sequences are also 
shown (Figure 5.11).  The Pustell DNA matrix clearly showed that the pig and 
human promoter for CYP27B1 was more closely conserved than human and mouse.  
The software Alibaba2.1 was used to predict the most probable transcription factor 
binding sites by constructing matrices automatically from TRANSFAC 4.0 sites 
(http://www.gene-regulation.com).  Analysis of the sequences show a gap caused by 
a repeat insertion in the pig, but otherwise there is very substantial conservation 
extending more than 1kb upstream.  A detailed ClustalW alignment showed subtle 
variation even in the proximal promoter conserved across all three species. At - 70 bp 
(relative to the start codon - ATG), the TATA box sequence was identical in pig and 
human but varied from the consensus in mouse. TATA-boxes are commonly 
associated with highly-regulated mammalian promoters (The FANTOM Consortium 
et al., 2005).  At -120 bp, a consensus CCAAT-enhancer-binding protein (C/EBP) 
binding site was found in all 3 species, but NFκB site at -425 in the human was 
conserved in pig but not in mouse.  On the reverse strand at the same position is a 
GAS (STAT1/3) binding site which was similarly conserved in human and pig but 
not mouse. Additionally, at -440 bp, a SP1 binding site is identical in human and pig. 
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Figure 5-11 The human and pig CYP27B1 promoter were conserved 
To explain the concordance of pig and human inducible gene expression, sequence conservation of promoter regions of divergently-
expressed genes was examined across the three species.  ClustalW alignments (A) for all three species and Pustell aligments of the human 
and mouse (B) and human and pig (C) promoters highlight the similarities between the promoters for CYP27B1 in human and pig 
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Figure 5-12 The human and pig CCL20 promoter were conserved 
To explain the concordance of pig and human inducible gene expression, sequence conservation of promoter regions of divergently-
expressed genes was examined across the three species.  ClustalW alignments (A) for all three species and Pustell aligments of the human 
and mouse (B) and human and pig (C) promoters highlight the similarities between the promoters for CCL20 in human and pig 
Chapter 5 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 173 
Figure 5-13 The human and pig IDO1 promoter were conserved 
To explain the concordance of pig and human inducible gene expression, sequence conservation of promoter regions of divergently-
expressed genes was examined across the three species.  ClustalW alignments (A) for all three species and Pustell aligments of the human 
and mouse (B) and human and pig (C) promoters highlight the similarities between the promoters for STAT4 in human and pig 
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Figure 5-14 The human and pig STAT4 promoter were conserved 
To explain the concordance of pig and human inducible gene expression, sequence conservation of promoter regions of divergently-
expressed genes was examined across the three species.  ClustalW alignments (A) for all three species and Pustell aligments of the human 
and mouse (B) and human and pig (C) promoters highlight the similarities between the promoters for IDO in human and pig
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In mouse, the part of the sequence was deleted and an IRF1 binding site was 
identified instead.  The promoters of other LPS regulated genes STAT4, IDO1 and 
CCL20 were analysed as above to see if the human and pig promoters for these genes 
were similarly conserved (Figure 5.12-14).  There is a TATA box in the CCL20 
promoters from all three species and the immediate proximal promoter is reasonably 
conserved (Figure 5.13).   Differences include a loss of sequence immediately 
downstream of the TATA box in the mouse, and the insertion of a large repeat at 
around –100 in the mouse that is not in human or pig. Moreover the start site is 
conserved in pig and human but not mouse.  Similarly the proximal promoter for 
STAT4 is quite highly conserved in all three species.  In this case, there is no TATA 
box although around 2190, there is an Octamer site in all three species (Figure 5.13). 
  Upstream elements such as a NFAT site at 2170 are also conserved in all three 
species but the Pustell alignment shows far greater sequence conservation between 
human and pig than human and mouse.   The human and mouse IDO1 promoters 
have a TATA box around 2220 (Figure 5.14) and an IRF binding site is conserved in 
all three species around 2140.  There are two GAS sites at 2148 and 1950 and an IRF 
binding site in the reverse strand which are not present in the mouse.  Overall as can 
clearly be seen from the Pustell alignments the promoters of these LPS regulated 
genes are more closely conserved in pig and human than for human and mouse 
suggesting the differential LPS expression between the species is regulated at the 
transcription level. 
 
5.2.3 Pig macrophages did not produce NO 
 
5.2.3.1 Analysis of genes involved in NO pathway in the pig 
As discussed in the introduction, mouse macrophages respond to LPS with induction 
of arginine metabolism, inducible nitric oxide synthase, and production of NO where 
human macrophages do not.  Figure 5.15 compares mouse BMDM and pig BMDM, 
grown under identical conditions in rhCSF1. As expected, LPS-stimulated mouse 
macrophages produced large amounts of NO, whereas there was no detectable NO in  
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Figure 5-15 NO was induced in mouse but not pig macrophages by LPS stimulation. 
Mouse and pig BMDM were grown under identical conditions.  LPS stimulated 

































Table 5.1 – Transcripts involved in NO pathway.  
CAT2; cationic amino acid transferase 2, NOS2, inducible nitric oxide synthase, 
ASL; argininosuccinate lyase, ASS1; argininosuccinate synthetase. GCH1; GTP 
cyclohydrolase,  ARG2; arginase 2, OAT; ornithine aminotransferase 
Transcript Gene name 0 2hrs LPS 7hrs LPS 24hrs LPS  
Ssc.22478.1.A1_at CAT2 8.9 9.4 9.7 9.7  
Ssc.24908.1.S1_at CAT2 14.5 15.1 16.0 15.8  
Ssc.29566.1.A1_at CAT2 18.4 16.4 18.7 13.0  
Ssc.7852.1.A1_at CAT2 55.6 53.5 53.2 56.2  
Ssc.16117.1.A1_at NOS2 11.8 13.4 13.2 12.9  
Ssc.16117.1.S1_at NOS2 24.2 27.3 26.8 23.7  
Ssc.16188.1.A1_at NOS2 61.3 60.4 62.7 61.9  
Ssc.16188.1.S1_at NOS2 42.8 43.3 43.9 43.0  
Ssc.17717.1.S1_at ASS1 41.9 49.2 54.6 55.2  
Ssc.20648.1.S1_at ASL 637.4 610.3 409.9 355.7  
Ssc.21975.1.S1_at GCH1 210.6 484.3 206.4 211.0  
Ssc.14444.2.S1_at ARG2 97.6 261.1 148.6 282.3  
Ssc.14444.3.A1_a_at ARG2 176.3 621.8 316.0 732.1  
Ssc.29654.1.A1_at ARG2 26.6 28.0 24.6 24.7  
Ssc.25198.1.A1_at OAT 1045.2 1000.7 864.9 805.3  
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LPS-stimulated pig macrophages.  The expression of other key genes of the NO 
pathway, GTP cyclohydrolase (GTCH1), inducible nitric oxide synthase (NOS2), 
argininosuccinate synthetase (ASS1), cationic amino acid transporter 2 (CAT2), 
argininosuccinate lyase (ASL), arginase 2 (ARG2) and ornithine aminotransferase 
(OAT), was obtained from the Affymetrix microarray on LPS stimulated pig BMDM.  
Expression of these genes was generally at very low levels (<50) or did not change 
with LPS stimulation (Table 5.1).  To validate the microarray, primers were 
designed against these 7 genes.  Again the genes were not detectable by RT qPCR, 
most of the transcripts were only present at very high CT values (>30, data not 
shown).  The lack of induction of these genes, particularly CAT2 the rate limiting 
step, confirmed that the NO pathway was not induced by LPS in the pig.   
 
5.2.4 An indoleamine 2, 3-dioxygenease inhibitor was not 
protective in the pig 
As described previously the indoleamine 2, 3-dioxygenease pathway has been 
implicated in sepsis, kynurenine a by-product of this pathway was increased in 
patients who later developed septic shock.  The IDO inhibitor 1-methyl-tryptophan 
(1-MT) has been used to treat mouse macrophages where it had a protective effect 
after LPS administration (Jung et al., 2009).  Pig MDMs were treated with LPS or 
LPS plus either 1-MT or excess tryptophan to determine if inhibition of IDO would 
have a similarly protective effect as previously described in the mouse.   
 
5.2.4.1 The effects of the IDO inhibitor 1-MT on production of key 
immune response genes after LPS stimulation 
The expression of three key immune response genes was examined by RT qPCR to 
assess the effects of blocking IDO on LPS activation of pig MDM. Primers were 
designed for TNFA, the archetypal LPS response gene, IL8, a neutrophil 
chemoattractant, and JAG1, a notch 1 ligand involved in hematopoeis and Th2 
responses.  1-MT massively increased the response of the three genes to LPS in pig 1 
and pig 2 versus LPS alone (Figure 5.16A&B, 5.17A&B, 5.18A&B).  The effect of 
Chapter 5 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 179 
excess tryptophan was however very different between these two animals.  In MDM 
from pig one excess tryptophan pushed the TNFA response to LPS forward so it 
peaked at 2 hours rather than 7 hours (Figure 5.16A) while increasing the late 
response of IL8 (Figure 5.17A) and JAG1 (Figure 5.18A).  Excess tryptophan had a 
much more dramatic effect in MDMs from pig two, here excess tryptophan increased 
the response of all genes to the same level as the IDO inhibitor (Figure 5.16B, 
5.17B, 5.18B).  1-MT initially displayed a protective effect on MDMs from pig 
three, reducing production of TNFA (Figure 5.16C), IL8 (Figure 5.17C) and JAG1 
(Figure 5.18C) to levels below that of LPS alone.  The protective effect disappeared 
after prolonged exposure to LPS, by 12 hours levels of TNFA and IL8 were the same 
for cells treated with LPS alone or LPS plus 1-MT and by 24 hours MDMs treated 
with LPS plus 1-MT produced in excess of  five-fold more TNFA and IL8 mRNA 
than cells treated with LPS alone.  1-MT did reduce the levels of JAG1 in MDMs 
from pig three (Figure 5.18C).  Data from pig four was slightly different.  Baseline 
levels of all three genes studied were higher in pig four than in the other three 
animals suggesting the macrophages were already activated before the administration 
of LPS (Figure 5.16D, 5.17D, 5.18D).  Initial levels of TNFA mRNA were similar in 
both LPS and LPS plus 1-MT treated MDMs from pig four with excess tryptophan 
plus LPS having a far greater effect (Figure 5.16D).  Surprisingly treatment with 1-
MT alone causes a constant increase in levels of TNFA until 24 hours when it 
increases massively.   Base levels of IL8 were particularly high and here again excess 
tryptophan plus LPS increased IL8 mRNA above treatment with LPS alone or in 
combination with 1-MT (Figure 5.17D).  Treatment with excess tryptophan plus 
LPS also increased levels of JAG1 although only to similar levels as LPS plus 1-MT, 
both were higher than LPS alone (Figure 5.18D). Treatment with the IDO inhibitor 
1-MT did not protect pig macrophages from activation by LPS.  The kinetics of 
response were different in each animal, possibly due to breed specific differences, 
but overall 1-MT increased production of the immune mediators TNFA, IL8  and 
JAG1 suggesting that treating patients suffering from sepsis with an IDO inhibitor 
may worsen their condition.  
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Figure 5-16 1MT increased the TNFA response to LPS. 
rhCSF1 derived MDM from 4 animals, (A) LWL2 ,(B) LW2 ,(C) LW3  and (D) 
LAN1 were treated with LPS (100ng/ml), the IDO inhibitor 1-methyltryptophan 









Figure 5-17 1MT increased the IL8 response to LPS. 
rhCSF1 derived MDM from 4 animals, (A) LWL2 ,(B) LW2 ,(C) LW3  and (D) 
LAN1 were treated with LPS (100ng/ml), the IDO inhibitor 1-methyltryptophan 










Figure 5-18 1MT increased the JAG1 response to LPS. 
rhCSF1 derived MDM from 4 animals, (A) LWL2 ,(B) LW2 ,(C) LW3  and (D) 
LAN1 were treated with LPS (100ng/ml), the IDO inhibitor 1-methyltryptophan 










5.3.1 A core set of genes were LPS inducible in the pig 
There is a well reported sequential cascade of primary and secondary responses to 
LPS in mice and men (Nilsson et al., 2006; Gilchrist et al., 2006; Ghisletti et al., 
2010).  Previous studies have identified a core set of genes that responded in a 
similar manner regardless of the genetic background of the mouse (Wells et al., 
2003).  Similarly a core set of genes were induced in human PBMCs in response to 
PAMPs from different organisms showing that a stereotypical immune response 
exists regardless of the inflammatory stimulus (Boldrick et al., 2002).  The 
segregation of porcine LPS-regulated genes into clusters using BioLayout ExpressTM 
(Freeman et al., 2007) generated 99 distinct clusters. The second largest cluster of 
co-expressed genes, cluster 2 (Figure 5.5) consisted of 481 transcripts which were 
induced by LPS.  Many of these genes relate to control of cell death such as the 
BCL2 associated athanogene BAG1 and several caspases (CASP3, CASP4, CASP7, 
CASP8), CASP7 has previously shown to be LPS inducible in the mouse (Wells et 
al., 2003).  As expected the cellular response to LPS required the switching on of 
many genes so it was unsurprising to see transcription factors, or genes involved with 
control of transcription in this cluster such as STAT1.  STAT1 is involved in the 
induction of IDO, one of the most LPS inducible genes in both pigs and men, 
through co-operation with interferon regulatory factor 1 (IRF1) (Chon et al., 1996) 
which was also one of the early response genes in pig BMDM (Figure 5.5). Many of 
the transcription factors seen in the early response clusters may regulate the response 
of genes induced at a later point.   Cluster 2 also contained some genes associated 
with negative regulation of the immune response such as IL1RN which was induced 
after 7 hours of LPS stimulation and functions as a negative regulator of IL1α (IL1A) 
and IL1β (IL1B), both of which were early response genes in this study.  Wells et al. 
found that the largest proportion of LPS inducible genes in mouse macrophages were 
cytoskeletal or phagosomal components, perhaps unsurprising when considering the 
morphological changes observed in LPS treated BMDM in vitro.  Genes induced 
immediately in response to LPS, the “early” cluster, were often involved in 
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activation of the inflammatory response.  Typical early genes in human and mouse 
endotoxin activated macrophages include known targets of NF-κB, immediate-early 
gene 3 (IER3) and GADD45B (Wells et al., 2003) as well as cytokines such as IL1A 
and IL1B, the chemokine IL8 and cell surface receptors such as CD40 (Boldrick et 
al., 2002).  All of these genes were induced by 2 hours LPS treatment in the pig 
suggesting many of the “core” LPS inducible genes of mice and men were also 
induced in the pig.  Furthermore RELA which binds to NFκB1 or NFκB2 to form the 
NFκB complex, and NFKBIA which inhibits the NFκB complex were both induced 
immediately in endotoxin activated pig BMDM reflecting the auto-regulation of this 
signalling pathway which is known to occur in both man and mice (Boldrick et al., 
2002).  In the mouse many LPS response genes were induced “early” and remained 
elevated by 21 hours stimulation.  The induction of such genes demonstrated that 
continuous exposure to LPS resulted in continual amplification of the inflammatory 
response in the mouse (Wells et al., 2003).  By contrast in the pig transcription of the 
early response genes had mostly returned to base levels after 24 hours LPS 
stimulation (Figure 5.5) suggesting that the pig response to LPS is more readily 
resolved than that of the mouse.  This is in contrast to the clinical response of the 
animals; most strains of mice are resistant to endotoxin while pigs, like man, are 
exquisitely sensitive (Munford, 2010).  This data is the first large scale analysis of 
LPS response genes in the pig and demonstrates that regulation of many of the 
“core” LPS response genes in man and mouse were conserved in the pig. 
   
Although LPS activation is often associated with the induction of genes to mount an 
effective response, typically as many if not more genes were repressed by LPS.  The 
largest cluster of co-expressed genes, Cluster 1 (Figure 5.4) contained genes which 
were initially expressed at high levels and which were down-regulated in response to 
LPS.  Many of these genes are involved in control of protein synthesis and have GO 
terms relating to control of mitochondrial processes, ATP binding and protein 
biosynthesis.  In the mouse many cell-cycle related genes were down-regulated upon 
cellular activation confirming the anti-proliferative effect of LPS (Nilsson et al., 
2006).  Similar down-regulation of cell cycle associated proteins (CDC34, CDC5L, 
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CDC25B, CDCA7, CDC123, CDC42BPA, CDCA7L) cyclin-dependent kinase 
inhibitors and associated proteins (CDKN1A, CDK2AP2, CDK2AP1) and cyclins 
(CCNY, CCNF, CCNC) were observed in the LPS treated pig BMDM.  As with the 
LPS induced genes this set of LPS-repressed genes demonstrates that pig 
macrophages switch off many of the cellular processes which are down-regulated by 
LPS in other species. 
 
Large scale genome analyses such as this provide a large amount of data to analyse.  
It is therefore important to look at all the data, not just that which fits the original 
hypothesis.  Correspondingly the list of genes down-regulated in cluster one 
disclosed some potential differences between pigs and humans.  Expression of the 
anion transporter ABCC5 which was down-regulated by LPS in pig BMDM has been 
shown to increase in HIV infected human macrophages (Jorajuria et al., 2004). 
Studies of other drug transporters in LPS-activated human macrophages have shown 
a wide range of effects  (Moreau et al., 2010) suggesting expression of some solute 
transporters may be altered in LPS treated macrophages versus untreated cells.  This 
could have important implications for use of antibiotics and anti-viral drugs in any 
pig model of human disease.  If a solute carrier is repressed by LPS this could result 
in increased resistance due to unavailability of the treatment within the cell.  Indeed 
LPS has previously been shown to induce resistance to a neomycin-related antibiotic 
and two chemotherapy drugs in a murine macrophage cell line (Sweet and Hume, 
1996).  Similarly heat shock proteins are generally up-regulated after cellular stress 
in humans (Lang et al., 2005; Barreto et al., 2003) but were down-regulated by LPS 
in pig BMDM in this study.   Heat shock protein 1 (HSPD1, Hsp60) is often thought 
of as an endogenous danger signal for the innate immune system.  It has been shown 
to enhance TLR signaling by binding LPS which led to an increase in production of 
IL12p40 by macrophages and IFNγ by T cells, thereby stimulating both the innate 
and adaptive immune systems (Osterloh et al., 2007).  There were four heat shock 
proteins in cluster 1 which were all down regulated upon LPS stimulation, an 
additional 3 HSPs were detectable in the array data (HSPB11, HSPBP1, HSP90AB1) 
of which HSPB11, which was in cluster 2, was the only one up-regulated upon 
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stimulation with LPS.  HSPs stabilize proteins and are involved in folding and 
unfolding, they are generally induced in response to stress.  Their repression in pig 
macrophages suggests that these cells may have another way of dealing with 
unwanted protein aggregation or perhaps more simply other HSPs which are induced 
in response to stress and which were not included in this array.  Differences between 
the guanine nucleotide binding (G) protein expression in endotoxin activated pig 
macrophages and what has been previously reported in human and mouse cells was 
also observed. GNAI2 was down-regulated by LPS in pig BMDMs contrary to both 
mouse macrophages and human macrophages where it was constitutively expressed 
at high levels and largely unaffected by LPS treatment (Biogps.gnf.org; (Schroder et 
al., 2012)). Experiments in human monocytes demonstrated an association between 
CD14 and the α subunits of various G proteins which regulated CD14-dependent 
endotoxin-activated p38 MAPK activation and cytokine production (Solomon et al., 
1998).  Furthermore p38 phosphorylation can be induced by LPS interacting with G 
α agonist while pertussis toxin, which inactivates G proteins, can inhibit this.  LPS 
tolerant cells therefore showed impairment of p38 and endotoxin tolerance has also 
been associated with decreased G protein function and the subsequent decrease in 
p38 phosphorylation (Coffee et al., 1992; Ferlito et al., 2001). Down-regulation of 
GNAI2 in pig macrophages would suggest decreased p38 phosphorylation and 
subsequent MAPK activation however LPS induced a strong reaction in pig BMDM 
which would suggest that GNAI2 at least does not regulate MAPK activation in pig 
BMDMs, another G protein may however fulfill this function. It is important when 
using any animal as a model for human immunity that genetic differences as well as 
similarities are taken into account.  Microarray data such as presented in this chapter 
allows researchers to integrate the expression patterns of a large number of genes and 
tease out any important differences between species. 
 
5.3.2  The pig response to LPS was more like the human 
response 
The microarray analysis revealed that around 1/3 of the most regulated genes in the 
pig BMDM were not induced in the mouse.  Of these, approximately 1/2 were 
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induced in endotoxin stimulated human monocyte-derived macrophages.  When 
comparing LPS inducible genes across species, it was notable that the porcine and 
human response to LPS seemed to have some involvement with the adaptive immune 
response, for example the lymphotactic chemokines CXCL9, CXCL13, CXCL11 and 
CCL20 were highly LPS inducible in pigs and humans but not mice (Figure 5.6-10).  
CCL20 which causes chemotaxis of CCR6 expressing cells to sites of inflammation 
(Ito et al., 2011), was one of the most LPS inducible genes in human MDM but was 
not induced by LPS in mouse BMDM or TEPMs ((Martinez et al., 2006; Nilsson et 
al., 2006)Biogps.gnf.org; (Schroder et al., 2012)).  CCL20 was highly inducible in 
pig MDM and BMDM as well as being up-regulated in PBMCs from pigs with septic 
shock (Figures 5.8-10).  Moreover, the most up-regulated gene at 7h in the pig was 
CXCL11, an IFN-inducible T cell alpha chemoattractant (Widney et al., 2000).  
Looking at Cluster 2 from the microarray dataset provided additional evidence for 
this theory.  The lymphocyte associated receptors IL27RA and IL7R were both 
switched on by LPS as was PHF11 which regulated Th1-type cytokine gene 
expression. IL7R was repressed by LPS in the mouse but highly inducible in man 
(Figure 5.6 & 5.7).  In addition to IDO1, pig BMDM also shared with human 
macrophages the induction of other tryptophan pathway enzymes, kynurenine 
hydroxylase (KMO), kynureninase (KYNU) (Figure 5.5) and tryptophan-tRNA 
synthetase (WARS).  This pathway is commonly referred to as interferon-gamma 
inducible, but was clearly responsive to LPS alone in the pig and there was some 
evidence that it is inducible by LPS alone in man (Taylor and Feng, 1991).  Another 
well-known human-specific inducible gene shared with pigs is CYP27B1, the 
enzyme that regulates the levels of biologically active vitamin D.  In humans, 
vitamin D has been firmly implicated in the control of antibacterial defence (Liu et 
al., 2006) and the vitamin D receptor was expressed constitutively by human 
monocytes and macrophages, but not by mouse (biogps.gnf.org).  Others have 
reported that the vitamin D3 receptor was expressed in pig bone marrow (Hittmeier 
et al., 2006).  Although it is not annotated in the microarray, constitutive expression 
was detected in the pig BMDM by qRT-PCR (data not shown) and CYP27B1 was 
highly inducible in pig BMDM (Figure 5.6).  Analysis of the promoters of genes 
which were LPS inducible in pigs and humans but not mice (CYP27B1, IDO, STAT4, 
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CCL20) showed striking conservation between the human and pig promoters and a 
lack of conservation when comparing human and mouse promoters (Figures 5.11-
14) suggesting the divergent expression of such genes may be due to differences at 
the transcription level as has been previously reported with NOS2 (Taylor and Geller, 
2000; Zhang et al., 1996; Yu et al., 2005).  Additionally promoters were enriched for 
motifs which bind LPS-regulated transcription factors such as NFκB, C/EBP, IRF 
and STATS (which bind to GAS sites).  Consistent with this STAT4 and STAT1 were 
both LPS inducible in human and pig macrophages but not in mouse macrophages. 
 
This comparison also highlighted several genes which were LPS inducible in pigs 
but not in mice or humans (data not shown).  IL33, which is a member of the IL1 
family, is one such.  IL33 signals through the IL1 receptor-related protein ST2 and 
can induce Th2 associated cytokines through a MyD88 dependant pathway which 
results in the phosphorylation of MAPKs (Hazlett et al., 2009).  IL33 was 
traditionally thought to be involved in host defence against nematode infection and 
allergic diseases such as asthma and dermatitis however more recently it has been 
implicated in the pathogenesis of some immune diseases and has been shown to drive 
production of Th2 cytokines through ligation with its receptor ST2 (Schmitz et al., 
2005; Dinarello, 2005).  IL33 is thought to function as a cytokine and a nuclear 
factor and can repress transcription (Carriere et al., 2007) but has also been shown to 
have an enhancing effect on the LPS response in mice by increasing expression of 
TLR4 and MD2 (Espinassous et al., 2009).  By contrast binding of the IL33 receptor, 
ST2, to murine BMDMs has been shown to lead to the down-regulation of TLR4 
preventing over-production of the proinflammatory cytokines IL6, IL12 and TNFα 
(Sweet et al., 2001).  Cyclooxygenase-1 (PTGS1, COX1) was also LPS inducible in 
pig macrophages but not in human or mouse cells.  COX1 and COX2 convert 
arachidonic acid to prostaglandin (PG)H2 and regulate angiogenesis in endothelial 
cells (Tsujii et al., 1998).  COX1 is known to be present in most tissues while COX2 
is found at sites of inflammation and has previously been shown to be LPS inducible 
in human macrophages (Ariasnegrete et al., 1995).  Several of the genes which were 
LPS inducible in the pig alone (LAMP2 and LRM) were constitutively expressed by 
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human macrophages suggesting they may still be involved in the human response to 
LPS. 
 
Fifteen genes were LPS inducible in pigs and mice but not human (data not shown) 
including ARG1.   As described in the introduction ARG1 is the classical gene of 
alternatively activated macrophages and is normally produced via STAT6 (Pauleau 
et al., 2004).  ARG1 has also been induced in classically activated mouse 
macrophages by intracellular pathogens through a MyD88 dependent pathway which 
was partially dependent on TLR2 (El Kasmi et al., 2008).  In mice Arg1 competes 
with Nos2; it may be that the absence of active NOS2 in pig BMDMs allowed the 
ARG1 pathway to become dominant.  Again several of the genes found to be LPS 
inducible in pigs and mice were constitutively expressed by human macrophages 
(IFI16, ARHGEF3, LGALS9, STK38L, TOR3A). 
 
5.3.3 Pig Macrophages did not induce NO in response to LPS 
In common with human macrophages LPS did not induce NO nor any of the genes 
involved in the NO pathway (excepting GCH1 and ARG2) in pig macrophages 
(Figure 5.15, Table 5.1). The cationic amino acid transferase (CAT2) is the rate 
limiting step in this reaction so its lack of induction by LPS is clear evidence that this 
pathway was not active in LPS activated porcine BMDM.  GCH1, one of the few 
enzymes involved in the NO pathway which was LPS inducible in the pig, is the rate 
limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis.  BH4 is an essential co-
factor required for the synthesis of the neurotransmitters dopamine, noradrenaline, 
adrenaline and serotonin as well as all three forms of NOS.  Neopterin, a by-product 
of BH4 synthesis, is a common marker of inflammation (Gieseg et al., 2008) and like 
kynurenine, higher levels of neopterin in patients has been shown to be indicative of 
developing sepsis or septic shock (Baydar et al., 2009).  GCH1 was also highly 
expressed in human CD14+ monocytes (Biogps.gnf.org). Human macrophages do not 
accumulate BH4, instead GCH1 metabolises guanosine triphosphate to neopterin 
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(Figure 5.19).  It seems probable that the endotoxin-mediated activation of GCH1 in 
the pig may lead to the production of neopterin, as in man, rather than NO as in mice.  
The lack of expression in human monocytes of sepiaterin reductase (SPR) and 6-
pyruvoyltetrahydropterin synthase (PTPS) ((The FANTOM Consortium et al., 2005), 
FANTOM5 published data (DAH Personal communication)), which are required for 
the formation of BH4 from guanosine triphosphate, will lead to the formation of 
neopterin over biopterins in these cells.  In the pig PTPS and SPR were constitutively 
expressed at low levels and actually slightly repressed by LPS therefore BH4 was 
highly unlikely to be produced by pig macrophages in the normal state or after 
activation with LPS.  Previous studies in the pig have found synthesis of neopterin in 
response to stress (Breinekova et al., 2007) and LPS (Myers et al., 2003) suggesting 
that as in humans GCH1 induction leads to the formation of neopterin rather than 
BH4 as in mice.  The lack of NO induction in pig macrophages is an important 
similarity with human macrophages which makes the pig a more suitable model for 
studying human inflammatory disease than the more commonly used mouse. 
 
ARG2 was one of the few genes of the NO pathway which was LPS inducible in pig 
BMDMs.   ARG1 is found in the cytosol while ARG2 is mitochondrial and both 
catalyse the hydrolysis of L-arginine to L-ornithine and urea (Figure 5.19).  ARG1 
has been reported to be specifically expressed by M2 macrophage while ARG2 was 
expressed by M1 macrophages (Khallou-Laschet et al., 2010).  An excess of proline, 
which is a key component of collagen, can occur in the absence of NOS2 and 
arginase activity in the absence of NOS2, which has been associated with M2 
macrophages, has been proposed to be an important component of wound healing 
(Hesse et al., 2000; Shearer et al., 1997; Munder et al., 1998).  Interestingly, Benga et 
al. (Benga et al., 2009) have claimed that pig macrophages from some breeds can 
produce NO, but only in response to live microorganisms. As discussed above, others 
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Figure 5-19 The Nitric Oxide pathway 
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have made similar claims for human macrophages (St Clair et al., 1996; Nicholson et 
al., 1996; Hunt and Goldin, 1992; Anstey et al., 1996; St Clair et al., 1996). 
 
5.3.4 The IDO pathway was involved in feedback control of 
the immune response in the pig 
Most researchers now agree that human macrophages do not produce NO and this 
thesis has shown that the NO pathway was not induced in pig macrophages by LPS 
(Figure 5.15, Table 5.1).  Instead the IDO mediated metabolism of tryptophan to 
kynurenine was induced by LPS in both pig and human macrophages.  Interestingly 
IFNγ-induced tryptophan degradation has been shown to occur in parallel to the 
induction of GCH1 in human macrophages (Schroecksnadel et al., 2005; Werner et 
al., 1989) and this thesis has shown that pig macrophages stimulated with LPS 
induced GCH1 and IDO1, which metabolises tryptophan.  Furthermore the 
degradation of tryptophan and the formation of neopterin, which human 
macrophages make in preference to NO, are closely correlated (Huber et al., 1984; 
Murr et al., 2001).  Pig MDMs were activated with LPS and the IDO pathway 
blocked by the use of a specific inhibitor 1-MT.  1-MT exists as two stereoisomers, 
1-D-MT and 1-L-MT.  There is evidence to show that 1-L-MT preferentially targets 
IDO1 while 1-D-MT inhibits the novel IDO isoform IDO2 (Metz et al., 2007; Lob et 
al., 2009).  In man IDO1 and IDO2 were both highly LPS inducible in macrophages 
((The FANTOM Consortium et al., 2005), FANTOM5 published data (DAH 
Personal communication)).  1-D-MT has been used in mice where, contrary to what 
was seen in the pig,  it led to a decrease in TNFα, IL6 and IL12 and an increase in 
IL10 after treatment with LPS (Jung et al., 2009).  The racemic mix of 1-MT was 
used in the experiments described in this thesis which Opitz et al. found to have a 
similar, if slightly lesser effect to 1-L-MT alone and should inhibit both isoforms of 
IDO (Opitz et al., 2011).  Inhibiting IDO did not have a protective effect in the pig 
(Figure 5.16-18).  This suggests that in the pig induction of IDO is a feedback 
control mechanism of the immune response.  In addition kynurenine, the metabolite 
of this pathway, may have some anti-inflammatory effects.  That induction of IDO 
should result in regulation of the immune response isn’t entirely surprising; IDO-
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mediated effects can only occur after the enzyme has been induced and tryptophan 
metabolized.  Interestingly trials of 1-D-MT in human cancer cells did not show the 
protective effects previously described in the mouse.  Instead IDO mRNA and 
protein expression increased which led to increased kynurenine production by the 
cancer cells although 1-L-MT did have an inhibitory effect on kynurenine (Opitz et 
al., 2011).   Porcine MDMs were treated with either the IDO inhibitor or an excess of 
tryptophan in the absence or presence of LPS.  Perhaps surprisingly treatment with 
LPS in the presence of an excess of tryptophan had quite varied effects on the 
production of the immune mediators measured (Figures 5.16-18).  The differences in 
response of LPS stimulated pig MDMs to tryptophan may have been due to the 
quantity of excess tryptophan initially available.  Significant endogenous tryptophan 
may have caused a large early response to LPS and the addition of further tryptophan 
to the media would not have affect this however it may have prevented resolution 
and prolonged the response.  If there was not excess tryptophan in the media then the 
effects of the inhibitor may have taken effect before the LPS response and in this 
case the addition of further excess tryptophan may have made the initial response 
worse.  Tryptophan concentrations have previously been demonstrated to affect the 
state of cells in vitro.  High concentrations of tryptophan (22-400µg/mL) can be toxic 
to cells and cells grown in tryptophan rich media were more resistant to the anti-
proliferative effects of IFNγ (Taylor and Feng, 1991; de la Maza and Peterson, 
1988). 
 
This study showed IDO1 was LPS inducible in pig macrophages and there was some 
evidence IDO2 was also LPS inducible (unpublished observations).   Neither Ido1 
nor Ido2 were expressed by mouse macrophages accordingly the inhibitor used on 
these cells by Jung et al. would have affected Ido production by non-immune cells 
e.g. endothelial cells.  In murine lungs Ido was inhibited by inhibitors of fatty acid 
cyclo-oxygenase such as indomethacin, phenylbutasol and aspirin, and 
glucocorticoids such as dexamethasone, betamethasone and cortisone (Sayama et al., 
1981).  By contrast glucocorticoids have been shown to have a potentiating effect on 
induction of IDO1 by human monocytes (Ozaki et al., 1987).  Ido1 was most highly 
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expressed by white adipose tissue in the mouse (Biogps.org).  White fat expresses 
glucocorticoids receptors which may explain why glucocorticoids had an inhibitory 
effect in the mouse.  Ido2 was only expressed by mouse liver and at relatively low 
levels and neither isoform was LPS inducible in the mouse (Biogps.gnf.org).  By 
contrast IDO1 was one of the most LPS inducible genes in human MDM (Schroder 
et al., 2012; Hissong et al., 1995).  Mouse models seeking to simulate and 
uncontrolled TLR4 response must therefore always be viewed in light of the lack of 
induction of this highly inducible human response gene. 
 
In summary, the generation of pig BMDM provides a model system for studying 
macrophage functional genomics that more closely resembles human biology than 
traditional mouse models.  Like humans, pigs did not induce NO after microbial 
challenge and instead responded with induction of IDO.  Induction was conserved for 
many other immune-response genes, particularly those associated with the adaptive 
immune response, between man and mouse.  The promoters of such LPS-regulated 
immune response genes showed striking conservation when comparing the pig and 
human promoters and a loss of conservation when comparing human and mouse 
which is most likely responsible for the divergent regulation of these genes between 
man and pig versus mice.  It is likely that much of the difference in immune response 
of primates and rodents may originate at the transcription level.  The domestic pig 
also offers a potential intersection of genomics and genetics.  For example, Benga et 
al. (Benga et al., 2009) have reported significant variation in the response of 
individuals within and between pig breeds to microbial challenge.  The use of 
BMDM in future studies will permit the assessment of macrophage autonomous 
variation in populations of animals from diverse sources, separated from the 
influence of husbandry, nutrition and other variables.  This is turn may contribute to 
understanding genetic control of disease susceptibility in humans.
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Chapter 6: Conclusions and future work 
 
The work described in this thesis explores the use of the pig as a model to study 
human innate immunity.  The pig is important in its own right as a production 
animal, so the comparison also underpins the possible view of humans, which have 
been much more extensively studied, as models for pig immune responses.  There are 
many advantages to using the pig as a model; a large number of cells can be isolated 
from one animal and stored for future use, many experiments can be performed from 
the same animal and macrophages from different anatomical locations and in 
different states of differentiation from the same animal can be compared.  Unlike 
commonly-used mouse models, the pig is not inbred (although inbred lines do exist), 
but breed diversity provides genetic resources for the study of within-breed variation 
in innate immunity and macrophage biology. 
 
 Chapter 3 demonstrated some of the major advantages to the pig as a model over 
the more commonly used rodents and analysed the expression of widely studied 
immune markers on porcine monocytes and macrophages from different locations 
and the effects of rhCSF1 on macrophage differentiation in the pig.  Expression of  
the LPS receptor CD14 and Fc receptor CD16 have been extensively studied in man 
(Ziegler-Heitbrock, 2007).  Despite the fact that CD16 exists as multiple copies in 
the human genome, and there is copy-number variation amongst individuals (Aitman 
et al., 2006; Mamtani et al., 2010; Molokhia et al., 2011) recent studies have shown 
that both CD14 and CD16 are also differentially expressed on mouse monocytes 
(Ingersoll et al., 2010).  As well as delineating human monocytes into subsets which 
are presumed to have specific functions in vivo, there is evidence that genetic 
variation in CD14 and CD16 (including the copy number variation) is associated 
with increased susceptibility to disease (Mamtani et al., 2010; Molokhia et al., 2011; 
Zhou et al., 2010; Yu et al., 2011).  The scavenger receptor CD163 is expressed by 
most macrophage populations in man (Fabriek et al., 2005) and also differentially-
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expressed amongst human monocyte subsets, being highest on the CD16- subset 
(Tippett et al., 2011).  CD163 has been used previously to differentiate porcine 
monocytes into subsets (Chamorro et al., 2000).  CD163 functions as a receptor for 
PRRSV (Calvert et al., 2007) and expression levels have been correlated to 
permissiveness to ASF (Sanchez-Torres et al., 2003) in pigs.  In man HIV infected 
subjects had higher levels of CD163 on the intermediate CD14hiCD16+ monocyte 
subset than uninfected individuals and culture with CSF1 increased expression in the 
same subset (Tippett et al., 2011).   
 
CD172a (SWC3, SIRPα) is expressed on all cells of myeloid origin in the pig from 
early myeloid progenitors and along with SWC1 and SWC8 (discussed in Chapter 
1) has been used to separate out the main peripheral blood leukocyte populations 
(Lunney, 1993; Saalmuller, 1996) and define populations in porcine bone marrow 
(Summerfield and McCullough, 1997).  Knowledge of the different populations 
present in porcine bone marrow and blood is important to help understand the role 
these cells may play under normal conditions or during disease.  All early porcine 
myeloid progenitors expressed low levels of CD172a and expression continued on 
cells which were committed to both the granulocyte or monocyte lineage then 
increased as cells matured.   Low level expression of CD172a was also seen on 
plasmacytoid DCs (Summerfield and McCullough, 1997; Summerfield et al., 2003).  
The early expression and retention on all myeloid cells of CD172a suggest it may be 
important in control of proliferation, differentiation and activation.   CD172a is a 
member of the immunoglobulin superfamily and functions as a receptor for CD47 in 
humans and rodents (Vernon-Wilson et al., 2000; Ezquerra et al., 2009; Seiffert et 
al., 1999).  The expression of CD47 on murine red blood cells (RBCs) has been 
reported to act as a “marker of self” by interacting with CD172a on macrophages 
(Oldenborg et al., 2000) although similar effects have not been reported in humans 
(Arndt and Garratty, 2004) and the lack of interactions between CD47 expressing 
human mesenchymal stem cells and CD172a suggest that any such interactions must 
be at least cell type specific if not species specific (Subramanian et al., 2006).  Lack 
of conservation in the sequence of key areas of CD172a and CD47 between human 
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and mice also suggests function may not be conserved between the species 
(Subramanian et al., 2006; Jiang et al., 1999; Subramanian et al., 2007). By contrast 
human CD172a bound strongly to both human and pig CD47 but not rat or mouse 
CD47.   Similarly porcine specific CD172a antibodies have been shown to react 
across species (Summerfield and McCullough, 1997)  and several human anti-CD47 
antibodies bound to pig RBCs but not RBCs from rodents (Subramanian et al., 
2006). This thesis found CD172a to be highly expressed by all CD14+ monocytes 
(Chapter 3) while others detected  higher expression at the mRNA and protein level 
by human CD16- monocytes and at the protein level alone by mouse Ly6Clo 
monocytes (Ingersoll et al., 2010).  
 
6.1 Comparison of monocytes/macrophages in the 
pig 
Macrophages originate in the bone marrow from stem cells that differentiate into 
promonocytes before moving to the blood stream as monocytes, and thence into 
tissues where they further differentiate into specialised tissue macrophages (Gordon 
and Taylor, 2005). Distinct tissue macrophage populations are found in specific sites 
in the body and heterogeneity has been identified between macrophage populations 
in the lungs (Nicod et al., 1987; Prokhorova et al., 1994) .  Previous investigations 
have compared rodent macrophages from different anatomical niches to determine 
any differences and possible functional roles in vivo. Rat alveolar macrophages 
displayed higher phagocytic ability and were better able to kill bacteria and fungi 
than peritoneal macrophages.  By contrast rat PMs functioned as better accessory 
cells and were stronger stimulators of T cell proliferation than AMs suggesting the 
two mature macrophage populations probably fulfil specific roles in vivo (Gjomarkaj 
et al., 1999).  
 
With the availability of large numbers of macrophages from different anatomical 
sites in the pig, it will be interesting to determine their antigen-presenting capacities.  
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This is important for the development of vaccine strategies.  There is a limited 
literature on this topic linking sialoadhesion (CD169, siglec1) and CD163 with 
antigen presentation to T cells (Poderoso et al., 2011; Revilla et al., 2009).  Linking 
of antigens to antibodies against CD169 or CD163, endocytic receptors expressed by 
APC, led to increased T cell proliferation (Revilla et al., 2009; Poderoso et al., 2011)   
The minimal requirements for antigen-presentation are expression of class II MHC 
and co-stimulator molecules.  Others in the laboratory are in the process of array 
profiling isolated alveolar macrophages which will provide data on the expression 
levels of Class II genes and co-stimulatory molecules. 
 
It will also be of interest to compare the phagocytic ability, cytokine production and 
response to challenge of different macrophage populations.  This would enable 
differences to be fully elucidated between macrophages from the lungs and 
peritoneal cavity or between different macrophage populations from the same 
location. Peritoneal lavage in the rat resulted in a far greater variety of cell types than 
alveolar lavage and Gjomarkaj et al. (1999) suggested the stronger T cell stimulatory 
function of rat PMs may result from simply encountering a wider variety of cells 
than AMs.    The composition of non-macrophage cells from either of these locations 
in the pig was not examined so it would be interesting to determine if the ability to 
promote lymphocyte proliferation relates to the cell types encountered as it may do in 
rodents.  Rat AMs also expressed higher levels of the antigen ED9 (SIRPα) than PMs 
(Gjomarkaj et al., 1999).  Similarly murine AMs have been shown to produce higher 
levels of the pro-inflammatory cytokine TNFα after stimulation with LPS than 
resident or elicited PMs (Tachibana et al., 1992) while PMs produced the anti-
inflammatory cytokine IL10 which was not produced by AMs under similar 
conditions suggesting each population may have a different function in the 
inflammatory state (Salez et al., 2000).  The larger size and relative availability of 
tissues also presents the possibility of isolating large numbers of tissue macrophages 
from key organs such as the spleen, liver and gastrointestinal tract.  The latter 
location contains a very abundant macrophage population (Pavli et al., 1990), which 
is relatively unresponsive to TLR ligands (Bain and Mowat, 2011).  
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Expression of the immune markers CD14, CD16, CD163 and CD172a was examined 
on several porcine monocytes/macrophage populations.  The mature macrophage 
populations from the lungs and peritoneal cavity expressed uniformly high levels of 
the immune markers studied in this thesis.  FACS analysis using an extensive array 
of antibodies will most likely identify markers specific to each population or 
differences within a cell type.  Further unpublished experiments in our laboratory 
have identified two populations of AMs based on adherence (unpublished, Ronan 
Kapetanovic) as has been noted previously in man (Nicod et al., 1987).  The markers 
used in this study were unable to differentiate between these populations 
(unpublished, Ronan Kapetanovic). One might expect that expression of adhesion 
molecules would differ between the two populations and explain the differential 
adhesion to plastic; for instance several integrins as well as the CSF1R have been 
shown to have adhesive properties (Lin et al., 1994b; Rosen and Gordon, 1987; 
Elsegood et al., 2006).  The level of adhesion has also been related to differences in 
proliferation suggesting the two AM populations may differ in this respect (Xaus et 
al., 2001).  Previous investigations have suggested porcine AMs and PMs respond to 
viral products through different pathways (Loving et al., 2006) suggesting intrinsic 
differences between the two cell types.  The immune response to viral infection is 
characterised by induction of type I interferons (IFNα/β) which leads to inhibition of 
viral replication. Porcine AMs and PMs responded to the synthetic dsRNA analog 
poly(I:C) with induction of transcription of type I IFNs although the “fold change” 
increase in transcription was greater in AMs.  In contrast induction of transcription of 
the dsRNA-dependent protein kinase R (PKR) and Myxo-virus resistant, IFN-
inducible GTPase (Mx) was higher in PMs.   Loving et al. refer to “fold change” 
when comparing expression levels throughout this paper, so it is not clear whether 
the difference is due to high basal expression or lack of induction. Interestingly the 
AM response to poly(I:C) was still elevated after 24 hours.  Unfortunately, these 
workers used only a single time point.  Similar experiments in our laboratory 
comparing the TLR4 response in porcine AMs and PMs demonstrated a more 
sustained response from AMs.  Production of TNFα by LPS-stimulated MDMs and 
BMDMs peaked at between 7-12 hours then declined thereafter.  Production of 
TNFα by PMs stimulated with LPS remained constant for up to 55 hours after 
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initially increasing  sharply while TNFα production by LPS-stimulated AMs was till 
increasing at the last time point assayed (55 hours)  (unpublished, Ronan 
Kapetanovic).  Similarly this thesis showed a clear time-dependent profile in the 
response of BMDMs to LPS.  It is therefore likely that hyper-responsiveness of AM 
to TLR3 stimulation, which uses the same co-receptors as TLR4 (Takeuchi and 
Akira, 2010), would be even more obvious in an extended time course.   
 
AMs are critical in the immune response to influenza (Tumpey et al., 2005) and the 
recent emergence of highly pathogenic strains highlights the need for a good model 
of pulmonary anti-viral responses.  Pig AMs are readily available in large numbers 
and pigs, unlike mice (where one must use specifically adapted strains) are highly 
susceptible to influenza.  The study described above by Loving et al. (2006) 
investigated the response of AMs to dsRNA. The authors suggested that recognition 
of and subsequent response to dsRNA was mediated by TLR3 in AMs and PKR in 
PMs.  The IFN response of AMs needs to be tightly regulated in order to avoid 
uncontrolled inflammation which could lead to pathological effects in the lung.  
Loving et al. therefore suggested that transcription of the interferon stimulated genes 
(ISG) PKR and Mx could be inhibited by constitutive expression of the suppressors 
of cytokine signalling (SOCS) proteins or by the transcription factor NFκB which 
could block binding by other transcription factors to the relevant promoters 
specifically in AMs.  Differences in type I IFN responses have been described 
between rodents and humans (Rogge et al., 1998) meaning rodent models of viral 
infections may not always accurately replicate what would occur in a human patient.  
Further studies on porcine AMs could more fully elucidate the control of type I IFNs 
in the pig and lead to better models of lung macrophage response to virus. 
 
6.2 Breed diversity 
Another advantage of the pig system is the availability of different breeds which 
differ in their disease susceptibility.  This variation is of both intellectual and 
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practical significance.  An ongoing project in our laboratory seeks to identify 
differentially-expressed genes and macrophage-expressed sequence variants (snps), 
that distinguish the major breeds.  In this thesis, freshly isolated blood monocytes 
from six different pig breeds were divided into populations based on differential 
expression of CD14 and CD163 as previously (Chamorro et al., 2000) or CD14 and 
CD16 as in human and mice (Ingersoll et al., 2010).  Expression of the markers 
examined showed only subtle variation between breeds suggesting no major 
polymorphisms were present at any of the genetic loci despite previous reports 
suggesting some pig breeds are more/less susceptible to PRRSV (Ait-ali et al., 2007) 
and variation in CD14 and CD16 noted among humans (Molokhia et al., 2011; Yu et 
al., 2011).  A minimum of 2 animals from each breed were analysed which would 
have detected absolute breed specific variation but is clearly too small a sample size 
to detect animal specific variation. Polymorphisms at CD14 and CD16 are correlated 
with disease in some human ethnicities and similar genetic diversity may be reflected 
among breeds of pigs.  
 
6.3 Effects of CSF1 in the pig 
In mice and humans, CSF1 has been shown to promote monocyte and macrophage 
differentiation and proliferation (Hume and MacDonald, 2011).  Work in this thesis 
extended these studies to the pig. Analysis of surface marker expression by AMs 
grown in the presence or absence of CSF1 suggested an exogenous source of CSF1 
was required for the maintenance of the mature AM phenotype.  Macrophages grown 
in the absence of CSF1 or with a CSF1R inhibitor expressed lower levels of CD14, 
CD163 and CD172a and almost entirely lost expression of CD16.  Cells cultured 
with the inhibitor had further loss of surface marker expression compared to those 
simply deprived of CSF1 suggesting production of autocrine CSF1 was able to 
partially rescue the mature macrophage phenotype.  Expression of immune markers 
is likely to relate to differences in immune function in vivo and suggests CSF1 is 
necessary for maintenance of full functionality of lung macrophages.   
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Mice lacking Csf1 had reduced numbers of lung macrophages compared to wild type 
(Wiktor-Jedrzejczak et al., 1992) while Gmcsf -/- mice displayed impaired lung 
development (Stanley et al., 1994).  Mice deficient in both growth factors however 
displayed a more severe phenotype than mice lacking either growth factor alone 
(Lieschke et al., 1994).  This thesis showed that CSF1 was necessary for maintaining 
the mature AM phenotype.  Thus far, there have been relatively few studies of pig 
GMCSF.  One study highlighted the role of GMCSF in improving the immune 
response to vaccine in pigs and suggested it could a protective role in lung pathology.  
Adenoviral constructs fusing PRRSV proteins with GMCSF resulted in enhanced 
immune response in pigs.  Moreover pigs pre-treated with the constructs then later 
infected with PRRSV had less lung damage than pigs pre-treated with constructs 
expressing only the PRRSV proteins (Wang et al., 2009).  GMCSF was not 
constitutively expressed by the BMDMs examined in this thesis but was induced by 
LPS.  Array data for porcine AMs is currently being analysed in our laboratory and 
will allow the level of expression of GMCSF in lung macrophages to be determined 
(Kapetanovic, unpublished).   
 
As in humans and mice, it is possible to grow “dendritic cells” from pig bone 
marrow in GMCSF (Guzylack-Piriou et al., 2010). In the mouse at least (Mabbott et 
al., 2010), these kinds of cells are largely indistinguishable from macrophages based 
upon their gene expression profile, and should probably be called antigen-presenting 
macrophages. A comparison of pig macrophages, from bone marrow, blood or lung, 
grown in CSF1 or GMCSF will be an interesting future direction to elucidate the 
biological importance of the two factors.  In addition porcine specific anti-CSF1R 
monoclonal antibodies are currently being developed in our laboratory (Gow, 
unpublished) which will allow analysis of expression levels of CSF1R on different 
macrophage populations.   
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Previous studies have shown murine AMs to be dependent upon continuous CSF1 
signaling, (Macdonald et al., 2010; Lenzo et al., 2011).  Similarly murine BMDM 
required exogenous CSF1 for survival although expression of Csf1 mRNA has been 
shown in the inflammatory macrophage population, TEPMs (Irvine et al., 2006).  By 
contrast although freshly-isolated human monocytes did not express CSF1, 
(Biogps.org.info;(Hume and MacDonald, 2011)) differentiated human macrophages 
did produce autocrine CSF1 in culture (Becker et al., 1987). As described in 
Chapter 3, inhibitors against the protein tyrosine kinase activity of the CSF1R or 
anti-CSF1R antibodies have been used to block the actions of CSF1 (Irvine et al., 
2006; Hume and MacDonald, 2011; Macdonald et al., 2010; Lenzo et al., 2011; 
Hashimoto et al., 2011). The anti-CSF1R antibody (M279) selectively depleted 
several tissue macrophage populations, including macrophages from established 
tumours but had no effect on macrophage numbers in the lung or in inflammatory 
models of disease in the mouse (Macdonald et al., 2010).  Macdonald et al. found the 
differentiation of Ly6Chi cells into the more mature Ly6Clo subset to be the only non-
redundant function of CSF1.  Administration of anti-CSF1R antibodies also resulted 
in loss of peritoneal macrophages (Hashimoto et al., 2011; Lenzo et al., 2011; 
Macdonald et al., 2010) although this was most probably due to reduced numbers of 
Ly6Clo circulating monocytes, which are the precursors of mature tissue 
macrophages, rather than direct effects on PMs. Macdonald et al.  (2010) 
demonstrated that in the mouse the two monocyte subsets are almost certainly 
different maturation stages of the same cell and that CSF1 was essential for 
maturation of resident Ly6Chi cells into the more mature Ly6Clo subset and thence to 
tissue macrophages but not for generation of monocytes (Macdonald et al., 2010).  
The development of porcine specific anti-CSF1R antibodies would allow similar 
experiments in the pig to fully understand the role of CSF1 in monocyte/macrophage 
differentiation and the relationship between mononuclear phagocytes from different 
locations. 
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6.4 Species-specific differences in CSF-1 action 
Previous research has shown that the set of CSF1-induced genes in human and 
mouse monocytes differ.  Mouse macrophages exposed to CSF1 induced a set of pro-
inflammatory genes while human macrophages treated in a similar manner instead 
switched on genes associated with atherogenesis and cholesterol biosynthesis (Irvine 
et al., 2009).  The data generated in Chapter 5 partly addresses the position of the 
pig in this spectrum of species-specificity, although the effect of CSF1 deprivation 
and re-stimulation was not explicitly tested.  The mRNA levels of the pro-
atherogenic chemokine CCL2 were expressed at high levels by the rhCSF1-matured 
pig BMDM. Similarly many genes involved in cholesterol biosynthesis (HMGCR, 
MVD, IDI1, FDPS, SQLE, CYP51A1, EBP, NSDHL, DHCR7) were constitutively 
expressed by CSF1 treated porcine BMDM.  Unlike the human macrophages studied 
by Irvine et al. (2009) CSF1-matured porcine BMDM also expressed high mRNA 
levels of the anti-atherogenic chemokine receptor CXCR4.  Although further 
experiments are needed to assess if CSF1 induces similar genes in pigs and humans, 
CSF1 did not prime pig macrophages for production of TNFα (Kapetanovic et al., 
under review) suggesting that CSF1 did not support a pro-inflammatory response as 
has been described in the mouse (Irvine et al., 2009).  Given the ubiquitous use in 
many laboratories of CSF1 to differentiate immature monocytes into macrophages 
further data on its effects on transcription in the pig are required.   
 
Monocytes isolated from the blood or bone marrow and cultured in rhCSF1 
increased expression of CD14, CD16 and CD172a.  Perhaps surprisingly expression 
of CD163 did not increase as monocytes from either blood or bone marrow matured 
into macrophages.  The level of CD163 expression was an important difference 
between the in vitro CSF1-matured macrophages and freshly isolated mature 
macrophages which did express CD163.  CD163 is commonly used as a marker of 
monocyte maturation in the pig (Chamorro et al., 2005; Chamorro et al., 2004; 
Chamorro et al., 2000) and rhCSF1 has been shown to increase levels of CD163 on 
human monocytes (Tippett et al., 2011).  Differences in culture conditions may be 
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responsible for the variation in CD163 expression reported between the CSF1 
matured macrophages described in this study and previous experiments which 
examined CD163 expression on human CSF1 matured macrophages (Tippett et al., 
2011).  The macrophages described in this thesis were adherent and grown on 
bacteriological plastic.  Tippett et al.  (2011) differentiated macrophages in 
suspension cultures in either Teflon pots or polypropylene tubes. Unsurprisingly 
these different culture conditions may have affected the expression of surface 
molecules.  Tippett et al. also permeabilised the monocytes before staining with anti-
CD163 antibodies and found greater increases in CD163 expression after culture in 
CSF1 when comparing total (intracellular and surface) to surface CD163 expression 
alone.  The data presented in this thesis relates purely to surface expression of 
CD163.  Tippett et al. showed  peak CD163 expression occurring after 10 days 
culture in CSF1 with little increase being observed before 5 days.  This thesis only 
measured expression of CD163 in monocytes cultured for up to 7 days culture in 
CSF1.  In addition to using a wider panel of antibodies, future experiments would 
need to examine cells matured in CSF1 over a longer time course.   
 
6.5 Conservation of gene expression in CD14
hi
 
monocyte populations in humans and pigs 
Chapter 4 investigated gene expression in porcine monocyte subsets in the context 
of similar expression data from mice and humans.  This was the first analysis of 
differential gene expression in porcine monocyte populations and provided 
interesting data on possible roles for the populations isolated.  The results also raised 
questions on whether the previously identified porcine subsets could be considered as 
orthologous to human monocyte subsets.  Re-analysis of previous array data from 
human monocyte subsets in Chapter 4 (Ingersoll et al., 2010; Zhao et al., 2009; 
Ancuta et al., 2009) identified a list of genes which were consistently differentially 
expressed between monocyte subsets in man. Expression of many of these genes was 
conserved in pig monocyte subsets.  As discussed above, the main surface marker 
used to distinguish porcine monocytes subsets, CD163, has been shown to be 
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differentially expressed by human monocyte subsets albeit more highly expressed by 
human CD14hiCD16- monocytes (Tippett et al., 2011; Ingersoll et al., 2010).  Porcine 
CD14hiCD163lo monocytes expressed higher levels of pro-inflammatory genes such 
as those belonging to the S100 family and genes involved in control and regulation 
of the immune system such as IL8 and IL18.  Many of these genes were also 
expressed more highly by human CD14hi monocytes suggestive of a specific role for 
CD14hi monocytes in both species in regulating the immune response.  Similarly 
CD14lo monocytes from both species expressed higher levels of genes associated 
with antigen presentation but generally did not appear as closely related as the 
CD14hi subsets.  CD163hi porcine monocytes are commonly referred to as expressing 
low levels of CD14.  Analysis of FACs plots show they actually express only 
marginally lower levels of CD14 than the so called porcine CD14hi population and 
comparison with human FACS plots of CD14 vs CD16 staining suggests the level of 
CD14 expression on porcine CD163hi monocytes (Figure 6.1A population A3) may 
be closer to the human intermediate monocyte subset (Figure 6.1C population P3).  
There appeared to be no true CD14lo monocyte population when looking at CD163+ 
monocytes in the pig.  Interestingly a population of porcine monocytes which 
expressed very low levels of CD14 and did not express either CD16 or CD163 was 
also be seen by FACS analysis (Figure 6.1A, population A1).  The study of 
monocyte subsets in the pig is still in its infancy compared to the vast number of 
experiments carried out on similar monocyte populations in humans and mice.  These 
CD14loCD163- monocytes have never been examined in any previous publications 
and may warrant future investigation as an alternative CD14lo population.  Further 
analysis by FACS and gene expression studies could identify possible functional 





 Chapter 6 




Figure 6-1 comparison of previously identified monocyte subsets in pig and human 
Pig monocytes stained with CD14 and CD163 have been separated into two subsets 
(A),  A2 CD14hiCD163lo and A3 CD14loCD163hi.  There was also a population of 
CD14lo monocytes which did not express CD163(A1).  Isotype control is also shown 
(B).  Human monocytes stained with CD14 and CD16 have been separated into three 
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6.6 Relating gene expression to function 
Perhaps the most unexpected finding from this chapter was the higher expression of 
CCR2 by CD14loCD163hi monocytes.  This is in contrast to what was observed in 
human and mouse monocytes (Ingersoll et al., 2010) and previous reports in the pig 
(Moreno et al., 2010).  There were two probesets specific for CCR2 in the array used 
to determine relative gene expression in the monocyte subsets.  Although average 
expression of both probesets showed higher expression by CD14loCD163hi 
monocytes, one probeset was more highly expressed by CD163hi monocytes and one 
by CD163lo monocytes meaning the relative levels of CCR2 so the data are 
equivocal, and need to be resolved with qRT-PCR or FACS.  Unfortunately the 
porcine CCR2 gene has not been fully annotated and porcine specific anti-CCR2 
antibodies are not commercially available making further investigation of CCR2 
expression at the protein or mRNA level difficult.  Previous studies have relied on 
indirect methods to assess expression of CCR2 (Moreno et al., 2010). Development 
of porcine specific anti-CCR2 antibodies will allow quantitative determination of 
relative expression levels on the cell surface of different cell populations.  Similarly 
expression of CX3CR1 at the protein level has not been reported, porcine specific 
antibodies to CX3CR1 would allow analysis of surface expression of this molecule 
which is differentially expressed on human and mouse monocytes.  Expression of 
CCR2 and CX3CR1 is functionally important for recruitment of monocyte subsets to 
sites of inflammation by CCL2 or CX3CL1 expressing cells.  Porcine anti-CCR2 or 
CX3CR1 antibodies would help identify likely in vivo functions of the populations of 
monocytes which expressed these receptors. 
 
In addition to the subset-specific expression of inflammatory and immune regulatory 
genes by CD14hiCD163lo and antigen presentation related genes by CD14loCD163hi 
monocytes, one of the most differentially-expressed genes in the monocyte subsets 
was Clec7A (Dectin1).  Dectin1 has been shown to function as a co-receptor with 
TLR2 to mediate recognition of mycobacteria (Yadav and Schorey, 2006), zymosan 
(Dillon et al., 2006) and Candida albicans (Ferwerda et al., 2008b).  Dectin1 and 
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CD163 were among the most differentially expressed genes by CD163hi monocytes.  
CD163 is well characterised as a virus receptor for PRRSV and ASF, based upon 
previous studies describing dectin1 working in concert with TLRs in the recognition 
of a range of PAMPS, a role in virus recognition is at last plausible.  Use of anti-
dectin1 antibodies prior to infection with PRRSV would enable determination of the 
role of dectin1 in PRRSV to be assessed.   In addition stimulation of porcine 
macrophages with a specific dectin ligand such as curdlan (beta-1,3-glucan)  in 
combination with a range of TLR ligands such as the TLR4 ligand LPS, the TLR3 
ligand dsRNA or the TLR7/8 ligand ssRNA would highlight possible synergistic 
relationships with other immune receptors in porcine macrophages.   
 
The expectation with studies such as described in Chapter 4 is that differing 
expression of genes will relate to specific functions of each monocyte subset.  The 
increase of a particular monocyte subset in disease, after exercise or in the elderly 
has been described in humans (Allen et al., 1991; Baeten et al., 2000; Blumenstein et 
al., 1997; Fingerle et al., 1993; Kawanaka et al., 2002; Sadeghi et al., 1999; Saleh et 
al., 1995; Seidler et al., 2010; Zimmermann et al., 2010; Steppich et al., 2000). 
Identification of genes which are preferentially expressed by particular subsets is 
desirable in order to either track the relative numbers of that population as a measure 
of disease progression or to identify possible targets to manipulate in order to affect 
disease outcome.  Targeting of specific monocyte subsets to affect disease outcome 
is a promising area for future research (Leuschner et al., 2011) therefore the 
identification of possible target genes shared by multiple species is desirable to allow 
more accurate modelling of human pathologies by animal models. Analysis of 
porcine monocyte subsets is still in its infancy compared to the knowledge 
accumulated on these cell populations in humans and mice.  The pig is already used 
as a model for many inflammatory diseases (discussed in Chapter 1 and (Fairbairn 
et al., 2011)   and the investigation of relative numbers of each monocyte subset in 
already established models could provide important information on the role of 
monocyte subsets in disease in the pig.  Additionally the discovery that mouse Gr1- 
(Auffray et al., 2007) and human CD14dim (Cros et al., 2010) monocytes perform a 
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patrolling function in the blood vasculature raises the question of whether a specific 
monocyte subsets performs this function in the pig.  The large size of pigs already 
provides many benefits over the smaller rodent in allowing easier intervention and 
study of the animals.  Transgenic pigs, for example porcine versions of the 
MacGreen (Sasmono et al., 2003) or CX3CR1gfp (Jung et al., 2000) mice could be 
highly illuminating!  Previous studies of monocyte subsets in the pig have largely 
focused on investigating surface marker expression alone.  The work presented in 
Chapter 4 detailed a fuller examination of the proposed similarities between mouse, 
human and pig monocyte subsets than has been possible previously.  Nevertheless 
examination of expression of differentially expressed genes at the protein level is 
required to validate the gene expression data presented here.   The data presented in 
Chapter 4 identified specific functions likely to be preferentially carried out by 
CD163lo monocytes and it is hoped future experiments will confirm the specific 
functions proposed in this thesis for the CD163lo monocyte subset for instance 
possible interactions between CD14hiCD163lo monocytes and neutrophils or an 
antigen presentation role for CD14loCD163himonocytes. Whether the markers 
presently used to delineate monocyte subsets in the pig are adequate will require 
further investigation as well.  
 
6.7 Cross-species comparisons of the macrophage 
response to LPS 
Chapter 5 detailed the analysis of the porcine BMDM response to LPS, which 
allowed a comparison to similar data for mouse and human macrophages.  As 
expected a large number of genes were regulated by LPS including those involved in 
negative regulation and feedback control (Wells et al., 2005).  For instance a number 
of inhibitory cytokines such as IL1RN were up-regulated by LPS as shown 
previously in other species (Coll and O'Neill, 2010).  The macrophage response to 
LPS in humans and mice is a well studied temporal cascade of inducible transcription 
factors followed by induction of their target genes (Nilsson et al., 2006; Gilchrist et 
al., 2006; Ghisletti et al., 2010).  The data presented in this chapter extended that 
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knowledge to the pig, and identified many inducible transcription factors.  Murine 
BMDMs are one of the most commonly utilised cells in the laboratory but they may 
respond to infectious stimuli rather differently than human macrophage populations 
(Gordon et al., 2001; Fairbairn et al., 2011; Schroder et al., 2012).   Furthermore in 
vitro experiments on human macrophages most often use MDM meaning 
comparisons of the same macrophage populations across species have not previously 
been possible. Comparison of LPS regulated genes in pigs, humans and mice 
identified conservation of some pathways in the pig that were known to be 
differentially expressed between human and mouse macrophages e.g. the Vitamin D3 
pathway and the IDO pathway.  Comparison of LPS-inducible genes, which were 
divergently regulated in human and mice, showed that these genes were induced in 
both pig BMDM and MDM showing the differences previously noted between 
human and mouse macrophages were most likely attributable  to the species rather 
than cell type.  Analysis also showed the human and pig response to LPS appeared to 
involve the adaptive immune system in a way that the mouse response did not with 
induction of a number of lymphocyte regulating cytokines and receptors e.g. CCL20, 
CXCL9, CXCL11, CXCL13, IL7R, IL27R.   Alignment of the promoters of some of 
these genes suggested that divergent regulation most probably occurred at the 
transcription level, the promoters of pig and human genes were much more 
conserved than mouse and human.  Pigs, rodents and humans diverged at 
approximately the same time (Springer et al., 2003; Jorgensen et al., 2005) but 
because of short generation time and large effective population size, the mouse 
branch is considerably longer when one compares DNA sequences. At the sequence 
level pigs and humans are more alike, especially in 5’ and 3’ untranslated and 
flanking sequences (Wernersson et al., 2005). 
 
A striking example of the differing human and mouse response to LPS is the 
induction of NO by murine macrophages.  Human macrophages stimulated in vitro 
do not produce NO nor do they induce transcription of arginase or the arginase 
transporter (CAT2) (Schroder et al., 2012).  This thesis also demonstrated that the 
NO pathway was not activated by LPS in pig BMDM; in addition to an absence of 
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measurable NO, there was no detectable induction of the rate limiting enzyme CAT2. 
The lack of induction in human and pig macrophages of NO raised the interesting 
question of whether biopterin production is an alternative pathway in both species 
utilising the products of the inducible GTP cyclohydrolase, which is induced in both 
species.  There is some evidence biopterin is produced by pigs (Breinekova et al., 
2007; Myers et al., 2003) and the array data showed that the other enzymes needed to 
make tetrahydrobiopterin, the cofactor for NOS2, are expressed at very low levels in 
pig macrophages as they are in humans (biogps.gnf.org, (The FANTOM Consortium 
et al., 2005) and FANTOM5 published data (DAH Personal communication)). In 
summary, like human macrophages, pig macrophages did not produce NO or induce 
transcription of any of the rate limiting steps in the NO pathway when stimulated 
with LPS.  There remains a debate as to whether NOS2 has any function in human 
innate immunity.  The human and pig NOS2 promoter regions are reasonably well-
conserved (Kapetanovic et al manuscript under review).  The pig may therefore 
provide a model to study the function of NOS2, if any, in human immunity, there is 
some evidence that NOS2 may have a role in the macrophage response to 
Mycobacterium tuberculosis in man (Ehrt et al., 2001; Nicholson et al., 1996) and 
some experiments have suggested pigs may produce NO in response to live 
organisms (Benga et al., 2009). 
 
6.8 Future technologies 
Cross-species comparisons always pose difficulties.  When using microarray 
technology the comparative specificity of primers used in each species may not 
always be equal.  This can be overcome by the design of custom arrays which target 
the same part of the gene for each species although newer technologies such as 
CAGE and RNAseq may provide a better solution.  Microarrays limit the search to 
what is known while CAGE and RNAseq detect what is expressed whether it has 
been fully identified on the genome or not.  They can also show expression of genes 
across the species more clearly, for example mouse and human TNFα are not strict 
one-to-one orthologs so would be excluded from a custom designed orthologous 
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array despite fulfilling similar functions and having similar actions in both species.  
Future investigations using CAGE or RNAseq could be used to fully examine key 
differences in the response of murine macrophages to LPS compared to human and 
pig macrophages.  Pig macrophage libraries have been prepared and sequenced in 
our laboratory, and the data will allow comparative analysis of the massive datasets 
of CAGE for humans previously published (Carninci et al., 2006), and currently 
being generated in the FANTOM5 project.  Identifying such differences could lead to 
the discovery of why humans are more susceptible to LPS and provide targets for the 
therapy of sepsis in man, an area where little success has been seen with rodent 
models.   
 
At present one of the major benefits of working on rodents is the large number of 
transgenic animals available. There is a huge genetic diversity already present in the 
porcine population, as in humans, therefore it is likely that some pigs will possess 
natural mutations that make them more or less susceptible to a disease.  Genetic 
diversity among pig breeds may therefore do away with some of the need for 
genetically engineered animals and could allow identification of genes which are 
involved in disease in both men and pigs.  Identification of such naturally occurring 
mutations may lead to animal models which are closer to what occurs in man.  Large 
numbers of apparent null mutations have been seen in pig macrophage RNAseq data 
from Large-White-Landrace F1 animals (unpublished, Dario Beraldi).  Because pigs 
are multiparous, such null mutants identified in an individual animal, could readily 
be bred to homozygosity through brother-sister matings of the progeny.  Hence, it 




Overall the aim of this thesis was to increase our knowledge of transcriptional 
control of macrophage function in the pig and its relationship to infectious disease 
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susceptibility.  It is hoped that the studies described here show some of the ways that 
pigs may address the shortcomings of commonly used mouse models for the study of 
macrophage differentiation and activation in vitro, and the biology of sepsis and 
other pathologies in vivo.  Gene expression analysis studies, such as presented in this 
thesis, provide possible targets for future studies rather than an end in their own 
right.  The regulation of genes in porcine BMDMs must now be studied in more 
detail and these results carried over to functional studies.  For instance IDO 
inhibitors did not show promising results in the pig despite early indication of 
success in mice models.  Induction of IDO is a relatively late response, and might 
conceivably be part of the feedback control rather than an antimicrobial effector.   
Additionally the high induction of genes regulating the adaptive immune system in 
response to LPS in both humans and pigs (e.g. CCL20, CXCL9, CXCL11, CXCL13, 
IL7R, IL27R) provides targets for future experiments to elucidate their role in the 
immune response.  The data presented in this thesis could provide the basis for future 
in vivo work by identifying genes differentially expressed between monocyte subsets 
in the pig or which are important in the pig response to LPS.  Gene studies in pigs 
with sepsis showed that some of the genes which were highly LPS-inducible in pig 
and human macrophages were also up-regulated in sick animals.  Further analysis 
could provide possible targets to manipulate in pursuit of a treatment for sepsis.  
Furthermore the easy availability of different cell populations from within the pig 
will allow the analysis of genes which are specific to particular cell types and may 
perhaps provide an answer to why some populations are more susceptible to certain 
pathogens. The completion of the pig genome and the characterisation of many key 
immune regulators and markers has ensured the value of the pig as a model of human 
immune responses is being increasingly recognised.    
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Chapter 7: Supplementary Information 
 
7.1 Appendix 1 
 
Antibody Concentration Source 
CD14 1:50 MCA1218F (AbD Serotec) 
CD16 1:200 MCA1971PE (AbD Serotec) 
CD163 1:200 MCA2311PE (AbD Serotec) 
CD172a 1:400 4525-09 (Southern Biotech) 
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Name Breed Age 
LWL1 Large White X Landrace 
F1 cross 
8 weeks 
LWL4 Large White X Landrace 
F1 cross 
11 weeks 
LWL5 Large White X Landrace 
F1 cross 
11 weeks 
LAN1 Landrace 7 weeks 
LWLxPIE Large White - Landrace 
F1 cross X Pietrain 
11 weeks 
LWL2 Large White X Landrace 
F1 cross 
9 weeks 
LW2 Large White 6 weeks 
LW3 Large White 7 weeks 
LAN1 Landrace 7 weeks 
Table 7.1-2 Animals used
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Forward primer Reverse primer Amplicon 
size (bp) 
HPRT ACACTGGCAAAACAATGCAA ACACTTCGAGGGGTCCTTTT 103 
CCL20 GGTGCTGCTGCTCTACCTCT GCTGTGTGAAGCCCATGATA 113 
IDO GGTTTCGCTATTGGTGGAAA CTTTTGCAAAGCATCCAGGT 100 
STAT4 GAAAGCCACCTTGGAGGAAT ACAACCGGCCTTTGTTGTAG 100 
LCN2 TCGTGCGTGTGGTGTCTACT ACCTTGGTCCTCCCGTAAAG 109 
NOS2A AGAGCCTCTGGACCTCAACA CTCACAGCAGAGTTCCACCA 136 
GTP CH1 AAGTTCTTGGCCTCAGCAAA TACTCCGACTCCAGCAGGTC 135 
AS CCCTCTACAACGAGGAGCTG TCTGGAGGCGATGATATTCC 117 
CAT2 GCCTCGCAGAGTATCCTGAC ACCCAGCCACCATAACAAAG 150 
AL GCCTGGACAAGGTAGCTGAG GTTCCGACTTCGTCCTGTGT 146 
ARG2 CACCCCTCACCACTTCATCT CAAGGCTTGATCCAGGAAAA 112 
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7.3 Appendix 3 
 
Molecule Function Expression in mice Expression in man References 
CD11a Involved in cellular adhesion through 
its interaction with ICAMS1-3.  
CD11a and CD18 together form 
LFA1 which binds to ICAM1.  
Required for patrolling behaviour of 
monocytes   









Auffray et al., 
2007) 
CD11c Forms complement receptor with 
CD18, often used as a marker for 
DCs 
 









CX3CR1 Fractalkine receptor, required for 
patrolling behaviour of monocytes 
Mast cells, 
macrophages,  
NK cells, DC, T 
cells, macrophages 
(Auffray et al., 
2007) 
CD43 Sialogycoprotein.  Pro and anti 
adhesion, involved in signalling and 
cytoskleetal intercation 





T cell, NK cell, 




(Ostberg et al., 
1998) 
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Molecule Function Expression in 
mice 
Expression in man References 
CD62L Leukocyte specific cell adhesion 
molecule which regulates entry of 
leukocytes to secondary lymphoid 
tissue 
 




T cell, B cell, NK 
cell, macrophage, 
granulocyte 
(Spertini et al., 1991; 
Smith et al., 1991) 
CCR1 G protein coupled receptor.  
Ligands include MIP1α, 








(Kaufmann et al., 
2001) 
CCR2 Ligands include MCP1, involved 
in monocyte recruitment from 




Monocytes, DC (Kaufmann et al., 
2001; Serbina and 
Pamer, 2006) 
     
     
     
Table 7.3-2 Surface markers commonly expressed by human CD14++CD16- and Murine Gr1+ 
monocytes 
LFA1: Lymphocyte function associated antigen 1.  ICAM: Intracellular adhesion 
molecules.  MIP1α: Macrophage inflammatory protein 1 α.  RANTES: regulated on 
activation normal T expressed and secreted protein.  MCP3: Monocyte 
chemoattractant protein 3.  MPIF1: myeloid progenitor inhibitory factor 1.  DC: 
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LWL1 M 3.80 3.00 22.00 2.90 2.70 7.20 9.80 
LWL2 M 2.90 0.90 19.00 3.40 3.50 4.20 15.50 
LWL4 F 3.40 2.70 11.00 2.60 1.50 7.90 7.60 
LWL5 M 4.20 3.90 12.00 3.70 4.20 8.00 10.00 
HAM1 M 7.70 4.60 11.90 6.60 5.40 11.40 8.10 
HAM2 F 5.50 4.50 10.30 5.30 4.30 9.80 7.60 
HAM5 F 2.60 2.20 19.20 1.70 1.70 4.50 4.90 
DUR3 F 2.00 3.00 22.60 2.00 3.50 5.50 13.30 
DUR4 M 5.50 2.80 42.70 5.00 3.00 9.80 8.00 
LW2 F 8.40 4.20 22.10 5.40 5.00 13.14 12.20 
LW3 M 2.40 1.70 28.70 1.90 1.90 5.00 9.30 
LW4 M 2.20 1.90 19.00 1.70 2.00 5.30 5.40 
LW5 F 3.00 1.20 31.30 2.60 1.10 4.20 3.70 
LAN2 F 3.60 2.50 26.00 3.20 2.20 6.80 7.30 
LAN3 F 1.10 1.20 12.50 1.10 0.80 2.70 3.90 
PIE2 F 0.90 0.30 19.30 1.00 0.54 1.50 2.60 
PIE3 M 10.70 8.40 12.80 13.40 5.20 15.40 13.70 
 
Average 4.11 2.88 20.14 3.74 2.86 7.20 8.41 
 
Average for all M 4.93 3.40 21.01 4.83 3.49 
  
 
Average for all F 3.39 2.42 19.37 2.77 2.29 6.23 7.01 
Table 7.4-1 Animals used for study of monocyte populations LWL; Large White x Landrace F1 X, HAM; Hampshire, DUR; Duroc, LW; Large White, LAN; 
Landrace, PIE; Pietrain 
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7.5 Appendix 5 
Table 7.5-1 Go-terms enriched in human CD16+ monocytes 
Category Term Count % PValue 
Annotation Cluster 1         
GOTERM_BP_FAT 
GO:0002683~negative regulation of 
immune system process 7 5.00 9.73E-05 
GOTERM_BP_FAT 
GO:0002695~negative regulation of 
leukocyte activation 6 4.29 1.52E-04 
GOTERM_BP_FAT 
GO:0050866~negative regulation of 
cell activation 6 4.29 2.10E-04 
GOTERM_BP_FAT 
GO:0051250~negative regulation of 
lymphocyte activation 5 3.57 1.36E-03 
GOTERM_BP_FAT 
GO:0070664~negative regulation of 
leukocyte proliferation 4 2.86 2.87E-03 
GOTERM_BP_FAT 
GO:0050672~negative regulation of 
lymphocyte proliferation 4 2.86 2.87E-03 
GOTERM_BP_FAT 
GO:0032945~negative regulation of 
mononuclear cell proliferation 4 2.86 2.87E-03 
GOTERM_BP_FAT 
GO:0002694~regulation of leukocyte 
activation 7 5.00 3.75E-03 
GOTERM_BP_FAT 
GO:0050865~regulation of cell 
activation 7 5.00 4.85E-03 
GOTERM_BP_FAT 
GO:0050868~negative regulation of T 
cell activation 4 2.86 6.22E-03 
GOTERM_BP_FAT 
GO:0050670~regulation of lymphocyte 
proliferation 5 3.57 6.50E-03 
GOTERM_BP_FAT 
GO:0070663~regulation of leukocyte 
proliferation 5 3.57 6.78E-03 
GOTERM_BP_FAT 
GO:0032944~regulation of 
mononuclear cell proliferation 5 3.57 6.78E-03 
GOTERM_BP_FAT 
GO:0051249~regulation of lymphocyte 
activation 6 4.29 1.06E-02 
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GO:0050863~regulation of T cell 
activation 5 3.57 2.08E-02 
GOTERM_BP_FAT 
GO:0042130~negative regulation of T 
cell proliferation 3 2.14 2.41E-02 
     Annotation Cluster 2     
GOTERM_BP_FAT GO:0042981~regulation of apoptosis 20 14.29 9.07E-05 
GOTERM_BP_FAT 
GO:0043067~regulation of 
programmed cell death 20 14.29 1.03E-04 
GOTERM_BP_FAT GO:0010941~regulation of cell death 20 14.29 1.08E-04 
GOTERM_BP_FAT 
GO:0042035~regulation of cytokine 
biosynthetic process 6 4.29 5.19E-04 
GOTERM_BP_FAT GO:0006917~induction of apoptosis 11 7.86 5.93E-04 
GOTERM_BP_FAT 
GO:0012502~induction of 
programmed cell death 11 7.86 6.07E-04 
GOTERM_BP_FAT 
GO:0042108~positive regulation of 
cytokine biosynthetic process 5 3.57 8.74E-04 
GOTERM_BP_FAT 
GO:0043065~positive regulation of 
apoptosis 12 8.57 1.63E-03 
GOTERM_BP_FAT 
GO:0043068~positive regulation of 
programmed cell death 12 8.57 1.72E-03 
GOTERM_BP_FAT 
GO:0010942~positive regulation of cell 
death 12 8.57 1.79E-03 
GOTERM_BP_FAT 
GO:0010557~positive regulation of 
macromolecule biosynthetic process 13 9.29 1.41E-02 
GOTERM_BP_FAT 
GO:0043066~negative regulation of 
apoptosis 9 6.43 1.42E-02 
GOTERM_BP_FAT 
GO:0043069~negative regulation of 
programmed cell death 9 6.43 1.53E-02 
GOTERM_BP_FAT 
GO:0060548~negative regulation of 
cell death 9 6.43 1.55E-02 
GOTERM_BP_FAT 
GO:0001817~regulation of cytokine 
6 4.29 2.32E-02 
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     Annotation Cluster 3     
Category Term Count % PValue 
GOTERM_CC_FAT GO:0044459~plasma membrane part 33 23.57 1.64E-03 
GOTERM_CC_FAT 
GO:0005887~integral to plasma 
membrane 20 14.29 6.47E-03 
GOTERM_CC_FAT 
GO:0031226~intrinsic to plasma 
membrane 20 14.29 8.18E-03 
GOTERM_BP_FAT 
GO:0007166~cell surface receptor 
linked signal transduction 25 17.86 3.83E-02 
     Annotation Cluster 4     
Category Term Count % PValue 
GOTERM_BP_FAT GO:0006952~defense response 14 10.00 3.38E-03 
GOTERM_BP_FAT GO:0009611~response to wounding 12 8.57 7.89E-03 
GOTERM_BP_FAT GO:0006954~inflammatory response 9 6.43 8.77E-03 
     Annotation Cluster 5     
Category Term Count % PValue 
GOTERM_CC_FAT GO:0000267~cell fraction 20 14.29 2.35E-03 
GOTERM_CC_FAT GO:0019717~synaptosome 5 3.57 6.36E-03 
GOTERM_CC_FAT GO:0045202~synapse 8 5.71 3.50E-02 
GOTERM_CC_FAT GO:0005626~insoluble fraction 13 9.29 5.99E-02 
GOTERM_CC_FAT GO:0005624~membrane fraction 12 8.57 9.24E-02 
     Annotation Cluster 6     
Category Term Count % PValue 
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GO:0042035~regulation of cytokine 
biosynthetic process 6 4.29 5.19E-04 
GOTERM_BP_FAT 
GO:0042108~positive regulation of 
cytokine biosynthetic process 5 3.57 8.74E-04 
GOTERM_BP_FAT 
GO:0009967~positive regulation of 
signal transduction 9 6.43 4.99E-03 
GOTERM_BP_FAT 
GO:0010647~positive regulation of cell 
communication 9 6.43 9.40E-03 
GOTERM_BP_FAT 
GO:0043123~positive regulation of I-
kappaB kinase/NF-kappaB cascade 5 3.57 1.11E-02 
GOTERM_BP_FAT 
GO:0051048~negative regulation of 
secretion 4 2.86 1.31E-02 
GOTERM_BP_FAT 
GO:0043122~regulation of I-kappaB 
kinase/NF-kappaB cascade 5 3.57 1.55E-02 
GOTERM_BP_FAT 
GO:0010740~positive regulation of 
protein kinase cascade 6 4.29 1.71E-02 
GOTERM_BP_FAT 
GO:0001817~regulation of cytokine 
production 6 4.29 2.32E-02 
GOTERM_BP_FAT 
GO:0010627~regulation of protein 
kinase cascade 7 5.00 2.44E-02 
GOTERM_BP_FAT 
GO:0051051~negative regulation of 
transport 5 3.57 3.29E-02 
     Annotation Cluster 7     
Category Term Count % PValue 
GOTERM_BP_FAT GO:0045087~innate immune response 6 4.29 7.95E-03 
GOTERM_BP_FAT GO:0006954~inflammatory response 9 6.43 8.77E-03 
GOTERM_BP_FAT 
GO:0002449~lymphocyte mediated 
immunity 4 2.86 2.48E-02 
GOTERM_BP_FAT 
GO:0006958~complement activation, 
classical pathway 3 2.14 2.75E-02 
GOTERM_BP_FAT GO:0002455~humoral immune 
response mediated by circulating 
3 2.14 3.12E-02 
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response 4 2.86 3.38E-02 
GOTERM_BP_FAT 
GO:0002443~leukocyte mediated 
immunity 4 2.86 4.18E-02 
GOTERM_BP_FAT GO:0006956~complement activation 3 2.14 5.42E-02 
GOTERM_BP_FAT 
GO:0002541~activation of plasma 
proteins involved in acute 
inflammatory response 3 2.14 5.65E-02 
GOTERM_BP_FAT 
GO:0002526~acute inflammatory 
response 4 2.86 5.76E-02 
GOTERM_BP_FAT 
GO:0016064~immunoglobulin 
mediated immune response 3 2.14 8.41E-02 
GOTERM_BP_FAT 
GO:0019724~B cell mediated 
immunity 3 2.14 8.95E-02 
     Annotation Cluster 8     
Category Term Count % PValue 
GOTERM_MF_FAT GO:0019955~cytokine binding 5 3.57 1.29E-02 
GOTERM_MF_FAT GO:0004896~cytokine receptor activity 3 2.14 7.66E-02 
     Annotation Cluster 9     
Category Term Count % PValue 
GOTERM_CC_FAT GO:0005615~extracellular space 14 10.00 6.36E-03 
GOTERM_BP_FAT 
GO:0048534~hemopoietic or lymphoid 
organ development 8 5.71 8.82E-03 
GOTERM_BP_FAT 
GO:0002520~immune system 
development 8 5.71 1.20E-02 
GOTERM_CC_FAT GO:0044421~extracellular region part 15 10.71 3.81E-02 
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Annotation Cluster 10         
Category Term Count % PValue 
GOTERM_BP_FAT 
GO:0008284~positive regulation of cell 
proliferation 11 7.86 3.99E-03 
GOTERM_BP_FAT 
GO:0048534~hemopoietic or lymphoid 
organ development 8 5.71 8.82E-03 
 
Table 7.5-2 Go-terms enriched in human CD16+ monocytes 
Category Term Count % PValue 
Annotation Cluster 1         
GOTERM_CC_FAT GO:0031224~intrinsic to membrane 66 51.16 6.21E-04 
GOTERM_CC_FAT GO:0016021~integral to membrane 64 49.61 7.74E-04 
     
Annotation Cluster 2         
GOTERM_CC_FAT GO:0005576~extracellular region 35 27.13 5.81E-05 
GOTERM_CC_FAT GO:0005615~extracellular space 18 13.95 8.19E-05 
GOTERM_CC_FAT GO:0044421~extracellular region 
part 
21 16.28 2.03E-04 
     
Annotation Cluster 3         
GOTERM_CC_FAT GO:0005887~integral to plasma 
membrane 
25 19.38 6.76E-05 
GOTERM_CC_FAT GO:0031226~intrinsic to plasma 
membrane 
25 19.38 9.63E-05 
GOTERM_CC_FAT GO:0005886~plasma membrane 51 39.53 3.72E-04 
GOTERM_CC_FAT GO:0044459~plasma membrane part 32 24.81 3.29E-03 
     
Annotation Cluster 4         
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GOTERM_MF_FAT GO:0030246~carbohydrate binding 13 10.08 1.89E-05 
GOTERM_MF_FAT GO:0005529~sugar binding 8 6.20 8.10E-04 
     
Annotation Cluster 5         
GOTERM_BP_FAT GO:0042060~wound healing 13 10.08 5.72E-08 
GOTERM_BP_FAT GO:0007599~hemostasis 7 5.43 2.71E-04 
GOTERM_CC_FAT GO:0030141~secretory granule 8 6.20 9.70E-04 
GOTERM_BP_FAT GO:0050878~regulation of body fluid 
levels 
7 5.43 1.12E-03 
GOTERM_CC_FAT GO:0031091~platelet alpha granule 5 3.88 1.40E-03 
GOTERM_BP_FAT GO:0007596~blood coagulation 6 4.65 1.57E-03 
GOTERM_BP_FAT GO:0050817~coagulation 6 4.65 1.57E-03 
GOTERM_CC_FAT GO:0044433~cytoplasmic vesicle part 5 3.88 7.99E-02 
     
Annotation Cluster 6         
GOTERM_BP_FAT GO:0006928~cell motion 15 11.63 3.68E-05 
GOTERM_BP_FAT GO:0042330~taxis 9 6.98 5.39E-05 
GOTERM_BP_FAT GO:0006935~chemotaxis 9 6.98 5.39E-05 
GOTERM_BP_FAT GO:0007626~locomotory behavior 11 8.53 9.07E-05 
GOTERM_BP_FAT GO:0007610~behavior 14 10.85 1.32E-04 
GOTERM_BP_FAT GO:0001525~angiogenesis 8 6.20 2.26E-04 
GOTERM_BP_FAT GO:0051674~localization of cell 11 8.53 2.29E-04 
GOTERM_BP_FAT GO:0048870~cell motility 11 8.53 2.29E-04 
GOTERM_BP_FAT GO:0030593~neutrophil chemotaxis 4 3.10 4.12E-04 
GOTERM_BP_FAT GO:0016477~cell migration 10 7.75 4.72E-04 
GOTERM_BP_FAT GO:0048514~blood vessel 
morphogenesis 
8 6.20 1.85E-03 
 Chapter 7 
Transcriptional control of macrophage function in the pig and its relationship to disease susceptibility 
 
 229 
GOTERM_BP_FAT GO:0030595~leukocyte chemotaxis 4 3.10 3.50E-03 
GOTERM_BP_FAT GO:0060326~cell chemotaxis 4 3.10 4.06E-03 
GOTERM_MF_FAT GO:0005125~cytokine activity 7 5.43 4.14E-03 
GOTERM_BP_FAT GO:0001568~blood vessel 
development 
8 6.20 4.24E-03 
GOTERM_BP_FAT GO:0001944~vasculature 
development 
8 6.20 4.84E-03 
GOTERM_BP_FAT GO:0050900~leukocyte migration 4 3.10 1.17E-02 
GOTERM_BP_FAT GO:0045765~regulation of 
angiogenesis 
3 2.33 9.58E-02 
     
Annotation Cluster 7         
GOTERM_CC_FAT GO:0030141~secretory granule 8 6.20 9.70E-04 
GOTERM_CC_FAT GO:0031988~membrane-bounded 
vesicle 
14 10.85 1.27E-03 
GOTERM_CC_FAT GO:0031091~platelet alpha granule 5 3.88 1.40E-03 
GOTERM_CC_FAT GO:0031982~vesicle 15 11.63 1.95E-03 
GOTERM_CC_FAT GO:0016023~cytoplasmic 
membrane-bounded vesicle 
13 10.08 2.91E-03 
GOTERM_CC_FAT GO:0031410~cytoplasmic vesicle 14 10.85 3.71E-03 
GOTERM_CC_FAT GO:0031983~vesicle lumen 4 3.10 7.38E-03 
GOTERM_CC_FAT GO:0031093~platelet alpha granule 
lumen 
3 2.33 4.92E-02 
GOTERM_CC_FAT GO:0060205~cytoplasmic 
membrane-bounded vesicle lumen 
3 2.33 5.58E-02 
GOTERM_CC_FAT GO:0044433~cytoplasmic vesicle part 5 3.88 7.99E-02 
     
Annotation Cluster 8         
GOTERM_MF_FAT GO:0030246~carbohydrate binding 13 10.08 1.89E-05 
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5 3.88 2.37E-02 
GOTERM_MF_FAT GO:0030247~polysaccharide binding 5 3.88 3.21E-02 
GOTERM_MF_FAT GO:0001871~pattern binding 5 3.88 3.21E-02 
GOTERM_MF_FAT GO:0008201~heparin binding 4 3.10 4.62E-02 
     
Annotation Cluster 9         
GOTERM_CC_FAT GO:0043235~receptor complex 6 4.65 3.37E-03 
GOTERM_BP_FAT GO:0007229~integrin-mediated 
signaling pathway 
4 3.10 2.02E-02 
GOTERM_CC_FAT GO:0008305~integrin complex 3 2.33 2.60E-02 
GOTERM_CC_FAT GO:0009986~cell surface 7 5.43 8.25E-02 
     
Annotation Cluster 10         
GOTERM_BP_FAT GO:0048878~chemical homeostasis 12 9.30 3.42E-03 
GOTERM_BP_FAT GO:0042592~homeostatic process 15 11.63 3.58E-03 
GOTERM_BP_FAT GO:0019725~cellular homeostasis 11 8.53 5.26E-03 
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7.6 Appendix 6 
Table 7.6-1 Go-terms enriched in porcine CD163+ monocytes 
Category Term Count % PValue 
Annotation Cluster 1         
GOTERM_CC_FAT GO:0005739~mitochondrion 189 13.52 
3.94E-
26 
GOTERM_CC_FAT GO:0044429~mitochondrial part 115 8.23 
2.36E-
19 
GOTERM_CC_FAT GO:0031980~mitochondrial lumen 46 3.29 
9.80E-
09 
GOTERM_CC_FAT GO:0005759~mitochondrial matrix 46 3.29 
9.80E-
09 
     Annotation Cluster 2     





complex 112 8.01 
4.91E-
23 










elongation 39 2.79 
1.86E-
17 
GOTERM_CC_FAT GO:0033279~ribosomal subunit 41 2.93 
1.78E-
14 
GOTERM_CC_FAT GO:0044445~cytosolic part 45 3.22 
1.93E-
14 





subunit 21 1.50 
4.78E-
08 
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activity 73 5.22 
3.77E-
04 
     Annotation Cluster 3     
GOTERM_CC_FAT GO:0005739~mitochondrion 189 13.52 
3.94E-
26 
GOTERM_CC_FAT GO:0044429~mitochondrial part 115 8.23 
2.36E-
19 






























membrane 67 4.79 
5.34E-
14 
GOTERM_CC_FAT GO:0031967~organelle envelope 105 7.51 
1.59E-
13 
GOTERM_CC_FAT GO:0031975~envelope 105 7.51 
1.97E-
13 
GOTERM_BP_FAT GO:0045333~cellular respiration 31 2.22 
1.77E-
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GO:0015980~energy derivation by 




















electron transport, NADH to 




GO:0042773~ATP synthesis coupled 





synthesis coupled electron 
transport 17 1.22 
3.04E-
06 





activity, acting on NADH or NADPH, 
quinone or similar compound as 
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respiratory chain complex I 05 















activity 13 0.93 
5.98E-
05 
          
Annotation Cluster 4         
GOTERM_BP_FAT GO:0046907~intracellular transport 102 7.30 
8.86E-
12 




















localization 69 4.94 
1.21E-
09 
GOTERM_BP_FAT GO:0008104~protein localization 115 8.23 
1.77E-
08 
GOTERM_BP_FAT GO:0006605~protein targeting 37 2.65 
7.56E-
06 
     Annotation Cluster 5     
GOTERM_CC_FAT 
GO:0031974~membrane-enclosed 
lumen 232 16.60 
4.28E-
13 
GOTERM_CC_FAT GO:0043233~organelle lumen 225 16.09 
3.49E-
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lumen 219 15.67 
1.21E-
11 
GOTERM_CC_FAT GO:0005730~nucleolus 86 6.15 
5.50E-
05 
GOTERM_CC_FAT GO:0031981~nuclear lumen 155 11.09 
1.06E-
04 
GOTERM_CC_FAT GO:0005654~nucleoplasm 83 5.94 
8.44E-
02 
     Annotation Cluster 6     
GOTERM_CC_FAT GO:0048770~pigment granule 30 2.15 
2.27E-
11 










membrane-bounded vesicle 75 5.36 
5.85E-
06 
GOTERM_CC_FAT GO:0031410~cytoplasmic vesicle 84 6.01 
7.56E-
06 
GOTERM_CC_FAT GO:0031982~vesicle 86 6.15 
1.22E-
05 
     Annotation Cluster 7     
GOTERM_BP_FAT GO:0006396~RNA processing 84 6.01 
1.33E-
09 
GOTERM_BP_FAT GO:0008380~RNA splicing 52 3.72 
9.46E-
09 





process 59 4.22 
1.43E-
07 
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GO:0000377~RNA splicing, via 
transesterification reactions with 




GO:0000375~RNA splicing, via 
transesterification reactions 32 2.29 
5.26E-
07 
GOTERM_CC_FAT GO:0005681~spliceosome 27 1.93 
1.44E-
05 
     Annotation Cluster 8     





binding 26 1.86 
1.36E-
06 
     Annotation Cluster 9     




GO:0015980~energy derivation by 
oxidation of organic compounds 35 2.50 
2.59E-
09 















process 12 0.86 
3.09E-
07 





process 13 0.93 
1.47E-
06 
 Chapter 7 















metabolic process 10 0.72 
8.36E-
04 
     Annotation Cluster 
10         
GOTERM_BP_FAT 
GO:0022613~ribonucleoprotein 
complex biogenesis 42 3.00 
1.97E-
10 





process 22 1.57 
1.02E-
05 





process 36 2.58 
7.93E-
05 




Table 7.6-2 Go-terms enriched in porcine CD163- monocytes 
Category Term Count % PValue 
Annotation Cluster 1         
GOTERM_BP_FAT GO:0045321~leukocyte activation 45 4.46 
5.64E-
13 
GOTERM_BP_FAT GO:0001775~cell activation 48 4.75 
4.57E-
12 
GOTERM_BP_FAT GO:0046649~lymphocyte activation 35 3.47 
1.41E-
09 
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GO:0048534~hemopoietic or lymphoid 





development 40 3.96 
2.32E-
08 
GOTERM_BP_FAT GO:0030097~hemopoiesis 36 3.56 
3.58E-
08 
GOTERM_BP_FAT GO:0002521~leukocyte differentiation 25 2.48 
9.58E-
08 
GOTERM_BP_FAT GO:0030217~T cell differentiation 15 1.49 
6.46E-
06 
GOTERM_BP_FAT GO:0030098~lymphocyte differentiation 19 1.88 
7.62E-
06 
     Annotation Cluster 2 Enrichment Score: 5.44368698644761    
GOTERM_MF_FAT 
GO:0030528~transcription regulator 
activity 130 12.87 
6.35E-
09 




GO:0006357~regulation of transcription 




GO:0045941~positive regulation of 




GO:0010628~positive regulation of gene 




GO:0045935~positive regulation of 
nucleobase, nucleoside, nucleotide and 




GO:0051173~positive regulation of 
nitrogen compound metabolic process 62 6.14 
8.35E-
06 
GOTERM_BP_FAT GO:0006350~transcription 152 15.05 
4.63E-
05 
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GO:0006355~regulation of transcription, 
DNA-dependent 126 12.48 
5.50E-
04 




GO:0051252~regulation of RNA 
metabolic process 127 12.57 
8.94E-
04 
     Annotation Cluster 3 Enrichment Score: 5.428658183492806    
GOTERM_BP_FAT 
GO:0010557~positive regulation of 




GO:0010604~positive regulation of 




GO:0009891~positive regulation of 




GO:0031328~positive regulation of 




GO:0006357~regulation of transcription 




GO:0045941~positive regulation of 




GO:0010628~positive regulation of gene 




GO:0045935~positive regulation of 
nucleobase, nucleoside, nucleotide and 




GO:0051173~positive regulation of 




GO:0045944~positive regulation of 
transcription from RNA polymerase II 




GO:0045893~positive regulation of 
transcription, DNA-dependent 44 4.36 
5.31E-
04 
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GO:0051254~positive regulation of RNA 
metabolic process 44 4.36 
6.27E-
04 
     Annotation Cluster 4 Enrichment Score: 5.269221617369486    
GOTERM_BP_FAT GO:0006954~inflammatory response 41 4.06 
6.69E-
07 
GOTERM_BP_FAT GO:0006952~defense response 62 6.14 
1.94E-
06 
GOTERM_BP_FAT GO:0009611~response to wounding 50 4.95 
1.20E-
04 
     Annotation Cluster 5 Enrichment Score: 4.793189227096972    
GOTERM_BP_FAT 
GO:0043067~regulation of programmed 
cell death 81 8.02 
5.60E-
08 
GOTERM_BP_FAT GO:0010941~regulation of cell death 81 8.02 
6.67E-
08 




GO:0043065~positive regulation of 




GO:0043068~positive regulation of 




GO:0010942~positive regulation of cell 
death 49 4.85 
1.33E-
06 




GO:0012502~induction of programmed 




GO:0043069~negative regulation of 




GO:0060548~negative regulation of cell 




GO:0043066~negative regulation of 
33 3.27 
2.50E-
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GOTERM_BP_FAT GO:0006916~anti-apoptosis 18 1.78 
4.94E-
02 
     Annotation Cluster 6 Enrichment Score: 4.362997933144974    
GOTERM_MF_FAT 
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